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ABSTRACT
The results of this investigation 
demonstrated that antibody production in MAK 33 cells 
was not growth dependent suggesting that antibody 
synthesis could be maintained in the absence of cell 
division. The inhibition of cell growth with specific 
inhibitors of DNA synthesis enhanced the cell specific 
antibody production rate (CSAPR). Studies on the 
metabolism of MAK 33 cells under growth inhibited 
conditions showed that the rise in CSAPR was 
correlated with the rise in intracellular ATP 
concentration and the increase in the uptake rates of 
glucose and glutamine. These results suggested that one 
of the key factors initiating the rise in CSAPR was the 
increase in the availability of ATP for antibody 
synthesis. The rise in intracellular ATP concentration 
was proposed to be a consequence of the following 
changes in cell metabolism;
1. Increase in anaerobic glycolysis demonstrated by a 
concurrent rise in glucose consumption and lactate 
production.
2. The salvage of energy normally utilised in the 
processes pertaining to cell division (DNA synthesis 
and mitosis).
Also as part of this investigation a 
screening assay was developed which could identify 
compounds with the potential to arrest cell division
via the inhibition of DNA synthesis without impairing 
antibody synthesis. Upon the application of some of the 
compounds identified by the screening assay to 0.5 
litre stirrer cultures, it was discovered that both 
CSAPR and antibody yield could be enhanced if growth 
was arrested in mid-exponential phase. These results 
demonstrated that antibody yield of a batch culture was 
a function of both viable cell number and CSAPR. Both 
parameters should be considered with equal importance 
when designing production strategies intended to 
improve the antibody yield.
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CHAPTER 1 
INTRODUCTION
1.1 Brief history of antibodies
Antibodies were detected as early as the 1890’s 
in the serum of previously immunised animals. Their 
interaction with antigens during this early period was 
proposed to be analogous to the 'lock-and-key' theory 
(Ehrlich, 1906 ) of e n z y m e - substrate interaction 
postulated by Emil Fischer (1894). However, detailed 
studies on the interaction between antigen and 
antibodies later led to the discovery that both 
molecules were multivalent in nature (Marrack, 1934, 
1939; Heidelberger, 1935, 1939). The idea that antibody 
molecules were structurally complementary to the 
immunising antigens was proposed by a group of workers 
in the 1930's (Breinl and Haurowitz, 1930; Mudd, 1932). 
The chemical principles involved in the interaction 
between antibody and antigen was clarified by Hooker 
(1937) and Pauling et al. (1943).
The understanding of the structural basis of 
antibody specificity as we know it today was 
provided by Landsteiner (1945). He raised a panel of 
antibodies to simple hapten molecules of chemical 
diversity and subsequently demonstrated their 
specificity for them. This contributed to the 
postulation of the ’instructionist theory' which stated 
that antigens somehow 'instruct' the specificity of
antibodies by providing some sort of template. This 
theory was refuted as information began to accumulate 
about the genetic control of protein synthesis in the 
early 1950’s.
Nils Jerne in 1955 proposed that antibodies 
pre-existed in B-lymphocytes and required stimulation 
from the antigen to secrete the specific antibody. 
Although Jerne's postulate was not quite correct it did 
provide the platform for Burnet's clonal selection 
theory (Burnet, 1957) which is widely accepted today as 
being correct in the light of experimental evidence 
generated within the frame work of modern genetics. He 
suggested that each lymphocyte had a unique receptor 
specificity and was thus precommitted to making only 
one antibody after appropriate stimulation.
Also during this period, other workers (Franklin 
and Kunkel, 1957) were demonstrating that antibodies 
could be separated as gamma-globulin fractions from 
normal serum by electrophoresis. This in conjunction 
with the discovery of the close homology of myeloma 
proteins with gamma-globulins allowed detailed studies 
to be performed on the structure of antibody molecules. 
Consequently it became apparent that antibodies of 
various size and shapes existed, all of which today are 
grouped into five families: IgG, IgM, IgE, IgD, and 
IgA.
Although by the early 1970's much was already
known about the close relation between the structure 
and function of antibodies (Pressman, 1973; Clark, 
1983; Coding, 1986) further studies were impaired by 
the lack of appropriate technology. The production of 
highly specific antisera was considered difficult and 
unreliable. The uncertainties about the specificity of 
individual antisera led to many prolonged and 
acrimonious debates. All this changed with the 
introduction of a new technology which allowed the 
production of monclonal antibodies (see below) (Kohler 
and Milstein, 1975). It is now possible to produce 
unlimited quantities of specific antibodies against 
virtually any molecule regardless of the purity of the 
immunising antigen.
1.2 Monoclonal antibodies
When the outer defence mechanisms of a body are 
breached by an immunogenic substance (chemical or 
biological) an immune response is mounted and 
antibodies are raised as a consequence. The antibody 
response to an antigen is highly heterogenous due to 
the presence of many antigenic determinants on any one 
antigen. Each antigen initiates the formation of a 
complementary but diverse set of specific antibodies 
each of which is different in that it reacts primarily 
with only one determinant on the antigen. The specific 
antibodies arise from expanded single clones of 
B-derived plasma cells (Burnet, 1957) and therefore
are termed MONOCLONAL ANTIBODIES.
Burnet's proposal of the monoclonality of antibody 
was experimentally confirmed by Nossel and Lederberg in 
1958. They showed that a single rat B-lymphocyte 
immunised with two antigens made antibodies to either 
one antigen or the other but not both. This was 
followed by the elucidation of the epitope specificity 
of proteins secreted by diseased myeloma in the 
1 9 6 0 's, thus permitting detailed studies on the 
structure, function and monoclonality of antibodies to 
be carried out (Porter, 1967; Edelman, 1970). Also 
during this period the development of methods to induce 
myeloma in mice (Potter and Boyce, 1962) and the 
establishment of several myeloma cell lines (Horibata 
and Harris, 1970) made a significant contribution to 
the production of hybridomas pioneered by Kohler and 
Milstein (1975),
1.3 Hybridoma Technology
1,3.1 History of hybridoma production
Hybridomas are hybrid cells resulting from the 
fusion between myelomas and lymphoid cells (B or T 
cell). Before the advent of hybridoma technology 
experiments were carried out with mouse and rat myeloma 
cells fused with inactivated sendai virus for the 
purpose of studying the expression of immunoglobulin 
genes (Cotton and Milstein, 1973). In this case
analysis showed that immunoglobulins of both parent 
cells were produced by the hybrid cells. This 
observation was confirmed by Schwaber and Cohen (1974) 
who fused myeloma cells with human peripheral blood 
cells. In 1975, Kohler and Milstein further developed 
the technology and demonstrated the potential of 
monoclonal antibodies for use in research. Shortly 
after that the use of sendai virus as a fusogenic agent 
was superseded by polyethylene glycol (PEG) (Davidson 
et al., 1976) and more recently reports of a new 
method, electrofusion, have claimed to further improve 
the fusion efficiency (Zimmermann et al., 1985; Van 
Duijn et al., 1989).
1.3.2 Principle of monoclonal antibody production
Detailed description of the current protocol 
utilized for the production of hybridomas are found in 
several books and reviews (Coding, 1980; Campbell, 
1984; Epstein and Epstein, 1986) therefore only the 
basic principle will be outlined below (see Figures 1.1 
and 1.2).
Animals (usually mice) are immunised with the 
antigens to stimulate an immune response. B-lymphocytes 
are then recovered from the spleen of these hosts and 
fused with myeloma cells of a particular type. The 
myeloma partner is deficient in the enzyme 
hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT)
which utilizes hypoxanthine and guanine to
synthesize purines via the salvage pathway in the 
absence of de novo synthesis. Cells lacking this enzyme 
will die in the presence of aminopterin, a folate 
antagonist, which inhibits de novo synthesis of purine 
and pyrimidines. Normal B-cells which possess HGPRT and 
thymidine kinase (TK) can synthesize purines (from 
hypoxanthine) and pyrimidines (from thymidine) but are 
unable to proliferate In vitro and have a survival rate 
of 3-5 days post culture.
Successful B-cell myeloma fusions may therefore be 
selected by their ability to proliferate in HAT medium 
which contains hypoxanthine, aminopterin, and thymidine 
(Littlefield, 1964). Antibody production by hybridomas 
is screened between 7-21 days post fusion either with a 
specific enzyme linked immunosorbent assay (ELISA) or 
immunofluorescence. Positive cells are cloned and 
expanded as early as possible. Retention of these 
clones is governed by the following characteristics: 
(1) high antibody productivity, (2) stable antibody 
productivity, and (3) high antibody specificity.
Figure 1.1 : The involvement of HAT selection in
purine and pyrimidine biosynthesis.
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Figure 1.2 : A schematic representation of the steps in 
making a monoclonal antibody by hybridoma technology.
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1.4 Applications of monoclonal antibodies
Polyclonal antisera are being replaced in many 
applications by monoclonal antibodies primarily due to 
the points discussed below. Polyclonal antisera, 
however, will always be important not only because 
they are simple and relatively cheap to produce but 
also because of their useful functional properties 
which arise from their oligoclonality.
Advantages of monoclonal antibodies
1. The antigen binding site on monoclonal antibodies is 
uniform in its specificity and affinity in contrast to 
a specific antiserum which is composed of a mixed 
population of antibodies of different affinities and 
specificities.
2. Unlimited quantities of a particular monoclonal 
antibody can be produced, all the molecules of which 
demonstrate structural and functional consistency. This 
is in sharp contrast to the properties of an 
antiserum which may vary considerably from animal to 
animal and between bleedings of the same animal.
3. Monoclonal antibodies can be prepared by immunising 
animals with relatively impure antigen preparations 
because cells producing the desired antibody can be 
selected after cloning. This is not possible when 
raising antisera because an antigen preparation of the 
highest purity is required to ensure that the greatest 
proportion of antibodies are directed towards the
desired epitopes.
The significance of monoclonal antibodies in 
research development is demonstrated by their broad 
application to science. Only a brief overview of this 
is presented here.
1.4.1 Cancer diagnosis and therapy
Despite the progress in instrumentation during the 
1980's there still remained a need for reagents to 
detect and treat cancerous abnormalities In vivo. 
Monoclonal antibodies with their remarkable specificity 
have met these needs. Using isotopically labelled 
antibodies raised to tumour specific antigens it is 
possible to produce images of tumours in vivo 
(Buchegger et al., 1983). Furthermore, once tumours are 
identified they can be treated using target- 
directed drug therapy. For example, monoclonal 
antibodies specific for tumour-associated antigens 
conjugated to powerful toxins will selectively destroy 
cells bearing those antigens (Youle and Neville, 1980; 
Miller, 1982; Vitetta et al., 1987). Further studies on 
the efficacy of isotope-labelled antibodies in tumour 
therapy are under way (Byers and Baldwin, 1988).
A new approach to cancer therapy has been the 
raising of anti-idiotypic monoclonal antibodies which 
resemble the conformation of tumour associated 
antigens. These antibodies therefore have the potential 
to act as immunogens and could be used as vaccines to
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confer protection against specific cancers (Lowder et 
al., 1987; Byers and Baldwin, 1988).
1.4.2 Applications in immunology
The unique properties of monoclonal antibodies 
have contributed enormously to the delineation of 
closely related cell types such as lymphocytes (Talle 
et al., 1983) and subsequently have enabled 
the identification of many immunological disorders 
(Cahill and McDevitt, 1981). This has made feasible 
routine tests for blood grouping (Voak and Lennox, 
1983) and tissue typing, prior to organ transplantation 
(Parham and Bodmer, 1978), to be accomplished with 
relative ease. Further more the removal of tumour cells 
from autologous bone marrow transplants (Bast et al., 
1983) and T-cells from donor marrow (Vallera et al., 
1982; Kernan et al., 1988) can be successfully achieved 
by target-directed drug therapy utilizing toxins 
conjugated to monoclonal antibodies. The formation 
of new monoclonal antibodies to immunological material 
is continually breaching the limits of the recognition 
and treatment of immunological disorders. These are 
reviewed extensively elsewhere (Mizrahi, 1989).
1.4.3 The diagnosis and treatment of infectious agents
Conventional methods of isolation followed by 
identification of pathogenic microorganisms are being 
gradually superseded by serological and immunological
11
tests utilizing monoclonal antibodies. Previous 
difficulties in detecting microbes from clinical 
specimens, particularly viruses, are now being overcome 
as exemplified by the marked improvement in the 
detection of hepatitis B virus in blood prior 
to transfusion (Wands et al., 1981; Locasciulli et al.,
1986) and V. cholerae by slide agglutination 
(Gustafsson, 1984).
The wide panel of monoclonal antibodies developed 
to a multitude of pathogens, has provided 
epidemiologist's with an effective means of monitoring 
disease outbreaks (Gerhard and Webster, 1978), 
Necessary clinical trials for passive immunisation of 
animals can be set up rapidly (Dix et al., 1981; 
Sadowski, 1982) which can be valuable in evaluating the 
possibilties of using the same course of action in 
human epidemics. The obvious potential of such 
prophylactic agents has stimulated the generation of 
human monoclonal antibodies to the same pathogens 
(James and Bell, 1987). Active immunisation programmes 
with anti-idiotypic monoclonal antibodies have 
demonstrated encouraging results in rodents (Sack et 
al., 1982).
1.4.4 Protein purification and immunoassays
The application of monoclonal antibodies to the 
principles of protein separation has enabled the 
concentration of large quantities of biological
12
substances of commercial importance from impure 
material. Hepatitis B surface antigen (Spier, 1983) and 
Interferon (Secher and Barke, 1980) are two examples of 
valuable proteins being separated on an industrial 
scale by immunoaffinity chromatography from heavily 
contaminated materials. But the greatest impact by far 
of mononclonal antibodies has been on the 
development of diagnostic kits. Immunoassays such as 
Radioimmunoassay (RIA) and Enzyme linked immunosorbent 
assay (ELISA) (Nowinski et al., 1983) utilize the 
specificity of monoclonal antibodies to detect nanogram 
quantities of biological or chemical substances. The 
scope offered by immunoassays to medical and research 
laboratories is limitless. This is demonstrated by the 
broad spectrum of diagnostic kits on sale by large 
companies such as Boehringer Mannheim GmbH, Amersham 
Int. and Sigma Ltd.
Based on several recent market reports, it has 
been estimated that the world immunodiagnostic market 
has a volume of about U.S. $ 1.5 billion per year. 
This large market which has increased in the past 10 
years by more than 100% indicates a growing interest on 
the part of many laboratories at both research 
institutions as well as commercial companies (Mizrahi, 
1989). Such growing demand alone warrants research for 
the optimisation of processes involved in producing 
monoclonal antibodies.
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1.5 Large-scale production of monoclonal antibodies
Hybridomas can be cultured in vivo as tumours in 
the peritoneal cavities of immunodeficient mice or 
in vitro in culture vessels (flasks, bottles or 
fermentors). A single mouse may produce 5-15ml of 
ascites fluid containing 5-15mg of antibody per ml, 
(Kennett et al., 1980), before succumbing to the tumour 
(Hurrel, 1982). The productivity in vitro is small in 
comparison and ranges from 20-200ug of antibody per ml 
in suspension culture (Reuveny et al., 1985). However 
monoclonal antibody production in rodents is 
disadvantageous for numerous reasons:
1. Ascites produced in rodents is contaminated with 
host antibodies and other adventitious agents. This 
makes purification and quality control problematic.
2. Human hybridomas are difficult to propagate in 
rodents.
3. Large-scale cultivation of hybridomas in mice is not 
permitted because of the cruelty it involves. The 
production of 1kg of antibody in mice would require 
20,000 animals (Birch et al., 1985).
The obvious means of circumventing these problems 
was seen to be the development of viable in vitro 
production strategies. To date, three production 
processes are known that utilize a number of 
fermentor designs on industrial scale.
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A. Batch and modified batch cultures
A batch culture is a closed system in which 
hybridomas are inoculated into a fermentor and allowed 
to grow over a period of 4-7 days usually. The culture 
environment is in a state of flux with cells consuming 
the nutrients and releasing cellular wastes into the 
medium concomitantly.
Batch cultures yield the lowest cell densities in 
a given medium which for hybridomas is 1-2x10^ per ml 
(Reuveny et al., 1986a). The antibody productivities 
are also low and vary considerably during the course of 
the culture (Merten et al., 1985; Velez et al., 1986; 
Emery et al., 1987). These variations are essentially a 
consequence of nutrient depletion and toxic 
waste product accumlation (Reuveny et al., 1986), 
[discussed in a latter section].
In the modified batch culture (fed-batch), a 
limiting nutrient or the whole medium is fed 
continuously or intermittently. This in effect reduces 
growth limitation due to nutrient depletion but not 
toxic waste product accummulation (Reuveny et al., 
1986a). Cell densities of 3x10^ per ml (Merten et al., 
1987) and 4-5x10^ per ml (Backer et al., 1986) have 
been reported for this mode of culture. As a result 
of the elevated cell densities antibody titres are 
greatly raised (Backer et al., 1986).
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B . Continuous cultures
Continuous cultures differ from batch and fed- 
batch systems in that they provide an opportunity for 
maintaining steady-state culture conditions by a 
continuous medium feed with a simultaneous removal of 
cell suspension. The steady-state in a continuous 
culture is maintained by controlling the medium flow 
(dilution rate), which determines the specific growth 
rate of the culture. This permits the culture to be 
maintained at a fixed cell density and antibody 
production rate for long periods ( Fazekas de St Groth 
1983; Birch et al., 1985; Ray et al., 1989). Cell 
densities of 2-4x10^ per ml are reported in chemostat 
cultures with a dilution rate of 0.02h~^ (Dean et al.,
1987). At higher dilution rates, 0.025-0.05h“  ^ cell 
densities are much smaller due to cells being washed 
out along with the effluent medium.
Growth limitations experienced in batch culture do 
not affect a continuous culture system because of the 
constant flow of fresh and spent culture medium through 
the system. As a result continuous cultures are more 
cost-effective and productive. Rudge et a l . (1987)
reported that although monoclonal antibody titres were 
similar in both processes, the cost of Ig of antibody 
was estimated to be B326 in batch culture and B225 in 
continuous culture. Another report (Birch et al., 1985) 
stated that an output of 380mg of antibody per day
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could be obtained from a 5L glutamine- 
limited airlift chemostat. A batch fermentor of 
similar working volume would require seven days. 
However, one disadvantage of chemostat cultures is the 
loss of antibody productivity after a certain cell 
doubling as reported by Tharakan et al. (1986) and 
Mizrahi (1989). Therefore cell lines which are stable 
in growth and antibody production are an important 
prerequisite for successful continuous cultures.
C. Perfusion cultures
In a perfusion culture system cells are 
physically retained in the vessel such that continuous 
fresh medium is added while spent medium is removed 
without dilution of the culture (van der Velden-de 
Groot et al., 1987; Velez et al., 1989). The problem of 
growth limitation due to nutrient depletion and toxic 
waste accumulation is therefore not experienced. 
Unlike the chemostat of a continuous culture, the 
cell concentration increases until it becomes limited 
at a very high density due to space limitation. 
Cell densities of 2-5x10^ per ml (Velez et al., 1987; 
Velez et al., 1989) and 10® per ml (Tharakan et al.,
1988) are reported with equally high antibody yields,
0.66g/L/day [390ug/ml] (Reuveny et al., 1986a) and 
1.7g/L/day [950ug/ml] (Velez et al., 1987).
Down stream processesing of antibody is
facilitated by the fact that cells are separated from
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the spent medium in the vessels. However, difficulties 
are experienced in operating special devices for the 
continuous separation of cells from the medium during 
culture maintenance. This is true mainly in homogeneous 
systems in which filters used for this purpose tend to 
clog (Mizrahi, 1989). Hybridoma cultures that produce 
antibodies during stationary phase are particularly 
favoured by a perfusion system coupled with a two stage 
production strategy.
Table 1.1 displays the differences in 
productivities observed for one hybridoma culture 
propagated according to all the processes discussed 
above. Figure 1,3 depicts the principle culture 
characteristics of batch, continuous and perfusion 
systems.
Table 1.1
A B C D
Batch 1.5x10^ 15 80-130
Fed-batch 2x10® 27 220
Semi-continuous 2.5x10® 34 170
Perfusion 2.2x10? 660 390
Key; A: Mode of propagation
B: Maximal cell number per ml 
C: Antibody productivity (mg/L/day) 
D : Antibody titre (ug/ml)
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Figure 1.3 : Principle culture characteristics of (a)
batch, (b) continuous and (c) perfusion culture with 
respect to substrate concentration [#], growth rate 
[x], and cell density [■] (Scheirer, 1988).
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1.5.1 Homogeneous systems for monoclonal antibody 
production
In homogeneous systems, cells are propagated in 
vessels similar to those used in microbial fermentation 
where the cells are grown in suspension. The cells are 
maintained in suspension either by mechanical stirrers 
or sparged air. There are two major types of 
homogeneous reactors which are employed in monoclonal 
antibody production: the stirred tank reactor (Lavery
et al,, 1985; Reuveny et al., 1986; Mazars et al., 
1989; Blasey and Winzer, 1989) and the airlift reactor 
(Birch et al., 1987; Handa et al., 1987).
Although homogeneous systems are amenable to 
scale-up, to date only one 1300L stirred tank reactor 
has been reported for large-scale production of 
monoclonal antibodies (Backer et al., 1988). This may 
be ascribed to the fact that the energy required for 
adequate mixing and mass transfer in these reactors is 
such that hybridoma cell viability is reduced. Although 
sufficient experimental evidence is available to 
support this (Petersen et al., 1988; Papoutsakis and 
Kunas, 1989) a recent report demonstrated that 
some hybridoma cultures are insensitive to shear 
forces even when cultured in 2L stirred tanks at 450rpm 
(Oh et al., 1989). This suggests that different 
hybridoma cultures have differing degrees of 
sensitivity to shear (Smith et al., 1987).
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Even though sparged-air is claimed to cause damage 
to hybridomas in bubble columns (Handa et al., 
1987), non-mechanically mixed reactors may be the 
answer for circumventing the problem of shear-damage by 
stirring. Birch and his colleages (1985a) at 
Celltech have pioneered a lOOOL airlift reactor for 
commercial production of monoclonal antibodies which 
is claimed to produce 150g of antibody in a typical 
run. This fermentor has now been scaled-up to 2000L and 
is used for the production of both monoclonal 
antibodies and recombinant proteins by mammalian cells 
(Rhodes and Birch, 1988).
The concentration of product in a homogeneous 
suspension culture is limited by the maximum cell 
density attainable. The cell density is typically
1-2x10® per ml for hybridomas and the antibody titre 
range is 20-200ug per ml (see for example; Reuveny et 
al., 1985; Birch et al., 1985a). However, cell 
densities can be raised by perfusing the culture with 
fresh medium. This can be achieved in a number of ways. 
Variations of the spin-filter device first described by 
Himmelfarb et al (1969) to concentrate cells have been 
utilized for monoclonal antibody production (van Wezel 
et al., 1985; Tolert et al., 1985; Reuveny et al., 
1986a). These authors have reported hybridoma densities 
of 2-3x10? per ml and antibody titres of 50-500ug per 
ml in the effluent stream. More recently, Brennan and
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his colleagues (1987) have demonstrated a system
that uses tangential flow filtration to separate
hybridoma cells from the waste media. This greatly 
reduces filter blockage experienced when using 
spin-filter devices, such as the caged filter and 
mitigates regular filter replacement for the
maintenance of long term cultures.
1.5.2 Heterogeneous systems for monoclonal antibody 
production
In heterogeneous systems cells are immobilized at 
high concentration in a confined closed chamber under 
non-agitated conditions while growth medium is perfused 
through the growth chamber. These systems are therefore 
not exposed to hydrodynamic stresses experienced in 
agitated systems. However, they are prone to the 
development of concentration gradients of nutrients and 
cellular metabolites across the growth chamber. Because 
these system are operated in perfusion mode high cell 
densities are attainable and downstream processing of 
products is facilitated.
The technology currently employed in the 
immobilization of hybridomas is discussed below.
1. Entrapment of cells
Entrapment of cells was first developed by Lim and 
Sun (1980), for the encapsulation of islet cells, but 
subsequently has been used for the production of other 
biologicals (Jarvis and Gardina, 1983). Basically, the
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procedure involves immobilising cells in spheres which 
permit the diffusion of nutrients to entrapped cells 
and cellular metabolites away from cells. Hybridomas 
have been encapsulated by several soft gels: agarose 
(Scheirer et al,, 1980; Nilsson et al,, 1983; Katinger 
and Scheirer, 1985), alginates (Nilsson and Mosbach, 
1980; Sinacore et ai., 1989), collagen (Karkare et al,, 
1985) and a combination of soft gel/semipermeable 
membrane, for example alginate-polylysine (Duff, 1985).
The cell densities attained in entrapped-cultures 
is much higher than homogeneous suspension cultures. A 
cell density of l-2xl0?/ml can be expected inside 
agarose beads (Nilsson et ai., 1983). However the 
supernatant antibody concentration is comparable to 
that of homogeneous suspension batch cultures [for 
example; lOOug/ml (Bushier, 1984; Nilsson and Mosbach, 
1987)]. This does not apply to hybridomas encapsulated 
in semipermeable membranes in which much higher values 
have been observed for both parameters. Duff (1980) 
reported that after a culture period of 14-21 days 
hybridoma concentration of 5x10® cells were observed 
inside the spheres and an antibody yield of 5-20g 
(5mg/ml intracapsular cone.) from their 40L culture 
vessel. Monoclonal antibody may represent 50% of the 
total intracapsular protein, therefore product recovery 
during downstream processing is improved.
Entrapped hybridoma cells can be cultured in
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either batch or continuous mode, in a variety of 
culture vessels, for example; stirred tanks (Rupp, 
1985), airlift reactors (Familletti et al., 1987), 
fluidized beds (Himmler et al., 1985) and packed bed 
reactors (Lazar et al., 1987; Murdin et al., 1987).
The major disadvantage of such technology is the 
manufacture of sterile spheres which is technically 
complex.
2. Hollow fibre systems
The use of hollow fibres for the cultivation of 
animal cells was first described by Knazek et al 1972 
and subsequently employed for large-scale monoclonal 
antibody production in 1981 (Calabresi et al., 1981). A 
hollow fibre culture unit consists of a bundle of 
fibres mounted inside a cylinder which is potted, 
inside a resin bed, at both ends. Cells are inoculated 
into the extracapillary space and medium is pumped 
through the lumen of the porous fibres. Nutrients 
diffuse into the extracapillary space and waste 
metabolites diffuse into the capillaries and are 
removed by the medium stream. The fibres are made of 
semipermeable membrane material of a wide range of pore 
size (10-100 K daltons molecular weight cutoff).
In the hollow fibre devices cells can grow to very 
high local densities (>10® cells/ml) and in principle 
be maintained in a viable state in a continuous culture 
mode (Hopkinson, 1985). Antibody production per volume
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of medium varies from 10-60ug/ml. This is within the 
range found in static cultures but the yield can vary 
between 80-200mg per module per day (Schonherr et 
al., 1987), and upto 100-200g per year in a 12 module 
reactor (Endotronics, 1986).
The principles of cell cultivation is the same for 
all hollow fibre reactors but numerous configurations 
of the bioreactor have been developed since their first 
description (Knazek et al., 1972). New designs have 
been encouraged as an alternative to axial flow of 
medium which is prone to the development of steep 
gradients in nutrients, waste products, pH, and oxygen 
across the cartridge and consequently reduces cell 
density and product yield.
The dual-circuit hollow fibre system designed by 
Gullino and Knazek in 1979, utilized a mixed bundle of 
fibres to deliver separate gases and media. The main 
disadvantages of the dual-circuit system are the 
complexity of the design and that it is not amenable to 
scale-up.
These problems were significantly reduced by the 
development of cross-flow systems used in flat-bed 
hollow fibre reactors (Ku et al., 1981). Nutrients and 
gases were supplied across the lumen of the fibres 
avoiding the generation of axial gradients of nutrients 
and gases.
Another approach to solve the axial flow problems
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is the radial flow reactor (Tharakan and Chau, 1985). 
This system utilizes a central distribution device to 
deliver the medium across the extracapillary space. 
Further improvements were reported by Endotronics in 
1986. In their design of the Acusyst-P system they 
overcame the difficulties of axial flow systems by 
reengineering the fluid dynamics. In their system, 
medium flow through an external expansion chamber 
connected to the extracapillary space by a one-way 
value system was controlled by a microcomputer. The 
improvements in the system enabled Endotronics to scale 
up the production unit. Productivity of 100-200g 
monoclonal antibody per year was achieved in the 
Acusyst-P production system in which 12 modules, each 
having a 100ml extracapillary volume, was employed. The 
major disadvantage of hollow fibre systems is the 
problem of scale-up, which currently is an issue 
requiring more attention, brought on by the 
anticipated increase in demand for monoclonal 
antibodies in the 1990's.
1.6 Factors affecting monoclonal antibody production in 
culture
Antibody production in hybridoma cultures can be 
sustained provided cells remain viable and precursors 
for antibody synthesis are available (Luan et al., 
1987b) regardless of the culture medium used (Long et 
al., 1988). Factors which influence cell viabililty
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also affect monoclonal antibody production. These are 
discussed below.
1.6.1 Biochemical factors
1. Serum
The role of serum constituents in cell 
proliferation is well documented (Griffiths, 1986; 
Maurer, 1986). However, its specific role in antibody 
production is unclear. For example, some workers 
(Renard et al., 1988; Lee et al., 1989 ) have 
demonstrated that varying the serum concentration of 
the culture medium had no effect on antibody 
productivity while others have shown a significant 
increase (Tharakan et al., 1986; Schliermann et al.,
1987) or a decrease (Low and Harbour, 1985a) with 
reduction in serum concentration. Nevertheless with the 
development and subsequent application of serum-free 
media to monoclonal antibody production (see review 
Glassy et al., 1988), it has become clear that serum is 
not essential for antibody production in hybridoma 
cultures. Futhermore, antibody production has been 
shown to be elevated in serum-free media (Tharakan et 
al., 1986; Cole et al., 1985; Glassy et al., 1987). 
This taken together with the observation of the 
negative correlation between the rise in antibody 
productivity and drop in growth rate of cultures grown 
in low-serum (Schliermann et al., 1987) or serum-free 
medium (Tharakan and Chau, 1986a; Glassy et al., 1988),
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suggests that the effect of serum on antibody 
production in serum supplemented cultures is a 
reflection of its effect on cell growth.
2. Amino acids
Although the effects of amino acid metabolism on 
mammalian cell proliferation has been extensively 
reviewed (Eagle, 1955; Eagle, 1959), with the 
conclusion that the most important amino acids 
appeared to be glutamine, leucine, isoleucine, 
lysine and valine (McCarty, 1962; Griffith and Pirt, 
1967; Roberts et al., 1976), there are very few 
reports on the quantitative utilization of individual 
amino acids (apart from glutamine) in lymphoid cells 
(Lazo, 1981; Glassy and Furlong, 1981) in particular 
hybridomas (Merten et al., 1986). As yet the specific 
role of individual amino acids (apart from glutamine) 
in monoclonal antibody production in hybridoma cultures 
is not clearly understood. However, a few reports are 
available which have investigated the effect of 
essential amino acids on antibody production. Luan and 
his colleagues (1987b) reported that the 
supplementation of hybridoma cultures with essential 
amino acids during the onset of cell death raised cell 
viability and enhanced antibody production. This was 
corroborated by Duval et al, (1989) who demonstrated 
that daily feeding of hybridoma cultures with 12 
amino acids, in particular, glutamine, valine,
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leucine, isoleucine and tryptophan not only increased 
but sustained viability and antibody production for 
longer periods. Rupp (1985) found that doubling the 
amino acid concentration in the culture medium elevated 
the monoclonal antibody production from 200ug/ml to 
l,100ug/ml without increasing the cell density. These 
reports indicate that the limited availability of 
essential amino acids in culture media may dramatically 
reduce antibody production in hybridoma cultures.
3. Glucose and glutamine
Glucose and glutamine are the major carbon energy 
sources for mammalian cell growth in culture (Mckeehan, 
1982). Glucose is utilised as an energy source and is 
also implicated in the formation of intermediates for 
nucleotide, amino acid, and lipid biosynthesis (Zielke 
et al., 1978; Pouysseguv et al., 1980; Romano and 
Connell, 1982). Glutamine is deaminated to glutamate 
and ammonia as it enters the cell and subsequently 
oxidized to aspartate, pyruvate, and lactate via the 
TCA cycle. The products of glutaminolysis are 
precursors for amino acid, nucleotide, protein, and 
lipid biosynthesis. Glycolysis and glutaminolysis are 
interconnected by the TCA cycle (see Figure 1.4) 
and therefore any flucuations in the concentration 
of glucose or glutamine can have a marked effect on 
both metabolic pathways (Miller et al., 1989a; 1989b).
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Most of the results of the investigations looking 
at the effects of glucose concentration on 
monoclonal antibody production suggests that they are 
both diverse and are secondary responses to its 
influence on cell growth rate. For example, Birch et 
al. (1985) and Miller et al. (1988a) demonstrated 
in a glucose-limited chemostats that more antibody was 
produced at low glucose concentrations which coincided 
with lower growth rates. Some, however have observed 
that glucose concentration had no effect on antibody 
production (Tharakan and Chau, 1986) and that 
glucose can altogether be substituted with other 
carbohydrates without affecting antibody production 
(Low and Harbour, 1985b). Others have shown that 
antibody productivity was elevated when glucose 
concentration was increased during steady-state growth 
(Miller et al., 1988a),
Unlike glucose, glutamine has been shown to be 
essential for antibody synthesis (Crawford and Cohan, 
1985; Dalili and Ollis, 1990). Therefore the effect of 
glutamine concentration of the culture medium on 
antibody productivity is more direct. Birch and his 
colleages (1985) demonstrated that antibody 
productivity was improved by increasing in glutamine 
concentration. This has been corroborated by others 
(Glacken et al., 1986; Renveny et al., 1987). However, 
Hayter (1989) demonstrated that the direct dependence 
of antibody productivity on glutamine concentration was
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limited to a certain range beyond which glutamine was 
no longer the limiting substrate.
Figure 1.4 : Glucose and glutamine metabolism in 
mammalian cells (Reuveny and Lazar, 1989).
GLUCOSE
GLYCOLYSIS
PYRUVATE
CELL
MASS
TCA 
Cyci e
lactate
H20 
amino ACIDS
4M AMMONIAg l u t a m i n e
4. Lactate and ammonia
Lactate is generated as a by-product of glucose 
and glutamine catabolism. Lactate concentration in 
spent medium (2-3mg/ml) has in some cases been 
sufficient to inhibit both hybridoma cell growth and 
antibody production (Glacken et al., 1986; Dodge et 
al., 1987). Others have found that lactate 
concentration in excess of 2.5mg/ml exhibited little 
effect on cell growth and antibody production (Reuveny 
et al., 1986; Miller et al., 1988b). Luan et al. 
(1987c) proposed that lactate’s control on growth and
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antibody production was a function of its capacity to 
regulate pH to pH 6.8. However, Glacken et al. (1986) 
suggested that lactate ions per se were 
responsible for the inhibition of cell growth and 
antibody production independently of their influence on 
pH. But it is equally valid to suggest that the 
sensitivity of hybridomas to lactate toxicity may vary 
considerably between cell lines and therefore different 
effects to a particular concentration would be 
expected. This would then suggest that both 
proposals could be correct.
Ammonia is generated by the deamination of 
glutamine and is reported to be toxic for mammalian 
cells above 2mM concentration (Holley et al., 1978; 
Butler and Spier, 1984). The inhibitory effect of 
ammonia on hybridoma growth and antibody production 
has been documented (Reuveny et al., 1986; Dodge et 
al., 1987; Miller et al,, 1988b) and appears to be 
concentration (Glacken et al., 1986), and pH dependent 
(Butler et al., 1990). Whether the effect is due to 
inhibition of immunoglobulin synthesis per se or a 
reflection of a general depression of cell metabolism 
has not been ascertained. However, the latter seems 
more likely because ammonium ions have been reported to 
inhibit transcription in embryonic cell cultures 
(Shiokawa et al., 1987).
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1.6.2 Physiochemical factors
The following factors: culture temperature, 
dissolved oxygen concentration (DOC), pH and the 
stirrer speed have all been shown to affect hybridoma 
cell viability and antibody production.
The effect of temperature on antibody production 
has been reported by Reuveny and his colleages (1986). 
In their study they demonstrated that temperatures 
3-9^0 below the optimum (37®C) increased cell 
viability and delayed the onset of cell death, but 
proved to be unfavourable for antibody production.
It can be inferred from many investigations on 
batch cultures that hybridoma growth and antibody 
production have different optima for DOC. A low DOC was 
observed to increase the antibody production in some 
hybridoma cultures (Reuveny et al., 1986; Phillips et 
al., 1987). This was in accordance with the 
observations reported for antibody production in 
lymphocyte cultures (Mizrahi et al., 1972; Mizrahi, 
1984; Deramoudt et al., 1990). In all cases the optimum 
DOC for antibody production fell within a range of
2-30%, while the optimum for maximal cell growth was 
found to lie within a range of 50-100%. However, 
hybridomas cultured in continuous mode respond 
differently to changes in DOC. In one study, where 
hybridomas were maintained at a constant growth rate, 
optimum antibody production occured at 50% DOC (Miller
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et al., 1987).
In most of these investigations it was evident 
that the effect of DOC on antibody production 
was a reflection of its influence on the cell growth 
and metabolism.
Although the effect of environmental pH on the 
growth of normal and malignant cells has been reviewed 
by Eagle (1973) there are very few reports illustrating 
the effects of pH on hybridoma growth and antibody 
production. Two of these investigations have been 
conducted by Miller et al. (1988a) and Hayter (1989). 
Both have observed that a low pH value (pH 6,8) was 
optimal for monoclonal antibody production. This was 
corroborated by Harbour and his colleages (1989a) who 
observed maximum antibody productivity at a pH range of 
6.75-7.05, significantly below the optimum for cell 
growth (pH 7.1-7.4). At low pH the hybridoma culture of 
Miller at a l . (1988a) demonstrated a reduced glucose 
consumption rate. This was in accordance with the 
results of Birch and Edwards (1980) for a lymphoblatoid 
cell line and Barton (1971) for Hela cells. It appears 
that a low environmental pH inhibits hybridoma cell 
growth by limiting glucose consumption, and 
consequently increases antibody yield by elevating the 
cell specific antibody production rate (CSAPR) (Miller 
et al., 1988a; Schmid et al., 1990b).
Some reports have demonstrated that agitator 
speeds can affect the viability of hybridoma suspension
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cultures. Fazekas de St Groth (1983) found that an 
agitator speed of lOOrpm was sufficient to reduce 
hybridoma growth significantly. Other authors have 
reported the same observation but at much higher 
stirrer speeds (Dodge and Hu, 1986; Papoutsakis and 
Kunas, 1987; Jeong-Hwan and Choi, 1988). However, most 
of these investigations have failed to demonstrate the 
effect agitator speed has on antibody production. In 
the study conducted by Al-Rubeai et al. (1989) neither 
the growth rate or antibody production was 
significantly affected by the stirrer speed over a 
range of 100-450rpm.
1.6.3 Chemical factors
Chemicals, some of which are normal constituents 
of hybridoma culture media, can at high concentrations 
impose stress on cell growth. Stressful conditions are 
often favourable for monoclonal antibody production. 
For example, it has been observed that cells cultured 
in hyperosmotic conditions (for example; 90mM NaCl ) 
have a much higher CSAPR (Oyass et al., 1989; Marshall 
et al 1990). Other compounds such as sodium and 
potassium phosphate at concentrations of 15mM have also 
demonstrated the ability to enhance antibody 
productivity per cell by suppressing cell growth (Sato 
et al., 1989). Dalili and Ollis (1988) reported that 
hybridomas exposed to concentrations of cyclic
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nucleotides above that normally present in culture 
media dramatically affected both cell growth and 
antibody production. In this case ImM concentration of 
cyclic AMP was shown to inhibit cell growth and enhance 
the CSAPR by 37%. On the other hand cyclic GMP-treated 
cells exhibited an elevation of 41% in the CSAPR, 
resulting in a 52% increase of antibody yield without 
inhibiting cell growth. As yet, only one report has 
shown that exogenous chemicals can also have profound 
effects on hybridoma cell growth and antibody 
production. Teillaud et a l . (1989 ) demonstrated that 
inhibitory concentrations of doxorubicin significantly 
reduced hybridoma growth and elevated CSAPR. This 
increase in production was a consequence of stimulated 
antibody synthesis.
From the discussion in section 1.6, it is apparent 
that in many cases factors which suppress the growth of 
hybridomas also raise the CSAPR. Therefore it appears 
that antibody production may be inversely related to 
the cell growth rate (replication). This is fully 
discussed in the following section.
1 » 7 Hybridoma cell growth and antibody production 
kinetics
Two questions which have been asked are 
(MacMichael, 1989):
a. Is monoclonal antibody production rate an 
independent metabolic phenomenon? or,
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b. Is it intricately related to the rate of growth of 
hybridoma cells?
These questions have arisen because the growth and 
production kinetics of hybridoma cell lines are the 
most important parameters to consider when monoclonal 
antibodies have to be produced on an industrial scale. 
Any attempts to answer these questions needs to address 
whether cell growth and antibody production kinetics in 
batch and continuous cultures are similar.
1.7.1 Batch culture kinetics
Batch culture growth kinetics is distinguished by 
a characteristic lag phase followed by an 
exponential and stationary/decline phase. In batch 
culture the existence of three distinct production 
kinetics have been described by Merten et al. (1987):
1. In type 1 production kinetics the highest CSAPR is 
observed during lag and early exponential phase.
2. In type 2 production kinetics, the highest CSAPR is 
observed at early exponential phase then at the onset 
of stationary phase.
3. In type 3 production kinetics a constant CSAPR is 
observed throughout the exponential phase only.
Types 1 and 2 are the most frequently reported 
production kinetics, in particular, type 2 (Birch et 
al., 1895; Tharakan et al., 1986; Velez et al., 1986; 
Phillips et al., 1987; Jeong-Hwan and Choi, 1988; 
Dalili and Ollis, 1989; Oyass et al., 1989). Both
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exhibit a non-growth dependent production kinetics in 
which the CSAPR and growth rate appear to be inversely 
r e l a t e d , Such production kinetics indicate that 
antibody synthesis is not associated or dependent on 
processes pertaining to cell replication ie. DNA 
synthesis, replication and mitosis.
Type 3 production kinetics is rare (Williams, 
1984; Lavery at al., 1985; Renard et al., 1988) and 
demonstrates a growth dependent production pattern, 
where an increase or decrease in cell growth rate is 
accompanied by a concomitant rise or fall in the 
CSAPR. This production pattern was postulated to be 
controlled by a feed-back inhibition mechanism brought 
about by the antibody concentration at late exponential 
phase (Merten et al., 1985), but evidence has not been 
adduced to verify the hypothesis.
The observation of the non-growth dependent 
production kinetics raises the question whether 
monoclonal antibodies are secreted by viable cells or 
released by dead/dying cells? Emery et a l . (1987)
claimed to detect the accumulation of intracellular 
pools of immunoglobulins during logarithmic growth in 
their cell line thus supporting the release theory. 
This was supported by two other groups (Velez et al., 
1986; Flickinger et al., 1987) both of whom interpreted 
the increase in supernate antibody titre during decline 
phase as antibody released from dead cells. Emery and
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his colleages (1990) have recently reported to have 
acquired further experimental evidence to confirm this. 
However, Birch et a l . (1987) reported that
intracellular antibody levels measured throughout 
batch growth were insuffucient to account for the 
observed production kinetics and therefore favoured the 
secretion theory. One problem associated with the 
hypothesis of antibody release as opposed to that of 
secretion is that it cannot explain the production 
yields obtained in perfusion cultures. For example, 
high cell specific antibody production rates have 
been reported in cultures maintained at stationary 
phase with a high cell viability (van Wezel et 
a l ., 1985; Reuveny et al., 1986a). Therefore it is
possible that the increase in antibody titre reported 
by Velez et a l . (1986) and Flickinger et al. (1987) 
during the onset of cell death was actually brought 
about by a rise in the CSAPR of the remaining viable 
cells. This is more likely because Renard et al. (1988) 
have provided experimental evidence that antibody 
production in hybridomas is a function of viable cells 
only. They demonstrated that the antibody titre in the 
culture supernatant at any time during batch 
cultivation was proportional to the integral of the 
equation for the viable cell curve.
The experimental data on antibody synthesis, 
assembly and secretion in lymphoid cells tends to 
favour the secretion theory. For example, Helmreich et
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al. (1961, 1962) detected fully assembled antibody
within 30 minutes of bathing isolated lymph node cells 
in medium containing radiolabelled amino acids. This 
was later corroborated by Baumal and Scharff (1973) who 
detected functionally active antibody within 20 minutes 
in a similar experiment. Others have reported similar 
results for hybridoma cells (Walker et al., 1987; 
Al-rubeai and Emery, 1990). In the pulse chase 
experiment of Walker and his colleages, five hybridoma 
cell lines of diverse background were bathed in medium 
containing radiolabelled methionine. Within two hours 
of incubation, the radioactivity of secreted antibody 
reached a peak demonstrating rapid synthesis, assembly 
and secretion of monoclonal antibodies. In another 
experiment a constant antibody secretion rate per 
viable cell was reported over the entire batch growth 
curve (Meilhoc et al., 1989). These observations 
substantiate the fact that antibodies are secreted by 
viable lymphoid cells and therefore the secretion 
theory holds more credibility over the release 
theory. Nevertheless it is probable that hybridoma 
cells are capable of both secreting and releasing 
antibody and that one may be more dominant over the 
other at different stages of the batch culture (Merten 
et al., 1990a).
It is apparent from the above discussion that 
antibody production kinetics in batch cultures is
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predominantly non-growth dependent. However, in batch 
culture the environment is in a state of flux and 
because parameters such as the growth rate, nutrient 
consumption, product secretion and waste product 
accumulation are interdependent, all statements of 
antibody production kinetics need to be considered 
critically. A search through the production kinetics of 
continuous cultures is required to verify the 
non-growth dependent production kinetics reported here.
1.7.2 Continuous culture kinetics
The reports available on hybridoma cultivation 
in continuous culture systems clearly demonstrate the 
existence of both the non-growth dependent and the 
growth-dependent production kinetics. For example, 
Fazekas de St Groth (1983) and MacMichael (1989) 
presented unequivocal results to support the direct 
correlation that existed between cell growth rate and 
CSAPR for their cell lines. In both cases it can be 
discerned that the cell lines tested exhibited the type 
3 production kinetics described by Merten et a l . 
(1987). Other authors have demonstrated, with equal 
significance, results that hybridoma growth rate is 
inversely related to the CSAPR, therefore supporting 
the non-growth dependent hypothesis (Birch et al., 
1985; Reuveny et al., 1986; Low et al., 1987; Miller et 
a l ., 1988a; Ray et al., 1989). In these reports the 
optimum growth rate for maximum antibody production
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fell within a narrow range of 0.02-0.025 h”  ^ while the 
optimum for maximum cell growth was within 0.04-0.05 
h“  ^ (Dean et al., 1987; Low et al., 1987; Ray et al., 
1989).
Therefore it can be tentatively concluded that 
antibody production in most hybridoma cultures is 
growth-independent.
The underlying factors which govern this type of 
production kinetics have not been elucidated. However, 
it is speculated that cell cycle-phase specific 
antibody production may be involved in generating the 
growth-independent production kinetics observed in many 
hydridoma cell lines.
1.8 Cell cycle and monoclonal antibody production
1.8.1 The cell cycle
Hertwig (1903) proposed that when a cell reached a 
certain point in its life time it must divide. This 
point was suggested to be when a critical ratio of cell 
volume to nuclear volume was reached. However, the 
modern concept of the cell cycle came into existence in 
1953 as a result of the observations reported by Howard 
and Pelc (1953). They noticed that mitosis was neither 
directly proceeded by nor immediately preceded by DNA 
synthesis. They later introduced a model of a cell 
cycle composed of four phases in which each phase was
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characterised by the biochemical processes it 
encompassed. The four phases were;
a. The M phase (mitosis)
b. The S phase (DNA synthesis)
c. The G-^  phase ("gap" between mitosis of one cell 
cycle and the onset of DNA synthesis of the next)
d. The G 2 phase ("gap" separating the end of DNA 
synthesis and the onset of mitosis)
Later another phase, the G q  was introduced 
designating a quiesent stage observed in some cells 
(Ley and Tobey, 1970),
The cell cycle is conveniently sub-divided into 
the chromosome cycle (S,M,G2 ) during which replication 
of nuclear material, chromosome condensation and cell 
division are visible, and the growth cycle (G^, G q ) 
characterised by the increase in cell size and mass as 
direct consequences of continual RNA and protein 
synthesis (Mitchison, 1971).
Figure 1.5 : A cell cycle
Chromosome cvcie
Growch cycle
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The time required for cells to traverse mitosis of 
one generation to the next is termed "doubling" or 
"generation" time. Variations in the doubling times of 
eukaryotic cells was first reported by Prescott in 
1959. It was later discovered that variations in 
doubling time for a given cell type was brought about 
by changes in duration of the phase (growth cycle) 
and not the S, M or G 2 phases (chromosome cycle) 
(Sisken and Morasca, 1955; Tobey et al., 1967; 
Smith and King, 1972; Prescott, 1976). Since then many 
factors have been known to influence the doubling time 
(John 1981). For hybridomas some of these factors are: 
serum (Schliermann et al., 1987), serum-free media 
(Glassy et al., 1988), oxygen (Phillips et al., 1987), 
temperature (Reuveny et al., 1987), pH (Miller et al., 
1988), cyclic nucleotides (Dalili and Ollis, 1988), and 
growth inhibitory drugs (Teillaud et al., 1989), all of 
which have reduced the cell growth rate. Some studies 
have shown that growth inhibitory conditions for 
hybridoma cultures cause the accumulation of cells in 
the G^ phase of the cell cycle (Schliermann et al., 
1897, Sen et al., 1988).
1.8.2 Phase-related biosynthesis of macromolecules
It is necessary to briefly review the current 
understanding of major biosynthetic processes which 
constitute primary and secondary metabolism in relation 
to their occurrence in the cell cycle. This will help
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us to better understand the antibody production 
patterns discussed earlier and those reviewed below 
(sec 1.8.3).
It is known that DNA synthesis in animal cells is 
confined to the S-phase of the cell cycle (for reviews 
see Mitchison, 1971; Lloyd et al., 1982). This is also 
true for hybridomas as demonstrated by the following 
reports (Altshuler et al., 1986; Schliermann et al., 
1987; Al-Rubeai et al., 1989). This may be brought 
about by the fact that many of the necessary proteins 
that initiate or regulate DNA synthesis are synthesised 
either prior to the onset of S-phase or immediately 
after the onset. For example, histone proteins 
(Artishevsky et al., 1984; Schumperli, 1986) and the 
following enzymes, thymidine kinase, dihydrofolate 
reductase and thymidylate synthase (Littlefield, 1966; 
Conrad, 1971; Johnson et al., 1978; Denhardt et al., 
1986) are expressed during the S-phase.
For RNA synthesis the general pattern that has 
arisen from many reports is that it is continuous 
throughout the entire cell cycle except during mitosis 
when synthesis appears to stop (Scharff and Robbins, 
1965; Zylber and Penman, 1971; Damiani et al., 1979; 
Altshuler et al., 1986). The rate of RNA synthesis 
usually doubles during the G^/S-phase transit. Whether 
this is brought about by a continuous increase in the 
rate of synthesis (Enger and Tobey, 1969) or an effect
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of gene dosage (Crippa, 1966) is debatable.
Protein synthesis in mammalian cells is observed 
continously throughout the cell cycle in a similar 
fashion to RNA synthesis. The increase may be 
exponential (Zetterberg and Killander, 1965), linear 
(Robbins and Scharff, 1967), or linear with a rate 
doubling at a specific point in the cell cycle (Martin 
et al., 1969). Most cell lines either demonstrate a 
continuation or a sharp reduction in the rate of 
synthesis during mitosis but not a complete cut off 
(Konrad, 1963; Martin et al., 1969) as is the case for 
RNA synthesis. The reduction may be explained by the 
sharp drop in polyribosomes observed by Scharff and 
Robbins (1966). The continuing synthesis observed may 
be accounted for by the presence of long lived mRNA in 
the cytoplasm during mitosis.
The processes described above could not function 
without energy. The importance of ATP in cellular 
metabolism has long been appreciated (Lipmann, 1941). 
Some reports on the level of ATP in the various phases 
of the cell cycle in synchronised cell cultures 
demonstrate that intracellular ATP content fluctuates. 
In Chinese hamster cells ATP levels per cell more than 
doubled during the G^-M-phase transit and then declined 
at the end of the G^-phase paralleling changes in cell 
volume (Chapman et al., 1971). In Ehrlich tumour cells 
ATP levels were seen to increase from the onset of G^- 
phase reaching a peak at M/G2 ~phase ( Skog et al.,
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1983).
These changes in ATP levels throughout the cell 
cycle are brought about by the changes in cell 
metabolism. This is depicted clearly in mitogen 
stimulated lymphocyte cultures in which an increase in 
glucose consumption, is followed by an increase in 
intracellular ATP level during the onset of DNA 
synthesis in the S-phase (Wang et al., 1976; Tollefsbol 
and Cohen, 1985). From this it would therefore appear 
that the dominant metabolic processe(s) in a particular 
phase of the cell cycle may be instrumental in the 
regulation of energy production and distribution in 
that particular phase. The significance of this to 
monoclonal antibody production in hybridoma cultures 
which have tended to show phase-related production 
kinetics is discussed below.
1.8.3 Phase-related antibody synthesis
Various investigations conducted on synchronised 
mouse and human myeloma cell lines indicate that 
phase-specific immunoglobulin synthesis is cell line 
dependent. For example, many have demonstrated that 
maximum immunoglobulin synthesis occurs during late G-j^ 
phase and early S phase (Buell and Fahey, 1969; Byars 
and Kidson, 1970; Lerner and Hodge, 1970; Turner et 
al . , 1985 ). Other investigators have reported an 
additional peak of antibody synthesis during G2 phase
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(Watanabe et al., 1973; Killander et al., 1977). On the 
other hand some have not found evidence to support that 
antibody synthesis is phase specific (Cowan and 
Milstein, 1972; Liberti and Baglioni, 1973; Damiani et 
al., 1979).
The few reports available for hybridoma cells 
endorse the concept that phase-specific monoclonal 
antibody synthesis is likely to be cell line dependent. 
Al Shuler et al . 1986 reported the detection of
intracellular antibody throughout the cell cycle in 
mouse hybridoma cells while Al-Rubeai and his colleages 
(1989) claim to show evidence for phase-specific 
synthesis. In another report Schliermann et al. (1987) 
deduced from their experimental data that antibody 
synthesis was phase-related. They demonstrated that the 
specific antibody production rates for various cultures 
correlated very well with the proportion of cells in 
the G^ phase.
The underlying mechanisms for such production 
patterns are not known but observations particularly on 
the nature of lymphoid cell immunoglobulin mRNA 
eliminates the regulation of immunoglobulin mRNA 
translation as a possible mechanism to explain 
phase-specific antibody synthesis. For example, it has 
been demonstrated that lymphoid cells selectively 
preserve immunoglobulin synthesis in conditions of 
amino acid starvation or actinomycin treatment 
(Melchers and Andersson, 1973; Sonenshien and
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Brawernan, 1976). Since both treatments affect 
polypeptide chain initiation it was concluded that 
mRNAs of immunoglobulins have a greater potential for 
initiation in comparison with other cellular mRNAs. 
More recently, this was confirmed by Morenkov et a l . 
(1989) who reported that the specific antibody 
production rate for their hybridoma cell line was 
unaffected by serum-limitation but the initiation of 
protein synthesis of other cellular proteins was 
significantly reduced. This would indicate that 
phase-specific antibody synthesis is controlled by 
other mechanism(s). One such mechanism could be the 
regulation of immunoglobulin mRMA transcription. Merten 
et al. (1990b) recently provided experimental evidence 
which alluded to this.
It has been suggested in a review article (Glacken 
1988) that biosynthetic reactions in animal cells 
compete for limited pools of ATP, NADPH and other 
metabolic intermediates. It is feasible then that 
phase-specific immunoglobulin synthesis observed in 
many cell lines is a manifestation of the limited 
availability of these resources, particularly ATP, for 
immunoglobulin synthesis in a particular phase.
A system of selective distribution of cellular 
resources to important biosynthetic reactions may exist 
in hybridoma cells where priority is shown first to the 
processes necessary for cell replication (DNA
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synthesis, and mitosis) then to other major 
biosynthetic processes which constitute the function of 
the cell (antibody synthesis). If cell replication is 
reduced (reduction in growth rate) then it is 
conceivable that more cellular resources could be 
diverted to biosynthetic reactions of second order of 
priority. This would explain the rise in antibody 
production normally accompanying hybridoma cultures 
exhibiting a drop in growth rate due to unfavourable 
culture condtions.
1.9 DNA synthesis inhibitors
The anticipated demand of monoclonal antibodies 
in the 1990's has provided fresh impetus for research 
in process optimisation of monoclonal antibody 
production at cellular level. The recognition that 
antibody synthesis in most hybridoma cell lines is 
growth-independent has led to the development of 
strategies that maintain cultures in a viable state 
with a low growth rate (Reuveny et al., 1986; 1986a; 
Low et al., 1987; Ray et al., 1989), In view of the 
conclusion that hybridoma cells arrested in cell growth 
( G-^  phase arrested) produce antibodies at a rate 
considerably higher than unarrested cultures, it would 
be beneficial to develop new methods of arresting cell 
growth while retaining high cell viability and density. 
In this investigation the feasibility of using DNA 
synthesis inhibitors to restrict hybridoma cell
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division while maintaining antibody production 
ascertained.
1.9.1 Types of inhibitors
Most of the DNA synthesis inhibitors have been 
discovered in the last five decades as compounds with a 
potential to combat cancer. These drugs have diverse 
origins and can be categorised according to their mode 
of action:
1. Intercalaters : These are drugs that bind to DNA 
causing strand breakages or prevent enzyme binding.
2. Enzyme inhibitors : These are drugs that prevent the 
action of enzymes known to regulate or initiate the 
replication sequence.
3. Nucleoside/nucleotide analogues : These are drugs 
that interfere with deoxynucleotide synthesis because 
of their structural similarities to purines and 
pyrimidines.
DNA synthesis inhibitors are often designated 
S-phase specific drugs because of their action upon 
genomic replication which occurs in the S-phase. The 
specific target site(s) of four of these drugs in 
purine and pyrimidine synthesis is/are shown on Figure 
1.6 as examples.
The applications of these inhibitors in cell 
biology are well documented (DeVita and Busch, 1971; 
Zimmermann et al., 1973; Baserga, 1985) but reports of 
their potential use as growth inhibitors of hybridoma
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cultures are not available.
Figure 1.6 : A metabolic map of nucleotide synthesis 
and the target site(s) of some inhibitory drugs.
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1 . 1 0  objectives of this thesis
Compounds that specifically inhibit enzymes which 
regulate DNA synthesis would be particularly useful in 
ascertaining the feasibility of inhibiting DNA 
synthesis without preventing DNA-dependent RNA and 
protein synthesis in hybridomas. There is experimental 
evidence of achieving this in other mammalian cell 
cultures (Baserga, 1985).
The objectives of this investigation were:
1. To determine the cell growth and antibody production 
kinetics of hybridoma cell line designated MAK 33 in 
both normal and growth inhibited culture conditions 
imposed by nutrient depravation or specific inhibitors 
DNA biosynthesis.
2. To develop a suitable assay to screen compounds 
which would selectively inhibit DNA synthesis and 
therefore arrest cell division without affecting 
antibody production.
3. To study the effect of these compounds on hybridoma 
cell growth and antibody production kinetics:
(i) In stirrer bottles in uncontrolled conditions.
( ii ) In a small laboratory fermentor under controlled 
conditions.
The overall aim was to determine, if any, the 
potential use of such compounds for large-scale 
production strategies.
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Chapter 2 
Materials and Methods
The materials and methods described in this 
section are those which are applicable to the 
subsequent chapters. Other methods which relate 
specifically to other work described will be delineated 
as part of that work. A detailed account of each 
experiment, however,is not described here but in the 
relevant results chapter.
2.1 Cell cultivation
2.1.1 Cell line
The hybridoma cell line used throughout this 
investigation was received as a gift from Boehringer 
Mannheim GmbH. It was produced by fusing spleen cells, 
(balb/c mice) sensitised to a human protein (creatine 
kinase isoenzyme MM) with the myeloma X63-Ag8.653. The 
monoclonal antibody secreted by the hybridoma is 
designated MAK 33 (IgGl/K) and is unique in that it 
binds selectively to the M-subunit on the isoenzyme MM 
and not MB (Buckel et al., 1987).
2.1.2 Cell storage and revival
Hybridoma cells in mid-exponential phase were 
harvested by centrifugation at lOOxg for 5 minutes. 
They were then resuspended at a density of either 5x10^ 
or 1x10^ cells/ml in a freezing mixture of 70% RPMI 
1640 (Gibco Ltd), 20% new born calf serum (Seralab) and 
10% dimethylsulphoxide (DMSO). One millilitre of the
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cell suspension was then aliquoted into cryotubes (Nunc 
Ltd) and frozen at an approximate rate 1-3^C per minute 
for 1-2 hour in a freezer at -70^C by placing the 
ampoules in a polystyrene block with walls of 
approximately 2cm t h i c k n e s s . Following this the 
ampoules were transferred to the vapour phase of a 
liquid nitrogen container for long term storage.
Cells were revived by thawing the ampoules 
rapidly in a 37® C water bath and tranferred to 15ml of 
prewarmed culture medium in a plastic universal tube 
(Flow Lab). After centrifugation, the supernatant was 
discarded and the cells resuspended in a 50cm^ culture 
flask (Flow Lab) at a cell density of 2xl0^/ml and 
incubated at 37® C. The medium was changed after 24 
hours to ensure complete removal of DMSO and then 
passaged as usual.
2.1.3 Cell culture
The culture medium consisted of RPMI 1640, 10% new 
born calf serum, 0.2% sodium hydrogen carbonate and 2mM 
glutamine. Glutamine was filter sterilized and stock 
solutions of 200mM were stored in 1-10 ml aliquots in 
plastic universels at -20° C . Glutamine was added to 
the culture medium prior to seeding the culture 
vessels.
Hybridoma cells were routinely cultured in tissue 
culture flasks or stirrer bottles in working volumes of 
10-200ml. Hybridoma cultures were seeded with 2x10^
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cells\ml and allowed to grow to a density of 
approximately 8x10^ cells\ml before passaging. Cells 
were passaged regularly and were harvested by 
centrifuging the culture at lOOxg for 5-10 minutes 
prior to resuspending them in fresh culture medium 
prewarmed to 37®C. Hybridoma cultures were then 
incubated in air in a hot room designed to maintain the 
environmental temperature at 37® +/- 0 . 5 ® C . All 
hybridoma cultures were cultured as described above 
unless otherwise stated in the subsequent chapters,
2.1.4 Cell counting
Cell counts were performed routinely on all 
cultures. This was achieved by recovering 0.2ml of the 
cell culture and diluting it 1:5 with 0 .5% trypan blue 
(Evans and Schulemann 1914) in saline and counting in a 
modified Fuchs-Rosenthal counting chamber. Cells 
excluding the dye were counted to determine the total 
viable cell number per millilitre of culture. Cells 
which incorporated trypan blue were considered to be 
non-viable.
2.2 Assay procedures
2.2.1 Glucose test
Glucose concentrations were determined by the 
Hexokinase enzymatic (Sigma) method based on the 
procedure described by Bondar and Mead (1974) utilizing 
the coupled enzyme reactions catalysed by hexokinase(l) 
and glucose-6 -phosphate dehydrogenase(2). The enzyme
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reactions involved in the assay are as follows:
Glucose + A T P   — > Glucose-6-phosphate + ADP
Glucose-6-phosphate + N A D 6 - P h o s p h o g l u c o n a t e  + NADH
Increase in absorbance at 340nm due to the 
formation of NADH is directly proportional to glucose 
concentration.
The glucose hexokinase reagents were prepared 
according to the instructions on the kit prior to 
using.
Samples for glucose assay were centrifuged at 
lOOxg for 5 minutes to remove the cells and stored at 
-20®C until required. For the assay, 0.01ml of sample 
was added to 1.5ml of glucose HK reagent in a plastic 
cuvet and incubated at room temperature for 5 minutes. 
The sample absorbance was measured at 340nm in an LKB 
4050 ultraspectrophotometer against a water blank. A 
series of duplicate glucose standards were also set up 
simultaneously with each batch of samples. The assay 
response was linear for glucose concentrations between 
0 and 2 ,5mg/ml and therefore the glucose concentration 
in mg/ml for each sample could be determined by direct 
extrapolation from the standard curve (see Appendix 1).
2.2.2 Lactate determination
During the conversion of lactate to pyruvate by 
lactate dehydrogenase, NAD is reduced to NADH. The
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increase in absorbance at 340nm due to reduction in NAD 
is proportional to the concentration of lactate 
converted to pyruvate (Hayter, 1989).
(a) Reagents
i. Glycine-Hydrazine buffer: This was made by adding 
7.5g of glycine (BDH) to 4ml of hydrazine hydrate (BDH) 
and making up the volume to 200ml with milli-Q water 
(MQ). The pH was adjusted to 9.0 with IM HCL.
ii. Nicotinamide adenine dinucleotide (NAD) grade III 
from yeast (Sigma), 30mg/ml in MQ water.
iii. Lactate dehydrogenase (LDH) type X from bovine 
muscle lOOOU/ml (Sigma).
iv. L-lactate standard 0.4mg/ml (4.44mmoles/l) (Sigma). 
V .  Perchloric acid 8 % w/v in MQ water.
(b) Procedure
Samples for lactate determination were centrifuged 
at lOOxg for 5 minutes to remove cells prior to 
performing the extraction step of the assay. One 
millilitre of ice cold 8 % perchloric acid was mixed 
with 0.5ml sample in Eppendorf tubes and stood on ice 
for 10 minutes. The samples were then centrifuged at 
ll,600xg for 10 minute to remove precipitated proteins 
and frozen at -20®C until required.
For the assay 0.2ml of extracted sample was mixed 
with 2.5ml NAD solution in LP3 t u b e s . A blank 
containing 0 .2ml of perchloric acid and a standard 
containing 0 .2ml of a 0.4mg/ml lactate standard diluted 
1/3 in perchloric acid were also included. After
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mixing, the initial absorbance of the extracted 
samples, blank and the standards were measured at 340nm 
in the LKB 4050 ultraspectrophotometer. Following this, 
50ul of LDH solution was added to all the mixtures and 
then they were incubated at 37®C for 30 minutes. The 
absorbance at 340nm for each sample was then measured. 
The concentration of lactate in each sapmle was 
calculated by the following equation:
Lactate (mg/ml) = dA-dB x 7.11 x 90/1000 
where: (a) dA = difference between initial and final
absorbance of sample,
(b) dB = difference between initial and final 
absorbance of the blank,
(c) 7.11 is a conversion factor based on an 
absorbance change of 6.22/mmole NADH and a dilution 
factor of 44.2,
(d) 90 is the molecular weight of lactate.
2.2.3 Glutamine and Ammonia determination
The concentration of glutamine in culture media 
was determined enzymically by monitoring the 
liberation of ammonia during the deamination of 
glutamine by glutaminase (Hayter, 1989).
(a) Reagents
i. Sodium acetate buffer: O.lM Na acetate was made up 
in MQ water and adjusted to pH 4.9 with acetic acid.
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ii. Ammonium chloride: IM NH4 CI solution was diluted to 
give a concentration range of O.OIM - O.OOOOIM.
iii. Sodium hydroxide: IM NaOH solution.
iv. Glutaminase: Grade V from E. coll (Sigma) was 
reconstituted and diluted to 5U/ml in Na acetate 
buffer.
(b ) Procedure
The ammonia content of the culture medium was 
determined using an EIL ammonia probe model 8002-8 
(Kent Instruments). A calibration curve for the probe 
was constructed using aqueous solutions of NH^Cl 
standards of the concentration range 1 0 ”  ^ to 1 0 ~^M 
starting with the most dilute solution. For the 
construction of the calibration curve 0.1ml of NaOH was 
added to 1ml of NH^Cl standard (see Appendix 1). The 
ammonia liberated was detected by inserting the probe 
into the mixture and noting the millivolt (mV) reading 
after 2 minutes. Once the probe was calibrated, it was 
used to determine the content of ammonia and glutamine 
in the samples.
For the assay, two tubes were set up (A and B) 
each containing 500ul of sample. To tube A, 450ul of Na 
acetate buffer and 50ul glutaminase were added. To tube 
B, SOOul of Na acetate alone was added. Both tubes were 
incubated at 37®C for 30 minutes. The ammonia content 
of each was determined by emptying the contents of both 
into individual glass vials and adding 0.1ml NaOH. The 
ammonia liberated was measured as described above.
60
Assuming that 1 mole of ammonia was liberated from the 
complete breakdown of 1 mole of glutamine, the 
glutamine concentration in mV of each sample can be 
quantified by the following expression:
XmV = mV of B - mV of A 
where XmV represents the millivolt reading generated by 
residual glutamine in the sample. XmV is then converted 
to glutamine concentration (mM) by extrapolating values 
from a glutamine/mV standard curve established as 
described below.
The specific concentration of glutamine for each 
sample was determined by setting up a series of 
standards of known concentrations: 0, 0.25, 0.5, 1, 2mM 
(see Appendix 1).
2.2.4 ELISA for MAK 33 antibody
Antibody concentration in the medium was measured 
by the sandwich enzyme-linked immunosorbent assay 
(ELISA). Two assays were used, both of which shared the 
same protocol except for one step. One detected the 
heavy chain on the antibody molecule and the other 
detected the whole antibody molecule.
(a) Reagents
i. Coating buffer: 0.2M Sodium carbonate buffer pH 9.5.
i i . Incubation buffer (IB): One litre was made up of 
9.5g phosphate buffered saline (PBS, Oxoid), lOg bovine 
serum albumin (BSA, Sigma), and 0.5ml tween 20 (Sigma).
iii. Wash buffer (WB): Just as IB but without BSA.
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iv. Coating antibody: 1. Mixture of anti-mouse Fc
chain and sheep Fab molecule, stored in -20®C, in 
aliquots of 0.5ml of 0.5mg/ml concentration.
2. Sheep Fab molecule alone,
stored as mixture 1 .
3. Creatine kinase (CK-MM) 
reconstituted in MQ water to a concentration of Img/ml. 
Working concentrations of the coating antibodies were 
achieved by diluting them in coating buffer,
V .  Standard antibody: Purified MAK 33, reconstituted in 
MQ water and stored in -20®C in aliquots of 25ul at a 
concentration of 0 .5mg/ml.
v i . Conjugate: Sheep anti-mouse IgG, whole molecule, 
conjugated to peroxidase (Sigma).
vii. Substrate: Made up by emptying one vial of
2,2' Azino-di [3-ethylbenzthiazoline sulfonate(6 )] 
(ABTS) into 120ml of ABTS buffer (BM GmbH).
viii. ELISA plates : 96 well flat bottom immuno-1- 
plates (Nunc Ltd).
(b) Procedure
1. For the non-specific ELISA all the plates were 
coated with lOug/ml of coating antibody (1 ), except one 
row of wells which were coated with lOug/ml of coating 
antibody (2). The latter was performed to determine any 
cross reactivity of MAK 33 to sheep antibody.
For the specific ELISA all the wells were coated 
with lOug/ml of protein 3. For both types of ELISA one 
well on each plate was designated as a blank. All the
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coated plates were left overnight at 4®C.
2. The plates were then washed 3 times with WB and were 
incubated with 200ul of IB for 20 minutes,
3. The plates were washed again 3 times with WB and 
2 0 0 ul of 400“  ^ diluted samples were pipetted into the 
wells of the first two and last rows (1,2 and 8 ). Into 
the other rows (3-7) lOOuI of IB was pipetted. Samples 
were then double diluted from wells in row 2 to row 7 
by transferring lOOul aliquots across the plate from 
well to adjacent well with mixing. The volume of each 
well was then made up to 200ul with IB and the plates 
were incubated at room temperature for 90 minutes. The 
dilution range of the samples was 400“^-25,600“^. 
Duplicate MAK 33 standards were also set-up on each 
plate and diluted to give a concentration range of 
lOOng/ml to 1.56ng/ml,
4. The plates were again washed 3 times with WB and to 
each well 2 0 0 ul of 1 0 0 0 “  ^ diluted conjugate was 
pipetted. The plates were then left at room temperature 
for another 90 minutes.
5. After incubation the plates were washed 3 times in 
WB and 200ul of substrate was pipetted into each well. 
The plates were then left at room temperature for 50 
minutes.
6 . The absorbance reading for each well was measured 
with a plate reader (Dynatech MR600) set up with test 
wavelength of 410nm and a reference wavelength of
63
570nm.
7. The antibody titres of the samples were determined 
from the standard curve constructed from the standard 
antibody samples.
2.2.5 Luciferase assay
The techniques described by Lundin et al., (1986) 
and Holm-Hansen and Karl (1978) were used to extract 
and measure levels of ATP, ADP, and AMP from hybridoma 
cells. The Fire-fly luciferase-luciferin (FLE) reaction 
described by them enabled the quantification of 
intracaellular ATP levels. One molecule of ATP yields 
one light forming unit of a specific intensity and 
wavelength in the presence of luciferase, which is 
detectable by a b i o l u m i n o m e t e r . ADP and AMP were 
converted enzymically to ATP before their measurement 
because luciferase is specific for ATP. The reactions 
which take place in the conversion are shown below:
ATP + LH2 + O2 — J-AMP + PPi + CO2 + P + hV
ADP + PEP — > ATP + Pyruvate
AMP + CTP ^ — ^2ADP
Key: LH2 = D-Luciferin, hV = light, MK = Myokinase, 
P = Pyruvate kinase, PEP = Phosphoenol pyruvate,
CTP = Cytidine triphosphate
(a) Reagents
i. TRIS/EDTA buffer (TE): O.lM Tris/EDTA was prepared
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in MQ water and adjusted to pH 7.75 with IM HCL. All 
the samples and standards were diluted with this 
buffer.
ii. Buffer A: 75mM Potassium phosphate and 15mM
magnesium chloride, pH 7.5.
iii. Buffer A/PEP: Buffer A supplemented with 2.5mM 
Phosphoenol pyruvate.
iv. Buffer B: Buffer A/PEP supplemented with lOOunits 
of pyruvate kinase enzyme.
V .  Buffer C: Buffer B supplemented with 200 units of 
myokinase enzyme.
vi. Perchloric acid: 20% v/v Perchloric acid containing 
20mM EDTA in filter sterilised MQ water.
vii. Pyruvate Kinase (PK)/ Myokinase (MK): PK and MK 
(Sigma) were reconstituted in 1ml of TE and stored in 
-20®C in 50ul aliquots until required.
viii. Luciferase-luciferin reagent (Lumac Ltd): Single 
vials of reagent were reconstituted in 7ml buffer 
supplied with the kit and stored in the dark at -20®C 
in 2ml aliquots until required.
ix. Phosphoenol pyruvate (PEP): PEP (Sigma) was 
dissolved in MQ water to solution of Img/ml and frozen 
in 0.5ml aliquots in -20®C until required.
X .  Cytidine triphosphate (CTP): CTP (Sigma) prepared 
and stored in the same way as PEP.
xi. Nucleotide standards: ATP, ADP and AMP (Sigma) were 
reconstituted in MQ water and stored as aliquots of
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Img/ml in -20®C until required.
xii. Potassium hydroxide: 5M KOH prepared in MQ water.
(b ) Procedure
1. Extraction
lOOul of 20% perchloric acid containing 20mM EDTA 
was mixed with 1ml of culture. This mixture was 
neutralized with 5M KOH and stood on ice for 10 
minutes. The latter was then centrifuged at ll,600xg 
for 5 minutes to remove precipitated proteins and the 
extract was stored at -20®C until required.
2. Assay
1. 50ul of each buffer; A/PEP, B and C were added 
individually to 2 0 0 ul samples of cell extract in 
an Eppendorf tubes and incubated at 30®C for 30 minutes 
in a water bath. The purpose of each buffer is shown 
below;
(a) Buffer A/PEP determines the concentration of ATP in 
sample.
(b) Buffer B determines the concentration of ATP and 
ADP in the sample.
(c) Buffer C determines the concentration of ATP, ADP 
and AMP in the sample.
2. 200ul of ATP standards diluted in TE buffer giving a 
range of O-lOOnM were also included with each batch of 
samples for the construction of a standard curve. ATP 
standards were incubated with 50ul of buffer A/PEP as
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above.
3. After incubation all the samples were boiled in a 
water bath for 2 minutes to stop the enzyme reaction 
and allowed to cool to room temperature.
4. Samples were then diluted 1/10 in TE buffer. A 50ul 
aliquot of a diluted sample was pipetted into lumac 
tubes containing 50ul of luciferase-luciferin reagent 
and the mixture shaken. The light emitted by the 
reaction was measured with a bioluminometer model M2050 
(LKB Ltd) over a 10 second period.
5. The total ATP concentration in sample was determined 
from the plot of the ATP standard curve ( see Appendix 
1) but the specific concentrations of ATP, ADP and AMP 
were calculated as follows:
ATP = Value obtained from mixture (a) above.
ADP = Value obtained by subtracting (b) from (a).
AMP = Value obtained by subtracting (c) from (b).
The specific concentrations of the individual 
nucleotides were used to determine the Energy charge 
(EC) of hybridoma cells. This was achieved by
substituting their values into the following equation: 
EC = ATP + 1 / 2  ADP 
ATP + ADP + AMP
2,2.6 Neutral red assay
The Neutral red assay as described by Parish and 
Mullbacher (1983) was modified and adapted to determine 
the nucleic acid content of hybridoma cells. It is
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described in the appropriate results section. Also its 
specificity for nucleic acid is fully discussed in 
chapter 4.
(a) Reagents
i. 0,075% Neutral red; 1% Neutral red dye (BDH) was 
diluted in PBS to give 0.075% solution.
ii. Solvent: 50:50 v/v mixture of Ethanol and O.lM 
Acetic acid.
(b) Procedure
1 . 2 0 0ul aliquots of hybridoma cells were pipetted into 
the wells of a v-bottom microtitre plate (Sterilin 
Ltd). The plate was then centrifuged in Beckman GPR 
bench top centrifuge with a special plate holder at 
ISOxg for 7 minutes.
2. The supernate was aspirated carefully, with a 
multichannel Finnpipette, by tilting the plates at 45®. 
The cells were resuspended in 200ul of pre-warmed
0.075% neutral red solution and incubated at 37®C for 
25 minutes in a 95% air 5% CO2 incubator.
3. Following incubation the plate was centrifuged again 
as described above and the dye aspirated as before. The 
cells were washed once in warm PBS to remove excess dye 
and the plate was centrifuged as described in (2 ).
4. After centrifugation, PBS was aspirated as above and 
discarded. The cells were then dissolved in ISOul of 
solvent to release cell bound neutral red. The Plate 
was centrifuged as above to pellet cell debris and
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lOOul of the solvent/dye mixture was transferred to the 
wells of a flat bottom ELISA plate.
5. The absorbance of the dye was measured with the 
MR600 spectrophotometer (Dynatech Ltd) using a 
reference wavelength of 630nm and a test wavelength of 
570nm. The plate was blanked with lOOul of solvent 
alone.
Controls containing just the culture medium were 
also set up to determine background absorbance with 
each test run.
Standard curve plots demonstrated a good 
correlation between cell number (nuclear material) and 
absorbance (see appropriate results section).
2.2.7 3-4,5 Dimethylthiazol-2,5 diphenyl tétrazolium
bromide (MTT) assay
The MTT assay, first described by Mosmann (1983), 
was used to determine the metabolic status of hybridoma 
cells. Modifications suggested by Twentyman and 
Luscombe (1987) were considered an improvement on the 
original protocol but did not satisfy the envisaged 
needs adequately. Therefore the MTT assay was further 
refined, as part of this work. The standardisation of 
the assay prior to its use in the screening programme 
is described in the relevant results section (chapter 
4).
(a ) Reagent
i . 3-4,5 Dimethylthiazol-2,5 diphenyl tétrazolium
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bromide (MTT); 5mg/ml MTT (Sigma) in MQ water.
ii. Dimethylsulphoxide (DMSO) (Sigma).
iii. RPMI 1540 without bicarbonate.
(b ) Procedure
1. Hybridoma cells were pipetted into the wells of a 
v-bottom microtitre plate in 2 0 0 ul aliquots and 
centrifuged at 150xg in the Beckman bench top 
centrifuge.
2. The supernate was aspirated as described in 
section 2 .2.6 (2 ) and the cells resuspended in 2 0 0ul of 
warm RPMI 1640 containing 20ul of MTT solution. The 
plate was then sealed with an adhesive seal (Flow Ltd) 
and incubated at 37®C for 4 hours.
3. The plate was again centrifuged as described above 
and the medium aspirated leaving only, the cells 
impregnated with MTT-formazan crystals. These crystals 
were dissolved with ISOul of DMSO.
4. lOOul of the dissolved crystals were transferred to 
to the wells of a flat bottom microtitre plate. The 
absorbance was determined with the MR600 
spectrophotometer using a test wavelength of 490nm and 
a reference wavelength of 630nm. The spectrophotometer 
was blanked with lOOul of DMSO alone.
The standard curves constructed demonstrated a 
good correlation between cell number and absorbance.
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2.2.8 Screening assay
A number of chemical compounds were screened as 
described below. The method used permitted the 
screening of four compounds per 24 well Linbro plates 
at five different concentrations with a control for 
each individual agent. The strategy used for screening 
compounds of interest is described below:
(a) Stage 1: Hybridoma cells (2xl0^/ml) were cultured 
in 2ml volumes in 24 well Linbro plates with test 
compounds at various concentrations for 24 hours,
(b) Stage 2: After incubation 200ul aliquots in 
triplicate were tranferred from each well to three 
individual wells of a microtitre plate (see below).
(c) Stage 3: The 200ul cell samples were processed
through the Neutral red assay (see sec. 2.2.5), MTT 
assay (see sec. 2.2.7) and ELISA (see sec. 2.2.5). The 
results from each assay were expressed as a mean of the 
three individual samples.
STAGE 1 STAGE 2 STAGE 3
N.RED
,3x200ul-- ^  ^ TT P\/~\/~\/~\/A/n
ELISA fi_i~L_n n n r
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2.3 Thymidine labelling of DNA
The measure of thymidine incorporation in DNA 
is the most commonly used method for quantifying 
cytotoxicity of chemical compounds. The procedure 
described by Freshney (1986) was used to measure the 
effect of some inhibitors on DNA synthesis in hybridoma 
cells.
(a ) Reagents
i. Radioisotope: [Methyl-®H] thymidine [5Ci/mmol]
(Amersham Int).
ii. Liquid scintillant: Cocktail '0' scintran (BDH).
iii. Trichloroacetic acid: 10% solution was made with 
distilled water by dissolving lOg into 100ml water.
iv. Solvents: 95% Methanol (BDH), Methanol/Ether 
mixture 50:50 mix v/v. Ether (BDH).
(b ) Procedure
Hybridoma cells were cultured in 25cm^ flasks with 
medium containing luCi radioisotope for 24 hours at 
37®C. These cells were then harvested and washed .thrice 
in warm PBS to remove excess radioisotope by 
transferring the contents of the culture flask into 
30ml universal tubes and centrifuging at lOOxg for 5 
minutes. The cells were then resuspended in 5ml 
ice-cold TCA and stood on ice for 10 minutes. The TCA 
step was repeated once more prior to resuspending the 
precipitate in 1 .5ml of methanol and transferring the 
contents into an Eppendorf tube. The precipitate was 
centrifuged at ll,600xg for 10 minutes and the methanol
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discarded. The pellet was then resuspended in a mixture 
of ether/methanol to dehydrate it and centrifuged as 
before. The solvent mixture was discarded and the 
pellet was resuspended in 1.5 ml of ether and 
centrifuged once more. Finally ether was discarded and 
the pellet allowed to dry in a fume hood. The dry 
pellet was dissolved in 1ml of liquid scintillant and 
allowed to stand for an hour before any further 
dilutions were made. The radioactivity of the sample 
was measured in a Rack Beta I scintillation p-counter 
model 1215 (LKB).
The p-radiation counts per minute per sample was 
directly proportional to the amount of radiolabel 
incorporated into cellular DNA.
2.4 Scanning Electron Microscopy
MAK 33 cells were fixed (on 0.7 cm diameter glass 
coverslips) for 20 minutes in 4% (w/v) glutaraldehyde 
at 4®C. The gluataldehyde was discarded and the fixed 
cells were dehydrated in a series of alcohol solutions 
for 10 minutes each, beginning with 30% ethanol in 
distilled water followed by 50%, 70%, 90%, 95% and 100% 
ethanol solutions. This was followed by passing the 
partially dehydrated cells through a series of 
ethanol/acetone mixtures in preparation for their final 
passage through neat acetone. Finally the cells were 
completely dehydrated in a critical point drier and
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vacuum coated with 200A of g o l d - p a l 1a d i u m . These 
samples were then viewed with a S-250 Cambridge 
Scanning Electron Microscope.
2.5 Calculation of specific rates
All the following expressions in this section were 
derived from those stated in 'Principles of microbe and 
cell cultivation' (Pirt 1975).
A. Growth rate and doubling time
The cell growth rate of a culture is expressed by 
the following equation;
p. = 1/X . dx/dt ........1,
where dx/dt expresses the change in viable cell number 
with respect to time, p represents the rate of change 
in cell growth and has the dimension of reciprocal time 
(l\t) and X is the viable cell number (10^/ml).
Integration of equation 1 produces the 
following expression;
InX = Iu Xq + p t ....... 2,
where X^ is the viable cell number when t=0. A plot of 
InX against time for a series of values during 
exponential phase generates a straight line with a 
gradient p. Equation 2 was used in this investigation 
to determine the growth rate of various cultures.
The doubling time (Td) is the time required for a 
culture to double its initial viable cell number, for 
example from X^ at t = 0 to 2X^ at t = Td, If the 
logarithms in equation 2 are converted to base 10 and
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Xq is replaced by 2X^ and t by Td then the doubling 
time of a culture can be determined by the following 
expression;
Td = In 2/p ........ 3.
B. Cell specific antibody production rate (CSAPR)
CSAPR is the rate of antibody production per 10^ 
cells ie. ug/10^ cells/hr. It is given by the 
following expression;
qA = dA/dt . 1/X ....... 4,
where qA is the CSAPR, A is the antibody concentration
in the supernatant, X is the viable cell number, and 
dA/dt is the rate of change of antibody 
concentration in the supernatant with respect to time.
C. Metabolite uptake rate
Glucose and glutamine uptake rates per 10^ cells 
ie. mg or mM/10^ cells/hr, were determined by the 
following expression;
Qu = dS/dt . 1/X  ...... 5,
where Qu expresses the metabolite uptake rate per 10^ 
cells, S is the nutrient concentration in the 
supernatant (mg or mM), dS/dt represents the change in 
glucose or glutamine concentration in the supernatant 
with respect to time and X represents the viable cell 
number.
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D. Metabolite production rate
Lactate and ammonia production rates per 10^ cells 
ie. mg or mM/10^ cells/hr, were determined by the 
following expression;
Qp = dP/dt . 1/X ........6 ,
where Qp expresses metabolite production rate per 10^ 
cells, P is the waste product concentration in the 
supernatant (mg or mM), dP/dt represents the change in 
lactate or ammonia concentration in the supernatant 
with respect to time and X represents the viable cell 
number.
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Chapter 3
Production kinetics of MAK 33 cells under normal and 
growth inhibited culture conditions
3.1 Introduction
Merten et al. (1987) reviewed three types of 
production kinetics for hybridoma cultures. Cells 
exhibiting types 1 and 2 (see section 1 ,7 .1 ) 
demonstrated non-growth dependent antibody production 
kinetics in batch culture. Antibody production in these 
cultures could be sustained under low growth rates 
(Tharakan et al., 1986; Phillips et al., 1987; Miller 
et al., 1988a; Harbour et al., 1989b).
In this chapter experimental results have been 
described which elucidate the type of production 
kinetics exhibited by hybridoma MAK 33. Also the 
feasibility of sustaining antibody production under 
growth inhibitory conditions imposed by nutrient 
limitation and specific growth inhibitors has been 
ascertained.
3.2 Materials and Methods
The determination of viable cell number and 
antibody concentrations were achieved as stated in 
chapter 2. Any modifications made are described where 
relevant in the text.
3.3 Results
3.3.1 Growth and production profile of hybridoma MAK 33 
in static flasks
Hybridoma MAK 33 cells were cultured in 25cm^
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flasks seeded with 2x10^ cells/ml and incubated at 37®C 
in air. 18 identical flasks were set up in duplicates. 
Each pair was harvested sequentially commencing from 
zero time and samples were recovered for cell counts 
and antibody determination.
Figure 3.1(a) illustrates a typical growth curve 
for hybridoma MAK 33 in static flasks. A maximum cell 
density of 7.8x10^ cells/ml was attained (usual range 
7-lOxlO^/ml) after approximately 80 hours (usual range 
65-75 h r s ) with a subsequent loss of cell viability. 
The mean specific growth rate during culture expansion 
was calculated to be 0.0165 hr“ .^
Antibody production was observed throughout the 
culture period. Fourty one percent of the accumulated 
antibody was produced during cell growth. Figure 
3.1(b) shows that this is accounted for by the increase 
in productivity experienced during lag phase within 22 
hours of culture initiation. The increase in antibody 
titre at 82 hrs coincides with the onset of cell death 
and an increase in cell specific antibody production 
rate (CSAPR). An antibody titre of 45ug/ml was 
typically observed for cultures under these conditions.
Figure 3.1(b) shows that in batch culture, growth 
rate and CSAPR are inversely related. This is 
p articularly pronounced during the growth period 
(0-60 hrs).
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Figure 3.1 : Cell growth and antibody production
profile of hybridoma MAK 33 in batch culture; (a) cell 
growth and antibody production, (b) growth rate and 
CSAPR.
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3.3.2 Serum limited growth
The effect of various growth rates on antibody 
production was investigated in this experiment. The 
growth rate was altered by culturing cells in medium 
containing different serum concentrations.
Cultures were seeded with a cell density of 
2xl0^/ml in 100ml of RPMI 1640 in ISOcm^ flasks. 
Experiments were set up with 1, 2, 5 and 10% new born 
calf serum in the medium. One millitre samples were 
recovered for cell counting and antibody determination 
every 12 hours for 120 hours.
Figure 3.2(a) illustrates cell growth curves 
observed at different serum concentrations. Although 
cell growth declined with decreasing serum 
concentration, a high cell viability was maintained 
even at 1 and 2% serum concentrations. Table 3.1 shows 
the mean growth rate over the growth period (0-60hrs) 
for each culture. The results of Table 3.1 taken 
together shows that a linear correlation (r=0.9684; 
0.02>P>0.05) was observed between serum concentration 
and growth rate indicating that serum concentration had 
a significant effect on the cell growth rate.
Figure 3.2(b) shows antibody accumulation with 
respect to time for cells cultured in the different 
serum concentrations. Antibody was produced throughout 
the growth period and continued after the onset of cell 
death at 60 hours but at a reduced rate. The antibody 
titres for cells cultured in 1, 2, and 5% serum were
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comparable and only a 9ug/ml difference was observed 
between 1% and 10% serum concentration. Tabulated in 
Table 3.1 are the mean cell specific antibody 
production rates over the growth period for cells 
cultured in different serum concentration. There does 
not appear to be a significant correlation (r=0.4253; 
0.1>P>0.5) between serum concentration and the mean 
CSAPR.
Figure 3.3 displays the results of Table 3.1. It 
can be inferred from the correlation curves that 
there did not appear to be a correlation (r=0.2920; 
P <0.5) between CSAPR and growth rate under these 
culture conditions. These results indicates that 
antibody production in MAK 33 cells is not dependent on 
cell growth (replication).
Table 3.1 : The mean growth rate, mean CSAPR and
doubling time for MAK 33 cells cultured in different 
serum concentrations.
Rates over growth 
period only
Serum concentration 
1 2  5
(%)
10
Growth rate (hr”^) 0.0147 0.0157 0.0193 0.0214
CSAPR (ug/lO^cells/hr) 0.0879 0.0981 0.0884 0.098
Doubling time (Hrs) 47 44.1 35.9 32.4
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Figure 3.2 : The effect of serum concentrations; 1%, 
2%, 5% and 10% on (a) cell growth and (b) antibody
production.
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Figure 3.3 : The effect of serum concentration on the 
mean growth rate and mean cell specific antibody 
production rate (CSAPR) over the growth period (curves 
are linear regressed).
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3.3.3 Inhibition o f cell growth using 1 imi ting 
concentrations of growth constituents.
In this experiment the differences in cell growth 
rate, and antibody productivity per cell were 
acertained under optimum and s u b -optimum culture 
conditions. Also an attempt was made to determine 
indirectly the method of antibody accumulation in the 
supernatant. Two growth constituents namely, serum 
and glutamine were used in particular combinations to
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provide the growth conditions mentioned above.
Two 25cm^ flasks containing 10ml of medium A and B 
were seeded with 2x10^ cells/ml. Medium A was composed 
of 2% new born calf serum and 0.25mM glutamine in RPMI 
1640, and supported limited cellular growth. Medium B 
contained 10% NBS and 2mM glutamine in RPMI and allowed 
unrestricted growth. Cells in both flasks were washed 
once in PBS and resuspended in fresh medium every day 
for 10 days to limit nutrient depletion and waste 
product accumulation. The viable cell counts and 
antibody concentration of each sample recovered daily 
were determined as described in chapter 2. Also cells 
recovered from the stock culture used to seed the 
flasks above were washed in PBS once and resuspended in 
1ml of sterile MQ water to generate concentrations of 
10^, 10^, 10^ and 10^ cells/ml. These cell suspensions 
were lysed by freezing in liquid nitrogen followed by 
rapid thawing in warm water. The antibody released was 
determined by the ELISA method.
Figure 3.4(a) shows cell growth and antibody 
production for hybridomas cultured in both media. 
Unrestricted growth was demonstrated by cells cultured 
in medium B. Antibody production accompanied cell 
growth and continued during decline phase. This 
continuation could not be ascribed soley to antibody 
release from dying/dead cells because it can be 
inferred from the results in Table 3.2 that
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concentrations of intracellular antibody are not 
sufficient alone to account for the increase in 
antibody titre observed during decline phase. The rise 
in CSAPR illustrated in Figure 3.5(b) for this culture 
suggests that antibody was actively synthesied and 
secreted during decline phase.
Antibody production and cell growth rate were both 
dramatically reduced by culturing the cells in medium A 
although the viability of this culture was comparable 
to that of the control over the 10 day period. However, 
cells grown under growth inhibitory conditions 
demonstrated a higher CSAPR than those cells cultured 
in medium B (see Figure 3.5(b)).
Viewing Figure 3.5(a) and (b) together shows that 
the growth rate and CSAPR of hybridoma MAK 33 are 
inversely related irrespective of the overall culture 
conditions corroborating the observation in the 
previous experiment that antibody production in this 
cell line is not dependent on cell growth and can be 
elevated when cell growth (cell division) is inhibited.
Table 3.2 : Antibody released from lysed MAK 33 cells
Lysed cell conc. /ml PBS Antibody released (ug/ml)
lO'^ 0 .0
1 0 ^ 0.09
loG 1.09
1 0? 8,7
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Figure 3.4 : Hybridoma MAK 33; (a) cell growth and
antibody production, and (b) cell viability, in medium 
A and B.
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Figure 3.5 : Cell growth and antibody production 
kinetics of cells cultured in medium A and B;
(a) growth rate, and (b) CSAPR.
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3.3.4 Growth inhibition with DNA synthesis inhibitors
It can be concluded from the results of the 
previous experiments that antibody production in MAK 33 
cells is enhanced in growth inhibitory culture 
conditions. This is because antibody production rate 
per cell is independent of cell growth rate in this 
cell line and many others (Merten, et al., 1987). The 
following experiment therefore investigates the effect 
of preventing cell proliferation by blocking DNA 
synthesis. The two inhibitors chosen were methotrexate 
and hydroxyurea. Methotrexate inhibits the enzyme 
dihydrofolate reductase thus restricting the 
availability of tetrahydrofolic acid an essential 
carrier molecule in the metabolic transfer of one 
carbon units in DNA synthesis (see section 1.9, 
Figure 1.6) Hydroxyurea inhibits the enzyme 
ribonucleotide reductase important in the conversion of 
nucleotides into deoxynucleotides. The optimum growth 
inhibitory, non-toxic, concentration for each compound 
for MAK 33 cells was established prior to this 
experiment (results not shown).
Three 50cm^ flasks were seeded with 2x10^ 
cells/ml, cultured in RPMI 1640 containing 2mM 
glutamine and 10% dialysed new born calf serum. One 
flask contained 2xlO~^M methotrexate, another lxlO~^M 
hydroxyurea and the third was used as a cell control. 
Samples for cell counts and antibody determination were
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recovered every 12 hours from the initiation of the 
experiment.
Figure 3.6(a) and (b) shows cell growth and 
antibody production for all three cultures. Table 3.3 
displays the mean values for cell growth rate and CSAPR 
over the first 72 hours (growth period). The figures in 
the parenthesis for cultures treated with the 
inhibitors indicate either an increase or decrease in 
the rates compared to the control.
These results demonstrate that methotrexate and 
hydroxyurea were both effective in selectively 
inhibiting cell growth without impairing antibody 
production. Although the CSAPR and cell growth rate 
were inversely related, the decrease in cell growth 
rate in each case was not accompanied by a 
proportional increase in CSAPR (see Table 3.3). 
However, these results do confirm the observations of 
previous experiments that growth inhibitory conditions 
enhance antibody production.
Figure 3.7 illustrates the cell growth and 
antibody production kinetics of the three cultures over 
the growth period only. Both growth dependent and 
independent antibody production was observed for the 
control culture (Figure 3.7a). However the same trend 
was not observed for the other two cultures. The growth 
rate and CSAPR in the drug treated cultures appeared to 
be inversely related. This relationship was maintained
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throughout the whole growth period. Such production 
kinetics indicate antibody production in MAK 33 cells 
is not dependent on cell growth.
These results show that inhibitors of DNA 
synthesis may be used to selectively inhibit cell 
growth rate without interfering with antibody 
production.
Similar results (data not displayed) were also 
observed when cells were cultured in media containing 
high concentrations of thymidine (DNA synthesis 
blocker) or lactate (cytostatic waste product) 
corroborating once more that growth inhibitory culture 
conditions bring about a rise in CSAPR in MAK 33 cells 
because antibody production in this cell line appears 
to be growth-independent.
Table 3.3 : The mean growth rate and mean CSAPR of drug 
treated and untreated MAK 33 cells.
Culturei conditions
Rates over growth Control HU MTXperiod only treated treated
Mean growth rate 0.0142 0.0129 0 . 0 0 2 1(hr  ^) (1 0%) (85%)
Mean CSAPR 0.0687 0.0923 0.0996(ug/10 cells/hr) (34%) (45%)
Figures in the parenthesis represent either a percentage increase or decrease in comparison to the control.
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Figure 3.6 : (a) Viable cell number and (b) antibody
concentration for the control c u l t u r e , met h o t r e x a t e  
treated culture and the hydroxyurea treated culture.
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Figure 3.7 : Cell growth and antibody production 
kinetics for, (s) control culture, ( b ) hydroxyurea 
treated culture and (c) methotrexate treated culture.
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3.4 Discussion
The data presented in this chapter showed that 
antibody production occurred continuously throughout 
the batch culture. The production kinetics demonstrated 
in Figure 3.1(b) resembles the type 2 production 
kinetics described by Merten et al. (1987). The highest 
CSAPR was observed during early exponential phase and 
during the onset of decline phase. These observations 
are consistent with those described by other authors 
(Merten et al., 1985; Birch et al., 1987; Velez et al., 
1987; Dalili and Ollis, 1989).
The apparent increase in antibody titre observed 
during entry into decline phase has been postulated by 
some to be due to the release of accumulated 
intracellular antibody from dying cells (Emery et al..
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1987; Emery and Al-rubeai 1990). The results presented 
in this section indicate that intracellular levels of 
antibody in viable cells are not sufficient to account 
for the increase in titre observed during decline 
phase. However, the increase in CSAPR of the remaining 
viable cells in the decline phase could account for 
the rise in antibody titre (Birch et al.,1987) as 
demonstrated by the experimental results. These 
observations are in accordance with those of Renard et 
al. (1988). They demonstrated that the increase in 
antibody titre during decline phase was due to antibody 
secretion by viable cells and not release from dying 
cells.
The rise in CSAPR during decline phase is most 
likely a consequence of the transition in the culture 
environment from being favourable to unfavourable for 
growth brought on by nutrient depletion. Condition 
unfavourable for cell division have been reported to be 
ideal for maximum antibody production (Phillips et al., 
1987; Miller et al., 1988a; Teillaud et al., 1989).
The concentration of new born calf serum in the 
medium had a distinct effect on both the growth rate 
and CSAPR. An increase in the serum concentration was 
accompanied by a concomitant rise in the mean growth 
rate of the hybridoma culture over the growth period 
(0-60hrs). This is illustrated in Figure 3.3 which 
shows the existence of a linear correlation between
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serum concentration and growth rate (r = 0 .9 684 ;
0.02>P>0,01 ) * Consequently higher cell densities and 
smaller doubling times were observed for cells cultured 
at 5% and 10% serum concentration than 1% and 2%, These 
results corroborate those of other authors who have 
concluded that serum is essential for cell growth (Low 
and Harbour, 1985; Tharakan et al., 1986; Dalili and 
Ollis, 1989).
However, there did not appear to be any 
significant correlation (r=0.4252; 0,1>P>0.5) between
the mean CSAPR and serum concentration in the range 
used in this investigation (see Figure 3.3). Similar 
observations have been reported by Renard et a l . 
(1988) and Lee et al. (1989) for their cell lines. The 
probability of any correlation existing between these 
two parameters below 1% NBS concentration is small, 
because the second author reported that cells cultured 
in media containing serum concentrations of 0.25% and
0.5% exhibited the same cell specific antibody 
production rates as those grown in 1 , 1.25, 5 , and 1 0%. 
These results indicate that serum is not essential for 
antibody production in MAK 33 cells.
The similarity in the antibody titres for cells 
cultured in 1, 2 and 5% NBS can be accounted for by 
the observation described by Schliermann et al. (1987). 
He reported that at low serum concentrations a greater 
proportion of cells aggregated in the G^-phase, the 
phase in which maximum antibody synthesis has been
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observed in lymphoid cells (Buell and Fahey, 1969; 
Byars and Kidson, 1970; Lerner and Hodge, 1970; Turner 
at al., 1985 Hayter, 1989). Therefore it is likely that 
cells grown in low serum concentration, although they 
exhibited the same CSAPR as those grown in high serum 
concentration, produced a larger volume of antibody 
over the growth period because a considerably larger 
proportion of cells resided in the G^-phase for longer 
periods.
The results presented in experiment 3.3.3 and
3.3.4 demonstrate that growth inhibitory conditions, 
whether achieved by nutrient limitation or by specific 
inhibitors of DNA synthesis enhance CSAPR. As shown in 
Figure 3.5(a) and (b), and also in Figure 3.7(b) and
(c) cell growth rate and CSAPR are inversely related 
for hybridoma MAK 33. This type of cell growth and 
antibody production kinetics has been observed by 
others for their cell lines (Velez et al., 1986, Low et 
al., 1987; Miller et al., 1988a; Ray et al., 1989) and 
is essential for maintaining high cell densities at low 
growth rates in perfusion cultures for the production 
of large amounts of monoclonal antibodies (Dean et al., 
1987; Velez et al., 1987).
Although growth inhibitory conditions are 
favourable for maximising antibody productivity per 
cell, it becomes apparent when the antibody titres of 
experiment 3.3.2 and 3.3.3 are compared with those of
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experiment 3.3.4, that the method of inhibiting cell 
division is of paramount importance when considering 
the development of new strategies for increasing the 
antibody yield per batch run. Inhibiting cell growth by 
means of limiting nutrients as used in the former two 
experiments, consequently reduced the antibody yield 
when compared with the control cultures although cell 
specific antibody production rates were either 
unaffected (expt 3.3.2) or raised (expt 3,3.3). Both 
serum and glutamine are important growth 
constituents in hybridoma culture media and are known 
to influence both cell growth and antibody production 
(Hayter, 1989). For example, glutamine is essential 
for DNA synthesis (Zetterberg and Engstrom, 1981), for 
generating energy for cell metabolism (Reitzer et al.,
1979) and antibody synthesis (Crawford and Cohen,
1985). Its depletion in growing cultures has recently 
been shown to be the direct cause of the cessation of 
antibody synthesis in hybridomas cells (Dalili and 
Ollis, 1990). Serum is known to contain growth 
stimulating factors such as albumin (Barnes and Sato,
1980) and insulin (Schubert 1979) which facilitate 
nutrient uptake. Hayter (1989) described results which 
showed that a high serum concentration in a growth 
inhibited culture increased the antibody yield. He 
proposed that this may be due to the stimulation of 
nutrient uptake by serum factors (James and Bradshaw, 
1984) providing a larger metabolic pool for protein
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synthesis. In view of these reports the concurrent 
increase in CSAPR and antibody yield observed in this 
investigation for cultures treated with MTX or HU can 
be ascribed to the fact that cell division was 
inhibited under optimum growth conditions ( 2 mM 
glutamine and 10% NBS). Similar observations were 
reported by Teillaud et al. (1989), An increase in 
CSAPR and antibody yield was noted in hybridoma 
cultures that were arrested in cell growth in optimum 
growth conditions with doxorubicin. These results may 
be explained by the suggestion offered by Hayter (1989) 
that the metabolic state of hybridoma cells in optimum 
growth conditions is more favourable for antibody 
synthesis and secretion.
In conclusion the results presented in this 
chapter demonstrate that :
1. Antibody production in MAK 33 cells appears to be 
growth-independent and dissociated from processes 
pertaining to cell division.
2. Growth arrested MAK 33 cells produce more antibody 
per cell.
3. Inhibiting cell growth by blocking DNA synthesis 
with specific inhibitors under conditions for optimum 
growth is feasible. Under such culture conditions MAK 
33 cells demonstrate a high antibody yield comparable 
to the control culture even though cell yield is 
considerably reduced. This is brought about by an
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increase in CSAPR.
The application of such compounds to larger 
cultures could provide a means to improving antibody 
yield in low producers. This calls for the need of a 
screening assay to identify substances with a potential 
of increasing antibody productivity per cell.
99
Chapter 4
The deve1opment and utilization of the screening assay
4.1 Introduction
It can be inferred from the previous chapter that 
inhibitors of DNA synthesis have the potential for 
specifically suppressing hybridoma cell division 
without impairing the production of monoclonal 
antibodies. Therefore the development of an assay for 
selecting compounds with these properties would be 
beneficial both for researchers seeking to separate 
cell growth and antibody production and for industries 
committed to improving existing strategies for large 
scale monoclonal antibody production.
Animal cells have been implicated in the isolation 
and testing of cytotoxic agents useful in tumour 
therapy since the late 1950’s (Arai and Suzuki, 1956; 
Eagle and Foley, 1958). Since then, many in vitro 
assays for screening chemical compounds utilizing 
animal cell cultures, have been developed (Freshney
1986). Most of them measure the action of compounds 
being screened by determining their effects on one of 
the following parameters; cell viability, cell 
function, cell morphology or cell reproductive capacity 
(see review Cook and Michell, 1989). The choice and 
nature of the assay is clearly dependent upon the 
eventual use of the compounds being screened. The 
development of a screening assay suitable.for this
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investigation was governed by a series of criteria 
which were closely related to the final context in 
which the assay was to be used, the availability of 
laboratory equipment and the cost. These were;
1. The ability to estimate nucleic acid content of 
cells, particularly DNA.
2. The ability to estimate the energy generating 
capacity of the cells.
3. The enumeration of viable cell number in 0.2ml 
samples of suspension cultures.
4. A microtitre plate assay enabling replicate samples 
to be assessed simultaneously.
5. A rapid and relatively reproducible assay.
Of the many types of biological techniques 
employed in the construction of screening assays only a 
few could be considered suitable when viewed with these 
criteria in mind. For example, protein assays 
(Bradford, 1976; Laughton, 1984; Shopsis and Mackay, 
1984), although rapid and reliable are non-specific. 
Therefore they are open to over estimation of cell 
number particularly when used for screening drugs which 
inhibit cell division without impairing protein 
synthesis. Other assays, known to be more specific 
than protein assays, are not appropriate because their 
specificity does not involve determining the nucleic 
acid content of cells (Koponen et al., 1982; Landegre, 
1984). Amongst those specific for determining the
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nucleic acid content of cells only those involving 
spectrophotometry are of any value. Procedures 
involving the radiolabelling (FitzGerald and Michael,
1987) or fluorescent staining of nuclear material (Funa 
et al., 1986) are technically demanding and require the 
use of expensive laboratory equipment. Amongst the 
nuclear staining techniques available, staining cells 
with Geimsa has been shown to be adaptable to 
microtitre plates for spectrophotometric analysis of 
replicate samples (Nilsson et al., 1983; Mirabelli et
al., 1985). However, the staining procedures reported
in these two cases are limited to anchorage dependent 
cells. Another water soluble stain reported to be 
specific for DNA (Parish and Mullbacher, 1983) is 
Neutral red. Its ability to stain viable suspension 
cells for the measure of cell survival has been 
reported (Kull and Cuatrecasas, 1981). Therefore, its 
use in conjunction with a tétrazolium salt MTT that 
determines the metabolic activity of viable cells 
appeared particularly suitable in designing an assay to 
meet all demands of the criteria layed out.
In this chapter experiments are described which 
demonstrate the suitability of both Neutral red and MTT 
in the development of the screening assay to the 
standard described in section 2.2,6 and 2.2.7. The 
hypothesis proposed later on in the chapter provided 
the basis for the work described in chapters 5 and 6 .
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4.2 Results
4.2.1 Neutral red assay
Neutral red is a water soluable weakly cationic 
dye which is believed to enter cells by non-ionic 
diffusion through the cell membrane of viable cells. 
Once inside it is has been proposed that it accumulates 
in lysosomes by some (Allison and Young, 1969) but 
others have suggested that it is trapped by cellular 
DNA (Parish and Mullbacher 1983). Neutral red has been 
utilised in testing the efficacy of tumour necrosis 
factor (Kull and Cuatrecasas 1981), the potency of 
cytotoxic T cells (Parish and Mullbacher 1983) and the 
effects of compounds on the growth of mammalian cells 
(Clonetic corporation pamphlet, 1990).
The experimental results for the optimisation of 
the assay are not shown in this chapter. They are 
displayed in Appendix 2 and are discussed briefly in 
the discussion section of this chapter.
4.2.1.1 Staining MAK 33 cells with neutral red
The location of the stain in viable cells was 
determined by microscopical examination.
1x 1 0 ^ cells from a culture in exponential phase 
were washed in warm PBS and resuspended in 1ml of 
prewarmed 0.036% neutral red solution (in PBS). The 
cell suspension was incubated at 37^0 for 20 minutes in 
an Eppendorf tube. After incubation the cell suspension
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was centrifuged at 150xg for 5 minutes to sediment the 
cells and remove excess dye. The cells were washed in 
PBS and centrifuged once again before finally being 
resuspended in 1ml of PBS, A 200ul aliquot was 
recovered and diluted with trypan blue solution to 
determine the viability of the cell suspension. Two 
50ul aliquots were pipetted onto warm glass slides and 
covered with plastic cover slips. The wet preparations 
were then examined microscopically to determine the 
location of the stain. 50 cells were counted from each 
slide randomly and the type of staining was noted as 
either;
1. Localised in the nuclear region, or,
2. Sporadically dispersed in the cytoplasm.
Photographs of stained cells were taken with a 
Nikon FE2 camera attached to a Nikon 108 phase contrast 
microscope. A Kodak colour gold G.A. 135 (24) Iso
1 0 0 \2 1° film was used for photography.
The viability of the culture after staining was 
shown to be 89%. Table 4.1 shows the results from 
counting stained cells. Almost all (99%) of the stained 
cells demonstrated neutral red dye localised within 
the nuclear region. Photographs 1 and 2 shown in Plate 
1, are of clusters of cells, and 3 and 4 of isolated 
cells. Some cells appear not to be stained even after 
20 minutes of incubation. These cells may be non-viable 
and therefore unable to take up the stain.
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Table 4.1 : Localisation of Neutral red stain within 
MAK 33 cells after absorption.
Localisation of 0.036% N. red cell no.
Nuclear region 99
Dispersed in the cytoplasm 1
Plate 4.1 : MAK 33 cells stained with 0.036% neutral 
red in PBS. Photographs 1, 2, 3, and 4 demonstrate the 
localisation of the stain (x320 mag.).
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4 . 2.1.2 Determining the specificity and action of 
Neutral red upon cellular components and metabolites
The results of the previous experiment indicated 
that neutral red stains the nucleus. Therefore in this 
experiment the nuclear components with which the dye 
reacts were identified. This was achieved by incubating 
individual nuclear components and cellular metabolites 
with the dye and monitoring the change in absorbance 
spectrum of neutral red. The suspected binding action 
of the dye to these cellular components was also 
acertained.
Two milligrammes of each component/metabolite 
(shown below) was diluted in warm PBS to give a 2mg/ml 
solution.
1. L-Glutamine 2 , L-Aspartate 3. L-Cysteine
4. L-Leucine 5. L-Serine 6 . L-Glutamate
7. RNA 8 . DNA 9. Histones
10. Thymidine 11. Uridine 12. Guanosine
An aliquot of 400ul of each solution was mixed 
with an equal volume of 0.075% neutral red dye diluted 
in PBS in an Eppendorf tube and incubated at 37^C for 
10 minutes. Two 200ul aliquots of each mixture was 
transferred to a flat bottom ELISA plate. The 
sample absorbance was measured using a Dynatech plate 
reader set at a test wavelength of 570nm and a 
reference wavelength of 630nm. The plate reader was 
blanked with 200ul of 0.075% neutral red dye alone.
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Also, lOOul of the above dye solution was 
incubated with lOOul of various phosphate buffers 
differing in pH. Included in the sample was lOOul of 
3M acetic acid solution of pH 2.24. The mixtures were 
made in the ELISA plate directly and the absorbance of 
each sample was measured as stated above.
Figure 4.1 shows the absorbance of neutral red dye 
after incubation with various nuclear and cellular 
components. The largest absorbance values (strongest 
reaction), observed were for the nucleic acids/dye 
mixtures corroborating the results of the previous 
experiment that neutral red stains the nucleus. A 
reaction was not observed when the dye solution was 
mixed with histone proteins suggesting that neutral red 
reacts specifically with DNA and RNA in the nucleus.
Other cellular components were also found to react 
with the dye. Glutamate, aspartate and cysteine were 
able to cause an absorbance change in the dye.
All of those components which caused a colour 
change when mixed with neutral red had two properties 
in common, they were weakly acidic in water and were 
negatively charged. This suggests that the reaction 
between these components and neutral red (cationic in 
solution) is analogous to the acid/base interaction 
(see Figure 4.3). This was confirmed by the results 
shown in Figure 4.2 demonstrating the influence of pH 
on the absorbance spectrum of the dye. The most acidic 
solution (3M acetic acid) was found to react strongly
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with neutral red in comparison to other pH buffers.
The results presented here indicate that neutral 
red binds to both DNA and RNA. The change in the 
absorbance spectrum of the dye upon contact with acidic 
solutions is manifested in a colour change from 
orange/red to mauve. The intensity of the colour 
(Absorbance value) is to some extent determined by the 
concentration of the negatively charged anions on the 
molecules (see Figure 4.3).
Figure 4.1 : The reaction of 0.075% Neutral red
solution with various nuclear components and cellular 
metabolites.
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Figure 4.2 : The absorbance of 0.075% neutral red
solution in various pH solutions.
A. 3M A c e tic  a c id  (pH  2.24)
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C. B u f fe r  (pH  7)
D. B u f fe r  (pH  9.2)
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Figure 4.3 : The interaction of a cationic molecule of 
neutral red with other anionically charged cellular 
components and metabolites.
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4.2.1.3 Radiolabelling of drug treated and untreated MAK 
33 cells
In this experiment a comparison was made between 
the neutral red test with a well established reference
oassay ( thymidine incorporation) for determining the 
effects of growth inhibitors on DNA synthesis. This was 
carried out to provided a more extensive evaluation on 
the potential use of the dye, in an assay designed to 
select agents specifically inhibiting DNA synthesis.
In this experiment 5-fluorodeoxyuridine (5-FUDR), 
an inhibitor of thymidylate synthetase was used at a 
concentration to partially inhibit DNA synthesis. 
5-FUDR inhibits pyrimidine synthesis by preventing dTTP 
production (H e i d e l b e r g e r , 1957 ) , [see Figure 1.6, 
chapter 1 ].
Two identical cultures (A and B) were established 
containing 2 x 1 0 ® cells/ml in 1 0 ml culture medium in
O25cm flasks. Two other flasks (C and D) were also set 
up exactly as stated above but containing lxlO“®M 
5-FUDR. All four cultures were incubated at 37^C in 5% 
CO2 and 95% air. One flask from each group (A and C) 
was radiolabelled with luCi H®-thymidine after 12 hours 
of incubation. Replicate samples from the remaining two 
flasks from each group (B and D) were recovered to 
determine the cell count and processed through the 
neutral red test described in section 2.2,6. All four 
cultures were then further incubated for another 24 
hours. After incubation the radiolabelled cultures were
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processed according to the method described in section
2.3 to determine the amount of radiolabel incorporated 
into cellular DNA. Samples from the unlabelled cultures 
were once again used to determine cell counts and 
processed through the neutral red test.
The results displayed in Table 4.2 shows the 
viable cell counts of both drug treated and untreated 
cultures at 12 and 36 hours. Table 4.3 shows 
neutral red uptake at 12 and 36 hours in drug treated 
cultures only. The increase in dye uptake is 
illustrated by an increase in absorbance and is 
indicative of the increase in nuclear material. Table
4.4 shows the results of H®-thymidine incorporation 
into DNA of both drug treated and untreated cells and 
therefore is a measure of the DNA synthetic activity in 
these cultures under the different culture 
conditions. Table 4.5 summarises the results of the 
above three tables for the drug treated culture only, 
enabling a comparison to be made between the neutral 
red test, viable cell count and thymidine 
incorporation.
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Table 4.2 : Cell counts for both drug treated and
untreated cultures at 12 and 36 hours. Figures 
represent the mean and standard deviation of replicate 
samples.
Time (hr) Unlabelled viable cell cultures no (1 0 ®/ml)
Untreated (B) Treated (D)
12 after culture 3.04 (±0,23) 2.32 (±0.37)
36 after culture 5.77 (±0.91) 2,76 (±0.17)
Increase in 24 hrs 89% 19%
Table 4,3 : Neutral red uptake by samples recovered 
from the drug treated culture at 1 2 and 36 hours. 
Figures represent the mean and standard deviation of 
replicate samples.
Time (h r ) Absorbance at 570/630nm
12 after culture 0,04 (±0.0033)
36 after culture 0.049 (±0.0033)
Increase in 24 hrs 2 2%
Table 4.4 : The results of radiolabelling both drug 
treated and untreated cultures for 24 hours. Figures 
represent the mean and standard deviation of replicate 
samples.
Untreated (A) Treated (C)
Radioactivity (CPM) 3177 (±378) 789 (±439)
Isotope incoporationas a percentage of the untreated culture 1 0 0% 24.8%
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Table 4.5 : Summary of the results for the drug treated 
culture, (1) the % increase in cell count over 24 
hours, (2 ) the % increase in neutral red uptake over 24 
hours, and (3) H^-thymidine incorporation over 24 
hours expressed as a % of the control.
1 2 3
5-FUDR treated 19% 2 2% 24.8%culture
The results of Table 4.5 are depicted in Figure
4.4.
It would follow that if neutral red binds 
predominantly to DNA, then any increase in the 
content of cellular DNA, over the 24 hour period would 
be detectable by neutral red test. Also, because DNA 
synthesis precedes any changes in intracellular DNA 
content of viable cells which in turn precedes cell 
division, comparable results would be anticipated 
between the assays that measures them over a fixed 
period of time. The results of Table 4.4 illustrates 
this to be the case. Figure 4.4 shows that DNA 
synthesis measured by H^-thymidine incorporation for 
the drug treated culture over 24 hours is accompanied 
by almost the same percentage increase in neutral red 
uptake (DNA content of cells) and viable cell number 
over the same period. Therefore these results seem to 
suggest that neutral red test as described in section
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2 .2.6 is capable of determining small increments in the 
intracellular DNA content of viable cells.
The following conclusion can be drawn from the 
observations so far made in experiments 4.2.1.1, 
4.2.1.2, 4.2.1.3;
a. Neutral red stains the nucleus of viable cells.
b. Neutral red reacts with both DNA and RNA.
c. The neutral red test is capable of detecting small 
increments in DNA content of viable cells.
These observations viewed with the understanding 
that less than 7% RNA is found in the nucleus 
demonstrates the suitability of the neutral red dye for 
the developement of an assay required to screen agents 
which have the potential of inhibiting DNA synthesis.
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Figure 4.4 : Cellular changes in drug treated cells 
over a 24 hour period. Represented below is the 
increase in viable cell count, DNA content measured by 
neutral red staining and DNA synthesis measured by
qH -thymidine incorporation.
A. V iab le  cell count
B. N e u tra l re d  s ta in ing
C. H —Th ym id in e  in c o rp o ra tio n
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4.2.1.4 The sensitvity of the neutral red test
The results of the previous experiments viewed 
together demonstrate the specificity of neutral red for 
cellular DNA, but do not provide information on the 
ability of the dye to enumerate viable cells in small 
sample volumes. For the neutral red test to be 
successfully employed in the development of an assay 
fulfilling all the criteria described in section 4,1 of 
this chapter, it is necessary for the dye to able to
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enumerate 2-4x10^ to 20-25x10^ cells per 200ul sample 
in microtitre plates. These cell concentrations 
correspond to 1-2x1 0  ^ to 1 0-1 2 .5xl0^cells/ml which are 
usually observed during normal batch culture.
Cells from a culture in exponential phase were 
washed once in PBS and diluted to give the following 
concentrations, 1.5x10^, 0.75x10^, 0.375x10^,
0.187x10^, and 0.093xl0^cells/ml PBS. Replicate samples 
(9x200ul) of each cell preparation were pipetted into 
the wells of a V-bottom microtitre plate (Sterilin 
Ltd). Likewise, replicate samples (BxlOOul) were also 
pipetted into Eppendorf tubes and diluted 1/11 with 
trypan blue solution to determine the exact viable cell 
concentration in each 200ul sample. The microtitre 
plate was sealed with a plastic seal and processed 
through the neutral red test as described in section 
2.2,6. Table 4.6 Shows the result of neutral red 
uptake by various concentrations of viable cells in 
2 0 0ul aliquots.
Table 4.6
Viable 
1 0^ per cell2 0 0ul number aliquot (N=8 ) Neutral red uptake Absorbance at 570/630nm
X SD CV X SD CV
29.31 1.89 6.6 0.411 0.0062 1.518.39 0.81 4.4 0.254 0.0087 3.49.7 0.69 7.1 0.128 0 .01 7.85.31 0.39 7.8 0.081 0 . 0 0 2 2.52.77 0.39 14 0.036 0.0035 9.70 0 0 0.004 0 0005 11.1
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Figure 4.5 below, shows the plot of viable cell 
number against neutral red uptake (absorbance). The 
results show that the neutral red test as it stands 
(sec. 2.2.5) is sensitive enough to enumerate 2-4x10^ 
cells per 200ul sample. The mean intraplate 
well-to-well variation for the absorbance values is 
demonstrated by a coefficient of variance of 6 %. 
These results also demonstrate the existence of a 
linear correlation (r=0.9991) between viable cell 
number and neutral red uptake for the cell 
concentration range tested. Therefore it can be 
inferred that the neutral red test is not only 
sufficiently sensitive but also capable of detecting 
changes in viable cell number in small volumes.
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Figure 4.5 : The correlation between neutral red 
uptake (absorbance) and viable cell number in 2 0 0 ul 
cell samples. Each point represents the mean -/+ 
standard deviation of 9 determinations.
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4.2.1.5 The reliability of the neutral red test
In this experiment the reliability of the neutral 
red test was determined by attempting to reproduce the 
results for neutral red uptake, for cell samples of the 
same concentration between different assay runs.
Five separate assays were performed within a 3 day 
period on replicate samples recovered from the same 
cell culture maintained in exponential phase. For each
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assay, the cell samples recovered were washed in PBS 
and diluted to give the following cell concentrations 
5, 10, 15, 20, and 25x10"^ cells per 200ul aliquots. 
Replicate samples (6x200ul) from each cell preparation 
were pipetted into the wells of a V-bottom microtitre 
plate as described in experiment 4.2.4 and processed 
through the neutral red test.
Table 4.7 displays the results for neutral red 
uptake by various cell concentrations for all the 
five assays.
Figure 4.6 depicts the difference in the results 
between each assay for neutral red uptake when cells of 
the same concentration were processed through the 
neutral red test. Neutral red uptake by cells of the 
same concentration varied from one assay to another. 
This is also demonstrated in Figure 4.7 showing the 
pooled results of all five assays. The mean value for 
the coefficient of variance at any particular point 
along the curve for the cell concentrations tested was 
calculated to be 10.18%. Therefore it can be concluded 
that the neutral red test described in section 2 .2.6 is 
reliable. The results are reproducible to within a 
range of +/- 10.18% of the mean from assay to assay.
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Table 4.7 : Results of neutral red uptake for five 
individual assays. Each value represents the mean of 6 
determinations,
Assay no. Cell concentration (lxl0^/200ul)
0 5 10 15 20 25
1 0.007 0.060 0.119 0.179 0.238 0.298
2 0 . 0 1 1 0.075 0.143 0.209 0.275 0.343
3 0 . 0 1 0 0.061 0.115 0.170 0.224 0.280
4 0.009 0.059 0 . 1 1 0 0.163 0.216 0.268
5 0.006 0.059 0.123 0.185 0.233 0.280
X 0.008 0.063 0 . 1 2 2 0.181 0.237 0.293
SD (-/+) 0. 0 0 2 0.007 0.013 0.018 0.023 0.030
CV (%) 24.1 10.9 10.4 9.7 9.6 10.3
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Figure 4.6 : Neutral red uptake by viable cells in five 
individual assays. Each point is a mean of 6 samples.
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Figure 4.7 : Inter-assay variation in the neutral red
test. Each point represents the mean -/+ standard 
deviation of 5 assays (n=6 for each assay).
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4.2.2 MTT assay
MTT (3-{4,5-dimethyl thiazol-2-yl}-2,5-diphenyl 
tétrazolium bromide) is a yellow tétrazolium salt, 
which upon absorption by viable cells is reduced by the 
mitochondrial enzyme succinate dehydrogenase to a 
purple insoluble product called formazan (Slater et 
al., 1963; Mosmann, 1983). Formazan absorbs light of a 
different wavelength to MTT and therefore its 
concentration can be determined spectrophotometrically 
with relative ease. This permits the measure of the 
activity of succinate dehydrogenase in viable cells. 
Because this enzyme plays a key role in energy 
production, an estimation of the energy generating 
capacity of the cell can be determined by assessing the 
change in the state of MTT. MTT has been widely used in 
assays screening cytotoxic agents (Park et al., 1987; 
Carmichael et al., 1987) and also for determining the 
metabolic activity of hybridoma cells (Wilson and 
Spier, 1988; Al-Rubeai and Spier, 1989).
The procedures used to optimise and adapt the 
neutral red test to a 96-well V-bottom plate were also 
applied to the MTT assay described by others (Mosmann, 
1983; Twentyman and Luscombe, 1987) to modify the assay 
to suit the screening programme described in sec 2 .2 .8 . 
The results leading to the optimisation of the MTT 
assay described in scetion 2.2.7 are shown in Appendix
3. They are briefly referred to in the discussion
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section of this chapter. Described below are 
experiments which demonstrate the sensitivity and 
reliability of the MTT assay in section 2.2.7.
4.2.2.1 The sensitivity of the MTT assay
A cell suspension of 1.25x10^ cells/ml was 
prepared in RPMI 1640 culture medium devoid of sodium 
bicarbonate but containing 5mg/ml MTT. It was diluted 
in a 1 : 2 ratio several times in the same medium to 
produce a series of cell suspensions differing in cell 
concentration. Replicate samples (6x200ul) of each cell 
preparation were pipetted into the wells of a V-bottom 
microtitre plate. The plate was sealed with a plastic 
adhesive seal and processed through the MTT assay as 
described in section 2.2.7. Numerous wells on the plate 
were occupied with just the culture medium. These were 
used to determine any non-specific production of 
formazan from MTT due to the constituents of the 
culture medium. Several lOOul aliquots were recovered 
from each cell suspension and diluted to a ratio of 
1:11 with trypan blue solution to determine the precise 
viable cell count in each cell preparation. The results 
of the viable cell counts and absorbance due to 
formazan production are found in Table 4.8 below. 
Figure 4.8 shows that a linear correlation (r=0.9967) 
was found to exist between absorbance due to formazan 
production and viable cell number in 2 0 0 ul cell 
samples. This correlation extended over the range of
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cell concentrations tested. The MTT assay was sensitive 
enough to detect 6.5x10^ cells per 200ul samples which 
extended beyond the range required (2-4x10'^ 
cells/2 0 0ul).
Table 4.8 : Variation in absorbance due to formazan 
production in samples containing different viable cells 
concentrations.
Viat(1 0 -)le cell no. V2Q0ul) N=3 Absorbance at 490/630nm N=6
X X SD
24.3 0.540 0.02812.3 0.303 0.0187.6 0.165 0.0233.08 0.098 0.003
0 .66 0.023 0.002
0 0.007 0.001
Figure 4.8 : Correlation between absorbance due to 
formazan production and viable cell number in 2 0 0 ul 
cell samples. Each point represents the mean -/+ 
standard deviation of 5 determinations.
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4.2.2.2 Determination of the intra-assay variability 
for the MTT assay
Experiment 4.2.2.1 was repeated but with one 
modification. The sample number for determining cell 
count and formazan production was increased.
The results for viable cell count and absorbance 
due to formazan production in 2 0 0 ul samples are 
tabulated in Table 4.9 and displayed in Figure 4.9.
Table 4.9 : Variation in absorbance due to formazan 
production in samples containing different viable cell 
concentrations.
Viable cell (10r / 2 0 0ul) no.(N=8 ) Absorbance at (N=8 ) 490/630nm
X SD X SD CV
27.27 2.7 0.626 0 . 0 2 1 3.313.42 2 0.334 0.025 7.4
6 .6 0.6 0.187 0.014 7.42.9 0.8 0 . 1 0 0 0.007 7
1.1 0.2 0.051 0.005 9.8
0 0 0.005 0 . 0 0 2 40
Figure 4,9 corroborates the linear correlation 
(r=0.9995) between viable cell number and absorbance 
due to formazan production observed in the previous 
experiment. The mean intraplate well-to-well variation 
over the whole range of cell concentrations processed 
was demonstrated by a coefficient of variance of 6.89%.
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Figure 4.9 : The correlation between formazan
production in MAK 33 cells and viable cell number in 
200ul samples. Each point represents the mean -/ + 
standard deviation for 8 determinations.
0.7
CO 0. b r= 0 .9 9 95
V iab le  cell no. (1x10  /2 0 0 u l)
4.2.3 The proposal and testing of a hypothesis which 
states that DNA synthesis inhibition in MAK 33 cells 
will bring about an increase in C S A P R .
Antibody production in MAK 33 cells was shown to 
be independent of cell growth in chapter 3 and 
therefore could be sustained in the absence of cell 
division. Also the CSAPR was shown to be elevated by 
arresting cell growth with inhibitors of DNA synthesis.
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Therefore on this premiss it was proposed that any 
extraneous compounds with the ability to arrest DNA 
synthesis without interfering with RNA transcription or 
translation and cellular metabolism would elevate 
CSAPR. To identify compounds with the ability to invoke 
such a response in hybridoma cultures, a new parameter 
called the GROWTH QUOTIENT (G Q ) was introduced. The 
derivation of GQ is shown below;
Neutral red uptake by drug treated cultures X 100....A Neutral red uptake by untreated cultures
Formazan production in drug treated cultures X 100.,,B Formazan production in untreated cultures
GROWTH QUOTIENT = -A
Key: A; Provides information on the effect of any
compound on the DNA synthesis in MAK 33 cells.
B; Provides information on the effect of any 
compound on the metabolic activity (energy generating 
capacity) of MAK 33 cells.
According to the hypothesis, a substance that 
specifically inhibits DNA synthesis to a greater extent 
than metabolism would be expected to generate a GQ 
value less than 1. A rise in CSAPR would be anticipated 
in such a case. Conversely, a decrease in CSAPR would 
be observed when the value of GQ is greater than 1. 
This would indicate that the substance has exerted a 
disproportionate effect favouring DNA synthesis. 
However, in the case where a GQ value of 1 is generated
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it can be inferred that the substance under test has 
had either a negligible or equal effect on both DNA 
synthesis and cellular metabolic activity. In this case 
CSAPR can either be expected to decrease or remain 
unchanged.
The use of GQ to measure the effect of a compound 
on the CSAPR was evaluated by culturing hybridoma 
cells with three chemicals of different primary 
action. These were;
(a) Hydroxyurea (Hu) : An anticancer agent known to 
prevent the conversion of nucleotides to 
deoxynucleotides in mammalian cells (Sinclair, 1967). 
Its action on DNA synthesis has also been reported to 
affect RNA synthesis (Mironescu and Ellen, 1977).
(b) Cytoarabinoside (Ara-C) ; A drug used in cancer 
therapy which specifically arrests DNA synthesis by 
inhibiting the enzyme DNA polymerase responsible for 
initiating DNA replication (Furth and Cohen, 1968).
(c) Cycloheximide (Cyc) : An inhibitor of peptidyl 
tranferase. Its inhibitory action on DNA replication is 
rapid and indirect through its action on protein 
synthesis (Hodge et al; 1969).
Hybridoma cells were cultured in 2ml growth medium 
in 24 well Linbro plates with an initial cell density 
of 2x10^ cells/ml. Cells were either treated with a 
drug of specific concentration or left untreated. The 
concentration range tested is shown below in the 
results table. After 24 hours incubation, replicate
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samples (3x200ul) were recovered from each well and 
processed as described in chapter 2 through the 
neutral red assay, MTT assay and ELISA.
The results presented in Tables 4.10, 4.11 and 
4.12 are those for Hu, Ara-C and Cyc respectively. The 
values represent the mean and standard error of the 
mean (parenthesis) for three separate experiments 
performed at different times (n=3 for each expt.). The 
values for cell number (DNA content determined by 
neutral red assay) and CSAPR (ug/cell number/24hr) are 
expressed as a percentage of those observed for the 
control cultures (untreated cultures).
Table 4,10 ; Hydroxyurea; Results for cell number, GQ, 
and CSAPR.
Drugcone, (M ) l x l O “ 4 5 x l O “ 5  2 . 5 x l O “ 5  1 . 2 5 x l O “ 5
Cell no. 6 2  ( 1 . 4 4 ) 8 6  ( 1 . 3 3 )  1 0 0  ( 0 . 6 6 ) 9 7  ( 1 . 0 )
GQ 1 . 0 9 ( 0 . 0 2 3 ) 1 . 1 0 ( 0 , 0 5 2 )  1 . 0 9 ( 0 . 0 2 7 ) 1 . 0 4 ( 0 . 0 3 )
CSAPR 9 2  ( 1 3 . 3 ) 7 . 9  ( 4 . 0 )  7 4  ( 5 . 0 ) 86 ( 1 1 . 3 )
Table 4,11 : Cytoarabinoside; Results for cell number, 
GQ and CSAPR.
Drug 3.3x10-7 1,65x10-7 8,25x10“® 4.12x10“®cone. (M )
Cell no. 49 (5.4) 51 (4.4) 66 (3.7) 76 (6 .6 )
GQ 0,89(0.004) 0,86(0.005) 1.04(0.007) 1.08(0.006)
CSAPR 154 (3.5) 148 (11,4) 116 (4.9) 108 (17,6)|
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Table 4.12 : Cycloheximide; Results for cell number, GQ 
and CSAPR.
Drugcone. (M ) 5x10“® 2.5x10“7 1.25x10”7 6.25"®
Cell no. 63 (3.5) 73 (0.35) 77 (2.0) 73(5.3 )
GQ 0.93(0.023) 0.94(0.046) 0.88(0.052) 0.80(0.098)
CSAPR 27 (7.3) 34 (2.0) 46 (7.6) 72 (8)
Figure 4.10 (a), (b) and (c) shows the
correlation between GQ and CSAPR for each drug tested 
at various drug concentrations. A good correlation was 
found to exist for Ara-C (r=-0.9799 ) between the two 
parameters. This response was observed also for 
cultures treated with Cyc (r=-0.9714). However in this 
case values less than 1 for GQ did not show the 
anticipated rise in the CSAPR as observed for Ara-C 
treated cultures. This is most likely due to the 
action of Cyc on protein synthesis. This indicates that 
all compounds demonstrating GQ<1 are not necessarily 
favourable for antibody production.
Values of 1 or slightly above for GQ were observed 
for cultures treated with Hu. According to the 
hypothesis such cultures would demonstrate either a 
negligible change or a slight decrease in the CSAPR. 
The results of this culture confirms this 
presupposition. There was no significant correlation 
(r=-0.2948) between GQ and CSAPR for the cells treated 
with Hu.
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The variation involved in calculating GQ values 
for a large sample (n=55) of untreated cultures 
(controls) was used to determine the statistical 
significance of the results observed for drug treated 
samples (results presented below).
X = 0.982 (theoretical value 1.0), for N=55
1 SD = “/+ 0.06 (6 8% significance); range 1.042-0.922
2 SD = -/+ 0.12 (95% significance); range 1.102-0.862
These results demonstrate a probability of 0.95 
for any future GQ values for untreated cultures to fall 
within a range of 1.102-0.862. Hence it can be said 
that GQ values for drug treated cultures falling 
outside this range are 95% significant. For those 
results it can be said that the GQ value is a product 
of the direct action of the compound on DNA replication 
and metabolic activity and not due to statistical 
variance.
The results shown in this investigation indicate 
that the GROWTH QUOTIENT is a useful index for 
selecting chemical compounds which can inhibit DNA 
replication without affecting cell metabolism. The GQ 
also permits the estimation of the effect of a compound 
on CSAPR.
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Figure 4.10 : The correlation between the growth 
quotient and CSAPR for drug treated cultures; 
(a) Hydroxyurea, (b) Cytoarabinoside and 
(c) Cycloheximide. Each point represents the mean -/+ 
SEM of 3 experiments (n=3 for each expt.).
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4,2.4 Screening of chemical agents
The growth quotient formulated and tested in the 
previous investigation was applied to the screening 
assay described in sec 2.2.8. The compounds screened 
are found in Appendix 4.
From the compounds screened those which 
demonstrated the desired correlation between GQ and 
CSAPR were; Ascorbic acid. Retinol, 6 -Mercaptoethanol, 
Trifluorothymidine, and 5-Fluorodeoxyuridine. However, 
only the latter two agents were able to achieve similar 
results upon repeated trials. The results of these two 
inhibitors are presented in Figure 4.11 (a) and (b). 
The individual points on both curves shown in Figure 
4.11 fell within a significance limit of 68-95% or 
>95%. The correlation coefficient for each curve shows 
that both compounds were capable of inhibiting DNA
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synthesis and elevating CSAPR concurrently.
Figure 4.11 : Correlation between the Growth
quotient and CSAPR for (a) Trifluorothymidine, and 
(b) 5-Fluorodeoxyuridine.
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4.3 Discussion
The results described in this chapter demonstrate 
the suitability of neutral red and MTT in the 
construction of a screening assay meeting the criteria 
as set out in section 4.1. The assay designed 
permitted, the selection of compounds specifically 
inhibiting DNA synthesis without affecting the 
metabolic activity of viable cells. It also allowed the 
action of chemical agents on the CSAPR to be 
ascertained. This was achieved by a combined use of 
neutral red and MTT in a screening strategy developed 
to test both compound treated and untreated cells in 24 
well Linbro plates simultaneously as described in 
section 2 .2 .8 .
A. Suitability of Neutral red dye
The results of experiment 4.2.1.1 demonstrated 
that neutral red taken up by viable cells tended to 
localise within the nuclear region. This is clearly 
illustrated by the photographs of stained cells in 
Plate 4.1. The specificity of neutral red for nuclear 
material was confirmed by results shown in section 
4.2.1.2. When the dye was allowed to react with various 
nuclear components or cellular metabolites, nucleic 
acids (DNA and RNA) in particular reacted strongly with 
neutral red (see Figure 4.1). The interaction between 
neutral red and nucleic acids is most likely a simple 
acid / base reaction. Both, low pH buffers (<7) and
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nucleic acids caused a noticeable colour change when 
incubated with 0,075% of the dye solution (see Figure 
4.2) which was quantifiable with a spectrophotometer. 
However, a similar, but weak, colour change was also 
observed upon mixing neutral red solution with 
solutions of glutamate, aspartate and cysteine. A 
common property noticed amongst all the substances 
which reacted with neutral red was the anionic charge. 
It appears that the cationic charge of neutral red when 
in solution attracts anions when coincubated with 
negatively charged molecules. Neutral red most likely 
binds to the phosphate linking groups of DNA and RNA 
molecules in viable cells. However, because 90-95% of 
all nucleic acid in the nucleus is composed of DNA, 
neutral red probably only binds to DNA once absorbed. 
Parish and Mullbacher (1983) reported that neutral red 
is trapped by DNA molecules once absorbed by the viacle 
cell.
The ability of neutral red to detect small 
increments in the DNA content of viable cells was 
ascertained in experiment 4.2.1.3. The results 
displayed in Table 4.5 and Figure 4.4 shows that an 
increase in the DNA content of viable cells, as a 
consequence of DNA synthesis, in partially inhibited 
cultures over a period 24 hours was quantifiable almost 
equally by both radiolabelling and neutral red 
staining. A comparison of the results presented in 
Tables 4.2 and 4.4 shows that the standard deviation
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for replicate samples processed through the neutral 
test is much lower than that of thymidine
incorporation for the drug treated culture. This 
suggests that neutral red test is not only comparable 
to the standard radiolabelling method but also more 
reliable in detecting small changes in intracellular 
DNA content.
B .  The optimisation of Neutral red test
The results which contributed to the optimisation 
of the more important parameters involved in 
establishing the neutral red assay to the standard 
described in section 2.2.6 are shown in Appendix 2. 
Figure A in Appendix 2 shows that a 35 minute 
incubation period was required for maximum neutral red 
uptake by viable cells. However, in another experiment 
(results not shown) the viability of the culture 
declined after 25 minutes of incubation with 0,075% 
neutral red solution. Therefore the incubation time for 
the assay was fixed at 25 minutes. Parish and 
Mullbacher (1983), and Borenfreund and Puerner (1985) 
demonstrated maximum neutral red uptake at 10 miunutes 
and 3 hours respectively for their cell lines. The 
optimal dye concentration for the assay was determined 
to be 0.075% (see Figure b). Although larger 
absorbance readings were observed at higher 
concentrations, the background reading for the stain 
alone was too high therefore higher concentrations
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were not considered further. Figure C shows that a 
mixture of O.IM acetic acid and ethanol (50:50 v/v) was 
far more efficient at extracting neutral red from cells 
than the other solvents.
C. The reliability and reproducibility of the Neutral 
red test
Once a protocol for the neutral red test was 
established as described in section 2 .2 . 6  the 
reliabilty and sensitivity of the test were 
ascertained. Figure 4.5 of section 4.2.1.4 demonstrates 
the ability of the neutral red test in enumerating 
2x10^ cells per well (O.D. 0.036). This value is lower 
than that reported by others for their cell lines 
(Parish and Mullbacher, 1983; Borenfreund and Puerner, 
1985). The sensitivity of the assay therefore may be 
related to the ability of individual cell lines to 
absorb neutral red (Parish and Mullbacher, 1983).
Figure 4.5 also shows the existence of a linear 
correlation (r=0.9991) between viable cell number in 
200ul samples per well and neutral red uptake. This 
correlation stretched over the cell concentration range 
(2x10^-30x10^ cells/0.2ml) tested. This range covered 
that usually observed during batch cultivation of MAK 
33 cells. Therefore the test permitted the 
determination of small differences in viable cell 
number between 0.2ml samples. This was essential 
because the neutral red test was later utilized for 
the screening of many compounds within a narrow
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concentration range. The small differences in the drug 
action upon cell number between similar concentrations 
could only be detected if the test was sufficiently 
sensitive.
The mean coefficient of variation for intraplate 
well-to-well variation was 6% for the whole range of 
cell concentrations tested. This is within the range 
(4-10%) reported by others for their colorimetric 
assays designed to enumerate cell concentrations in 
0.2ml samples in 96 well microtitre plates (Laughton, 
1984; Shopsis and Mackay, 1984; Parish and Mullbacher, 
1983; Borenfreund and Puerner, 1985).
The interplate variation for replicate samples is 
illustrated in Figures 4.6 and 4.7. The variation 
between assay results for the same cell concentrations 
was 10.18%. This variation is most likely to arise 
during the final step in the procedure described in 
section 2.2.6 which involves transferring lOOul 
volumes from one microtitre plate to another.
D. The optimisation of the MTT assay
For the MTT assay there was no need for 
ascertaining the suitability of the tétrazolium salt in 
estimating the metabolic activity in viable cells. Much 
of this work has already been accomplished by Slater et 
al, (1963) and Mosmann (1983). Also its application to 
various drug testing programmes have been extensively 
reviewed (Alley et al., 1986; Carmichael et al., 1987;
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Park et al., 1987). However, it was still necessary to 
ascertain its adaptability to hybridoma cultures in 96 
well V-bottom microtitre plates.
The results presented in Appendix 3 are those of 
experiments which contributed to the optimisation of 
the MTT assay for MAK 33 cells. It was discovered that 
both bicarbonate and serum in the culture medium 
reduced the amount of light absorbed by formazan at 
490nm (see Figures A and B). Bicarbonate caused this 
lowering effect by causing a shift in the maximum 
absorbance peak of formazan from 490nm to 570nm. The 
precise mechanism for serum was not known but was 
suspected to be involved with reducing the production 
of formazan crystals in viable cells.
Figure C shows that maximum formazan production 
for a given cell concentration was observed when cells 
were cultured in RPMI 1640 containing 5mg/ml MTT. This 
observation was in accordance to that described by 
Twentyman and Luscombe (1987) for their cell line. 
Figure D shows that optimum incubation time for 
formazan production by MAK 33 cells cultured in medium 
containing 5mg/ml was 4 hours. Only a slight increase 
in absorbance was detected when the incubation period 
was extended to 8 hours.
The results presented in Appendix 3 clearly 
demonstrate all the optimum conditions required for the 
MTT assay adapted for MAK 33 cells. In conclusion, it 
was necessary to incubate MAK 33 cells in RPMI 1640
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medium containing 5mg/ml MTT but devoid of bicarbonate 
and serum.
E. The reliability and reproducibility of the MTT assay
The sensitivity of the MTT assay was determined in 
experiment 4.2.2.1. As little as 6.6x10^ cells per 
2 0 0 ul sample per well could be enumerated with less 
than 7% (mean C V ) intraplate well-to-well variation. 
The variation over the cell concentration range tested,
0.66x10^-24x10^ cells/0.2ml, ranged from 3.3-9.8 % (see 
Table 4.9). Both Figure 4.8 and 4.9 show that a linear 
correlation (r=0.9967 and r=0.9995 respectively) was 
observed between formazan production and viable cell 
number over the cell concentration range tested. This 
indicates that the MTT assay described in section 
2.2.7 is capable of discerning small differences in 
viable cell number in 0 .2ml samples with a good degree 
of accuracy.
F . The proposal and testing of the hypothesis
The derivation of the growth quotient (GQ) is 
described in section 4.2,3. It was established from the 
understanding that antibody production in MAK 33 cells 
was growth-independent. The function of the GQ was to 
serve as an index to measure the action of any chemical 
compound on DNA synthesis and metabolic activity of 
hybridoma cells. This was achieved by utilising the 
data generated by processing cell samples recovered 
from compound treated and untreated cultures through
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the neutral red test and MTT test simultaneously.
It was proposed that a value for GQ less than 1 
would be obtained for a compound which specifically 
inhibited DNA replication and not DNA-dependent RNA 
synthesis or cellular metabolism. In this case a rise 
in CSAPR was anticipated. The converse of this would 
suggest that a GQ value greater than 1 would be 
obtained and accompanied by a fall in CSAPR when a 
compound impaired metabolic activity without 
suppressing DNA replication. Also, a situation in which 
a chemical compound equally affected both or neither of 
the parameters stated above, a GQ value of 1 would be 
expected, accompanied by either a reduction or 
negligible effect on CSAPR,
The efficacy of GQ as an index to measure the 
parameters described was ascertained with the aid of 
three compounds of known primary action. As anticipated 
cells cultured with Cytoarabinoside (Ara-C), a DNA 
synthesis specific inhibitor demonstrated the expected 
rise in CSAPR for values of GQ less than 1. Figure
4.10 (b) shows the existence of a linear correlation 
(r=-0.9799) between GQ and CSAPR. A similar observation 
(r=-0.9714) was noticed for Cycloheximide (Cyc), 
However, Figure 4.10 (c) shows that in this case 
values less than 1 for GQ did not show the anticipated 
rise in CSAPR as observed for Ara-C treated cultures. 
This is more than likely to be a consequence of the 
action of Cyc on antibody synthesis. This suggests
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that not all compounds demonstrating GQ<1 are 
favourable for antibody production. Other compounds 
which are capable of inhibiting DNA synthesis by 
indirect means may also produce the same response. This 
emphasizes the limitation of GQ stressed in the 
hypothesis that it is restricted to inhibitor which are 
specific for DNA synthesis only. Figure 4,10 (c) shows 
that cells treated with hydroxyurea (Hu) demonstrated 
GQ values slighty higher than 1. As expected in this 
case a slight drop in the CSAPR was observed compared 
to the control culture.
The results presented in section 4.2.3 indicated 
that GQ could be used as an index to measure the action 
of a chemical compound on hybridoma cells with 
reference to DNA synthesis, metabolic activity, and 
CSAPR. Also, a 95% confidence limit was established 
from the results of experiment 4.2.3. Any GQ value for 
compound treated cultures falling outside a range of 
1.102-0.862 were considered 95% significant. Those 
results were considered as experimental observations 
originating from the direct action of a compound on 
cell DNA synthesis and metabolism and not due to 
statistical variance.
Altogether 46 compounds (listed in Appendix 4) at 
various concentrations were tested by the screening 
strategy described in section 2.2.8. They encompassed a 
broad spectrum of compounds diverse in both their
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origin and mode of action. From all the compounds 
screened those which generated the desired correlation 
between GQ and CSAPR upon repeated trials were 
Trifluorothymidine and 5-Fluorodeoxyuridine (see Figure
4.11 (a) and (b)). Both compounds are known to be 
nucleotide analogues widely used in cancer chemotherapy 
(Zee-Cheng and Cheng, 1988), They prevent the 
production dTTP required for pyrimidine synthesis. 
Therefore their action on hybridoma cell DNA synthesis 
was specific. Their selection from a panel of 
compounds illustrates the use of the GQ in identifying 
agents which are able to elevate the CSAPR of 
hybridoma cells by specifically inhibiting DNA 
synthesis without affecting the metabolic activity.
G. Conclusion
In conclusion, the results presented in this 
chapter show that neutral red and MTT could be used to 
develop assays providing information on the DNA 
content and metabolic activity of hybridoma cells 
respectively. Their combined application to hybridoma 
cultures in conjunction with the ELISA assay for 
determining antibody concentrations was useful in 
evaluating the action of numerous compounds on DNA 
synthesis, metabolic activity, and CSAPR of MAK 33 
cells. The derivation and subsequent application of the 
GQ to the screening programme was of particular 
benefit in identifying agents from a panel of compounds 
those which could enhance CSAPR by means of selectively
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suppressing DNA synthesis without impairing metabolic 
activity.
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Chapter 5
The effects of specific DNA synthesis inhibitors on 
cell replication and monoclonal antibody production 
kinetics of hybridoma MAK 33 cells
5.1 Introduction
In previous chapters, the term ’growth' was used 
to define cell division, however in this chapter this 
process will be described by the term 'replication' and 
the term ' growth ' will be used to define cell 
enlargement (increase in cell size).
In chapter 4, the establishment of two 
colorimetric assays based on microtitire trays for 
enumerating viable cell number, intracellular DNA 
content and measuring the metabolic activity of MAK 33 
cells permitted the screening of a number of chemical 
compounds. The outcome of the screening programme was 
the identifiction of two compounds namely, 
5-Fluorodeoxyuridine (5-FUDR) and Trifluorothymidine 
(Trif). Both demonstrated the capacity to inhibit DNA 
synthesis without impairing antibody production.
Both compounds are recognised as antitumour drugs 
and have been implicated in cancer chemotherapy 
(Zee-Cheng and Cheng, 1988) because of the property of 
targetting their action on enzymes which regulate DNA 
synthesis. Both 5-FUDR and Trif are analogues of 
d e oxythymidine (see Figure 5.1); a precusor of
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deoxythymidine triphosphate (dTTP). Their inhibitory 
action is upon the enzyme thymidylate synthetase which 
catalyses the conversion of deoxyuridine monophosphate 
(dUMP) to deoxythymidine monophosphate (dTMP) during de 
novo synthesis of dTTP. Cell division is arrested as a 
consequence of their action on DNA replication.
The inhibitory properties of such drugs have in the 
past been utilised to demonstrate the feasibility of 
dissociating DNA replication from DNA-dependent RNA and 
protein synthesis. This has been possible because the 
chromosome cycle and growth cycle, both of which 
constitute cell growth, (see sec. 1 .8 .1 , chapter 1 ) are 
not synchronous in mammalian cells (Mitchison, 1971). 
For example, Rueckert and Mueller (1960) observed that 
5-FUDR treated cultures exhibited continued RNA and 
protein synthesis when DNA replication was suppressed. 
This observation was later confirmed by other authors 
for other DNA synthesis specific inhibitors (Cohen and 
Studzinski, 1967; Rosenberg and Gregg, 1969; Mironescu 
and Ellem, 1977). Continued cell growth (RNA and 
protein synthesis), as observed in the cases stated 
above, in the absence of DNA synthesis and cell 
division leads to the abnormal enlargement of cells 
(Cohen and Studzinski, 1967; Teillaud et al., 1989).
The study of continued cell growth in DNA 
synthesis inhibited hybridoma cultures was recently 
described by Teillaud et al, (1989). Although their
147
investigation demonstrated a continued production of 
antibody during the period when replication was 
inhibited, this study was lacking in that a 
comprehensive understanding of the effect of DNA 
specific inhibitors on cell replication and antibody 
production kinetics of hybridoma cultures was not 
clearly elucidated.
In this chapter 5-FUDR, Trif and Cytoarabinoside 
(Ara-C: an analogue of cytidine) an inhibitor of DNA 
polymerase, the enzyme responsible for initiating DNA 
synthesis, have been used to inhibit cell division in 
stirred cultures. Particular attention was devoted to 
monitoring the changes in cell morphology, replication 
rate, cell number (yield), antibody production rate, 
cell specific antibody productivity, and antibody yield 
under these conditions.
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Figure 5.1 : The inhibitory action of 5-FUDR and Trif
on dTTP production.
5 -Fluorodeoxyuri-dine T3ri.fluorothyTn±dine
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Figure 5.2 : The chemical structures of, (a) Trif,
(b) 5-FUDR, (c) Thymidine (d) Ara-C and (e) Cytidine.
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5.2 Results
5.2.1 Optimum inhibitory drug concentration
In this experiment drug concentrations maintaining 
cell cultures in a non-proliferating- yet viable state 
were determined for 5-FUDR, Trif, and Ara-C so that the 
effect of these concentrations on larger cultures could 
be ascertained.
MAK 33 cells were cultured in 2ml of RPMI 1640 
containing 10% NBS in 24 well Linbro plates at a
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density of 2x10^ cells/ml. Cells in test wells were 
cultured with medium containing one of the inhibitors 
at concentrations close to the predetermined optimum. 
The concentrations tested for each drug were;
1. 5-FUDR : 1, 2, 4 and 8xlO‘^M
2. Trif : 1, 2, 4 and 8xlO“®M
3. Ara-C : S.lSxlO"?, 1.57x10“'^, 7.8x10"^ and S.GxlO'^M
Control cells in other wells were not exposed to 
any of the DNA synthesis inhibitors.
Four identical plates were set up simultaneously 
and incubated at 37^C in 95% air and 5% CO2 . One plate 
was harvested sequentially every 24 hours during which 
replicate samples for viable cell count and antibody 
determination were recovered.
The concentration of each drug tested, which 
maintained the cultures in essentially a minimal 
proliferative yet viable state are shown in Table 5.1 
and illustrated in Figure 5.3(a). Figure 5.3(b) 
illustrates that culture viability was maintained 
either at or above 90% for 48 hours when hybridomas 
were cultured in medium containing either of the 
following; Ara-C at 1.57xlO"?M, 5-FUDR at lxlO”^M and 
Trif at 2xlO“®M. The maximum cell densities attained in 
these cultures were 3.5, 2.9, and 3.8x10^ cells/ml
respectively compared to 9.8x10^ cells/ml for the 
control culture.
The effect of these three specific concentrations
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on antibody production and CSAPR is shown in Figure 
5.4(a) and (b). Irrespective of the drug used the CSAPR 
was elevated and maintained at a rate above the control 
culture for at least 72 hours. However, the final 
antibody titre (at 96 hours) of the control culture 
was greater than that of the other three (see table 
5.1). This is likely to be brought about by the 
availability of a significantly greater number of 
antibody producing cells in the control culture.
Table 5.1 : The optimum cytostatic concentration of 
various DNA synthesis inhibitors and their effects on 
cell replication rate and antibody yield.
Various cultures
Optimum drug cone.(M )
Ara-C 5-FUDR
1.57x10-8 ixlO“ 8
Trif
2 x10-8
Control
Maximum cell density (1 0 ^/ml) 3.5 2.9 3.8 9.8
Antibody cone at 96 hrs (ug/ml) 46.2 41.6 49.6 61.8
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Figure 5.3 : MAK 33 cells cultured in growth media
either with or without DNA synthesis inhibitors, 
(a) Viable cell number, and, (b) Viability .
O C o n tro l ^ 5 -F U D R  ( lx lO ‘ °M)
A ra -C  (1 .57x10"''M ) □ T rif (2xlO^V)
o
100806040
T im e (H ours)20
80-
40-
20 -
1008040 60
T im e (H ours)20
153
Figure 5.4 : MAK 33 cells cultured in growth media 
either with or without DNA synthesis inhibitors, 
(a) Antibody concentration and (b) CSAPR.
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5.2.2 Maintaining MAK 33 cells under conditions of 
arrested replication in 0 .5 litre stirrer cultures.
The effects of specific growth inhibitory 
concentrations of Ara-C, 5-FUDR, and Trif on cell 
replication and antibody production kinetics of larger 
cultures of MAK 33 cells were acertained.
Four 0.5 litre stirred cultures were set up in 1 
litre duran bottles fitted with two 0.2um filters (Flow 
pore D) to permit gaseous exchange between the culture 
and the environment in which they were incubated (37^0 
in 95% air, 5% COg). These cultures consisted of cells 
grown in one of the following medium;
a. Culture medium (see sec. 2.1.3) + 1.6xlO”'^ M Ara-C
b. " + 3xlO“®M Trif
c. " " + lxlO“^M 5-FUDR
d. Culture medium alone (control culture).
All four cultures were seeded at a density of 
2x10^ cells/ml. Three millitre samples were recovered 
from each culture at regular intervals over a period of 
120 hours for determining changes in viable cell number 
and antibody concentration.
Table 5.2 below summarises the results of this 
investigation.
Figure 5.5(a) and (b) illustrate the effects of 
these DNA synthesis inhibitors on viable cell number 
(replication) and antibody production respectively. 
Although cell division was not totally inhibited, it
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was arrested considerably. This was reflected in the 
reduction in the cell replication rate. The mean 
replication rates of these cultures (over 1 2 0hrs) fell 
within a range of 27.5-40% of that observed for the 
control culture. Subsequently the maximum cell 
densities attained in these cultures were also reduced 
to 24.4-36,8% of that of the control culture. The 
viability of the these cultures was maintained at, 85% 
or above during the growth period (0-48 hours).
Table 5.2 : Results of cell replication and antibody 
production kinetics.
Culture !1
A B C D
Mean replication rate (Hr”^/over 120 hrs) 0 . 0 2(1 0 0%) 0.008(40%) 0.0055(27.5%)
1
0.0057(28.5%)
Maximum cell density 
(10 cells/ml) 11.2(1 0 0%) 4.1(36.6%) 2.8(25.4%) 3.6(32.1%)
Antibody titre (ug/ml at 120 hrs) 52.03(1 0 0%) 46.63(89.6%) 37.88(72.8%) 43.58(83.7%)
Mean APR (ug/ml/hr, over 120 hrs) 0.460(1 0 0%) 0.402(87.4%) 0.336(73%) 0.330(71.7%)
Mean CSAPR (over 120 hrs, ug/lO^cells/hr) 0.074(1 0 0%) 0.144(194%) 0.136(184%) 0.174(235%)
Key: A = Control cultureB = Culture exposed to Ara-C (1.6xlO"^M)C = " " 5-FUDR (lxlp“^M)D = " " Trif (3xlO"®M)
Figures in the parenthesis represent the results of cultures B, C and D as a percentage of the control.
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The effects of these inhibitors on the mean 
antibody production rate (APR) and the mean CSAPR is 
illustrated in Figure 5.5. A close analysis of the 
results in Table 5.2 shows that a reduction in 
replication rate in the drug treated cultures was 
accompanied by the following;
i. A reduction in APR,
ii. A reduction in antibody titre (yield),
iii. An elevation in CSAPR.
It appears that the drop in antibody titre was a 
reflection of the decline in APR in these cultures. 
Because the APR of a culture is influenced by the 
viable cell concentration, the low antibody titres 
observed for these cultures is most likely a reflection 
of the low cell densities. Therefore it can be 
concluded from this experiment that DNA synthesis 
inhibitors when used at non-toxic cytostatic 
concentrations are able to minimise cell division and 
elevate CSAPR concurrently but are not able to raise 
the antibody yield.
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Figure 5.5 : Hybridoma MAK 33 cells cultured in growth
media containing either no DNA synthesis inhibitor or
one of the following; Ara-C, 5-FUDR, or Trif.
(a) Viable cell number, (b) Antibody concentration in
culture medium.
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Figure 5.6 ; Replication and antibody production 
kinetics of MAK 33 cells under replication inhibited or 
normal culture conditions, (a) Replication rate,
(b) APR, and (c) CSAPR.
A — Control, B — Ara—C (1.6x 10“’M)
C - 5-FUDR (1x 10"“M). D - Trif (axlO'^ M)
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5.2.3 The effects of cell concentration on the antibody 
yield of replication inhibited cultures
In the previous experiment it was concluded that a 
rise in CSAPR in replication inhibited cultures was not 
necessarily accompanied by an increase in APR or 
antibody yield. Values for maximum cell density well 
below the optimum were thought to be the factors 
contributing to this phenomenon. Therefore the effect 
of raising the cell density of these cultures was 
investigated. This was accomplished by the addition of 
one inhibitor, Ara-C (model of DNA synthesis 
inhibitors), at different times after the onset of 
exponential growth. By doing this several replication 
arrested cultures of various maximum cell densities 
were established.
Four 0.5 litre hybridoma cultures were prepared 
and incubated as described previously. Ara-C 
( 1. 6xlO~'^M ) was added to 3 of the 4 cultures at 11, 19 
and 25 hours after culture incubation. The estimated 
lag phase for these cultures was 8 - 1 0 hours, therefore 
these times corresponded to the early, mid and late 
exponential growth phase. Three millilitre samples were 
recovered at regular intervals over a period of 1 2 0  
hours for the determination of viable cell count and 
antibody concentration.
The results of this investigation are summarised 
in Table 5.3. The addition of Ara-C at 11, 19 and 25
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hours reduced the mean replication rate (between 0-58 
hours; growth period) of hybridoma cultures to 61%, 65% 
and 77% of that observed for the uninhibited culture. 
Consequently (see Figure 5.7(a)), the maximum cell 
densities attained in these cultures were reduced to 
5.4, 6.6 and 6.9x10^ cells/ml respectively, compared to 
13x10^ cells/ml for the control culture.
Table 5.3 : Results of cell replication and antibody 
production kinetics.
A B C D
Mean replication rate 0.0281 0.0172 0 .0183 0 .0217(hr-1 ) (1 0 0%) (61%) (65%) (77%)
Cell density 13,0 5.4 6 .6 6.9(10 cells/ml) (1 0 0%) (42%) (51%) (53%)
Antibody titre 51.4 51.4 64,6 53.9(at 120 hrs, ug/ml) (1 0 0 %) (1 0 0%) (126%) (104%)
Mean APR (over 120 hrs) 0.430 0.515 0.604 0.554(ug/ml/hr) (1 0 0%) (1 2 0%) (140%) (129%)
Mean CSAPR (over 120 0.063 0.139 0.175 0.146hrs, ug/10 cells/hr) (1 0 0%) (2 2 0%) (278%) (232%)
Key : A - Control culture (uninhibited) B - Ara-C addition at 11 hours C - " " " 19 ”D - " " " 25 ”
Figures in parenthesis represent each value as a percentage of the control.
The effects of arresting cell division at 
different times on antibody titre, production rate 
(APR) and CSAPR are illustrated in Figures 5.7(b) and 
5.8(b) and (c) respectively. An antibody titre (at 120
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hours) of similar concentration to the control culture 
was observed when Ara-C was added at 11 hours. However, 
an increase of 26% and 4% was experienced when the 
hybridoma cultures were replication-arrested at 19 and 
25 hours respectively (see Table 5.3), In both cases 
this was brought about by the concurrent elevation of 
the mean APR and the mean CSAPR above that of the 
control culture. A rise of 40% and 29% was observed for 
the APR respectively and the CSAPR more than doubled. 
Therefore it appears that inhibiting cell division 
after the onset of exponential growth phase, 
particularly mid-phase (19 hours), raises the cell 
density of the culture to a sufficient concentration to 
make a significant difference on the APR and antibody 
yield. These results were reproduced in a subsequent 
experiment (results not shown). The addition of Ara-C 
at mid-exponential phase raised the antibody yield by 
30% above that observed for the control culture 
although the maximum cell density attained was only 50% 
of the control.
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Figure 5.7 : The effects of arresting replication with 
Ara-C at 11, 19 and 25 hours after culture incubation 
on cell division and antibody production; (a) viable 
cell number, and (b) antibody concentration, 
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Figure 5.8 : The effects of the addition of Ara-C at 11, 
19 and 25 hours to the; (a) mean replication rate 
during the growth period only, (b) mean APR, and (c) 
mean CSAPR over 120 hours.
A — Control, B — Ara—C (11 hour addition)
C — Ara—C (19 hour addition). D - Ara—C (25 hour addition)
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5.2.4 The effects of inhibiting DNA replication on cell 
morphology.
A consistent observation throughout all previous 
experiments has been the presence of enlarged cells in 
replication inhibited cultures. Therefore this 
experiment was designed to visually demonstrate this 
and detect other morphological changes on the cell 
surface possibly induced by the use DNA synthesis 
inhibitors.
oTwo 25cm tissue culture flasks, one containing 
growth medium alone the other growth medium and Ara-C 
(1.6xlO~^M) were seeded with 2x10^ cells/ml. During 
exponential growth phase (36 hours after incubation) 
cell samples were recovered for photography and 
scanning electron microscopy (SEM). They were prepared 
for these studies as described in section 4.2.1.1 and 
chapter 2, section 2,4 respectively.
Plate 5.1 shows photographs of cells cultured in 
the two different media. Cells of drug inhibited 
cultures were consistently 40-45% larger in size. The 
mean diameter of these cells was determined to be 26,8 
+/- 2,4um compared to the control cell diameter of 18.7 
+/- 0,9um. However, other morphological features,
discernable under a light microscope (eg, integrity of 
the cell membrane) appeared to the same in both 
cultures. This was corroborated with SEM studies. 
Plates 5.2 and 5.3 show the morphology of cells
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recovered from replication uninhibited and inhibited 
cultures respectively. In both cultures three distinct 
cell surface types could be identified;
a. Cell surfaces which were ’smooth and sparingly 
populated with microvilli'.
b. Cell surfaces which were 'densily populated with 
microvilli only’.
c . Cell surfaces with ’many blebs and few microvilli’.
None of these cell surface types were found 
predominating either of the samples suggesting that 
although DNA synthesis inhibitors induce cell 
enlargement other physical features are left unaffected 
and intact. This further suggests that the response of 
these inhibitors is specific and confined to the 
biochemical processes pertaining to DNA synthesis.
Plate 5.1 : Photographs of MAK 33 hybridoma cells
cultured in (a) replication inhibited culture 
conditions, and (b) optimum culture conditions (x320 
mag ).
50 urn
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Plate 5.2 ; SEM of MAK 33 hybridoma cells cultured in 
normal growth medium; a, b, and c correspond to the 
cell surface types described in the text (page 168)
Plate 5.3 ; SEM of MAK 33 hybridoma cells cultured in 
growth medium containing Ara-C (l.ôxlO'^M); a, b and c 
correspond to the cell surface types described in the 
text (page 169).
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5.3 Discussion
The results presented in this chapter illustrate 
that non-toxic, cytostatic concentrations of DNA 
synthesis inhibitors offer a means of maintaining 
hybridoma cultures in a viable non-replicating state 
(see Figure 5.3). Concentrations in the range of 
1.6xlO"^M (Ara-C)-lxlO“®M (5-FUDR) were sufficient to 
inhibit cell replication rate by 60-73% respectively 
(see Table 5.2), while maintaining the culture 
viability above 85% during cell growth. At these 
concentrations the maximum cell densities attained were 
considerably reduced (2.9-4.1x10^ cells/ml) compared to 
the control culture (1 1 .2x1 0^ cells/ml).
Under these culture conditions the mean CSAPR is 
elevated in small, 2ml, (Figure 5.4(b)) and large 0.5 
litre cultures (Figure 5.6(c)). Similar observations 
have been reported by other authors for different DNA
synthesis inhibitors (Sherr et al., 1988; Teillaud et
al., 1989 ). The evidence of an increase in
immunoglobulin translation, presented in both studies 
was proposed to be the cause of elevated CSAPR. Sherr 
and his colleages (1988) showed that this was due to an 
increase in the intracellular pools of both heavy and 
light chain mRNA. Merten et al, (1990) corroborated 
this by demonstrating the existence of a correlation 
between the rise in CSAPR and the increase in
intracellular levels of immunoglobulin mRNA.
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Although the mean CSAPR was enhanced in 
replication arrested cultures, the final antibody titre 
(yield), however was less than the value observed for 
the control culture (see Table 5.2, Figure 5.5(b)). 
Dalili and Ollis (1988) have reported similar results 
for hybridoma cultures arrested with cAMP (10“^M). On 
the other hand Teillaud et al, (1989) presented results 
which showed a 16% increase in the antibody yield in a 
culture treated with doxorubicin. From the results 
presented in Table 5.2 and illustrated in Figure 5.6, 
it can be inferred that the underlying factors 
producing these different results are low values for, 
(i) viable cell concentration and (ii) mean APR. 
Although these cultures on a per unit cell per hour 
basis demonstrated a greater capacity to produce 
antibody, the concentration of viable cells available 
for antibody production are not adequate to enhance APR 
sufficiently to increase the yield. This is in 
accordance with other reports stating that the antibody 
yield is governed, to some extent, by the viable cell 
concentration (Fazekas de st Groth, 1983; Tolbert et 
al,, 1985; Reuveny et al,, 1986a; Velez et al., 1987; 
Long et al., 1988). This was verified in a subsequent 
experiment (5.2.3).
The addition of Ara-C (1.6xlO"^M) at different 
times after the onset of exponential growth phase 
permitted the establishment of replication-arrested 
cultures of various cell densities (see Figure 5.7(a)).
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The addition of Ara-C at 11, 19, and 25 hours after 
culture incubation elevated the maximum cell density 
attained from 36.6% (of the control) in the previous 
experiment (Ara-C addition at t=0) to 42%, 51%, and 53% 
respectively. The mean APR of these cultures was raised 
by 2 0 %, 40% and 29% respectively above that observed 
for the control. Consequently for the latter two 
cultures the final antibody titres were greater than 
the control by 26% and 4% respectively. However, only 
in the case of adding Ara-C at 19 hours (mid­
exponential phase) was the rise in antibody titre 
significant. Arresting cell division either at 11 hours 
(early exponential phase) or at 25 hours (late 
exponential phase) did not prove to be beneficial. In 
the former case it was suspected that an early 
replication arrest prevented the culture attaining an 
adequate cell density to elevate the mean APR to a 
significant level. In the latter case, it was suspected 
that arresting cell division too close to the decline 
phase provided viable cells with only a short period 
for antibody synthesis at the elevated CSAPR, prior to 
entering a phase in which the nutrients necessary for 
antibody synthesis are depleted (Luan et al., 1987b; 
Duval et al., 1989; Dalili and Ollis, 1990).
The enlargement of animal cells in drug treated 
cultures has been shown to be a consequence of 
continued RNA and protein synthesis in the absence of
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DNA replication (Rosenberg and Gregg, 1969; Mitchison, 
1971). In the light of this observation the results 
presented in Plate 5.1 demonstrate a situation in which 
selective inhibition of DNA replication has caused the 
enlargement of MAK 33 cells to a size 40-45% (26.8 +/- 
2.4um) greater than the control (18.7 +/- 0.9um). The 
major factors contributing to the enlargement of 
replication arrested MAK 33 cells are likely to be the 
increase in the synthesis rate of antibody (more than 
100% increase in CSAPR) and non-secretory proteins 
(Teillaud et al., 1989).
The results of the SEM analysis of MAK 33 cells 
cultured in both normal physiological conditions and 
medium containing 1. 6xlO""^M Ara-C are presented in 
Plates 5.2 and 5.3 respectively. Similar proportions of 
cells were found to contain the three different cell 
surface types (a, b, and c) in both samples. Therefore 
the presence of ’blebs' or 'microvilli' on the cell 
surfaces cannot be attributed to the effect of Ara-C on 
MAK 33 cells. These protrusions have been reported to 
exist on the surface of many cell types; CHO and Hela 
cells (Hodge and Muir, 1972; Lloyd et al., 1982), BHK 
21, NSl and TB/C3 hybridomas (Handa, 1986). Changes in 
their density has been shown to be correlated to the 
transition of cells through various stages of the cell 
cycle during cellular growth in normal 
physiological conditions (for review see Lloyd et al., 
1982). Therefore it appears that the action of Ara-C
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(and possibly other specific inhibitors) on DNA 
replication is confined to the biochemical processes 
pertaining to DNA synthesis and does not alter the 
structural integrity of the cell. The enlargement of 
cells treated with Ara-C is most probably the 
consequence of ever increasing cell mass and volume due 
to continued RNA and proteins synthesis (particularly 
antibody) in the absence of cell division (Cohen and 
Studzinski, 1967).
In conclusion the experimental results in this 
chapter have illustrated that;
1. DNA synthesis inhibitors can be used to induce a 
n o n - r e p H e a t i n g  viable state (almost static) in 
hybridoma cultures of laboratory scale (0.5L) without 
inhibiting antibody production.
2. The induction of this state during mid-exponential 
growth phase was favourable for the concurrent 
elevation of the APR and CSAPR. The antibody yield in 
such cultures was significantly enhanced.
3. The selective inhibition of DNA synthesis in MAK 33 
cells causes cell enlargement without initiating other 
morphological changes observable by SEM. Cell 
enlargement was likely to have been a consequence of 
continued/elevated synthesis of immunoglobulins and 
possibly other non-secretory proteins in the absence of 
cell division.
From these results it can be inferred that the
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improvement of antibody yields from existing batch 
cultures of MAK 33 cells requires the implemetation of 
a two stage production strategy;
Stage 1 : Conditions optimised for cell replication to 
raise cell density.
Stage 2 : Optimising conditions for antibody production 
by inhibiting cell replication.
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Chapter 6
The effects of Ara-C on the metabolic state of MAK 33 
cells cultured under optimum growth conditions
6.1 Introduction
In this chapter the experiments designed have 
attempted to relatethe rise in CSAPR observed in 
growth inhibited cultures to the changes in cell 
metabolism induced by inhibiting DNA synthesis. From 
the results of chapter 3 and a few other studies 
(Dalili and Ollis, 1988; Hayter, 1989; Teillaud et al., 
1989) its appears that hybridoma cells are maintained 
in a metabolic state more favourable for antibody 
production when cultured in optimum culture conditions 
in the absence of cell division. The inhibition of DNA 
synthesis may be an important step necessary in the 
process of initiating such a favourable metabolic state 
in which case inhibitors of DNA synthesis could be used 
as agents to induce this state.
The changes in cell metabolism with respect to 
flucuations in intracellular concentrations of ATP, 
energy charge, nutrient uptake rate, and waste product 
secretion rate are described in this chapter. The 
energy charge is a linear measure of the amount of 
metabolic energy stored in the adenine nucleotide pool. 
It is used as an index to measure the energy status of 
viable cells (Atkinson, 1969).
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6 .2 Materials and Methods
6.2.1 Apparatus for the controlled cultures o f 
experiment 6.3.2
The vessels used for culturing hybridoma cells 
were 1 litre glass reactors with a stainless steel head 
plate (Gallenkamp). The temperature in each vessel was 
maintained at 37^C by circulating water through a 
hollow steel rod (which was immersed in the culture 
medium) connected to a water bath. The culture medium 
was agitated at 150 rpm with a magnetically coupled 
large Teflon-coated stirrer bar fixed through the 
stirrer shaft. The ratio of the diameter of the vessel 
to the impeller was 2 .
Aeration and pH control of the culture was 
achieved by sparging air through the culture medium by 
a porous sparger connected to an air cylinder. 
Dissolved oxygen (DO) concentration was maintained at 
40% air saturation, and monitored by a G2 oxygen probe 
(Uniprobe instrument Ltd) connected to a controlling 
devise (Kent electronics). The pH was maintained at pH
7.2 and monitored by a Russel autoclavable pH probe 
linked to a Gallenkamp modular unit. Both controlling 
devises for DO and pH operated a series of valves 
which permitted the passage of air from the air 
cylinder to sparge the culture.
Plate 6.1 illustrates a vessel set for the 
e x p e r i m e n t .
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Plate 6.1 : A single 1 litre Gallenkamp fermenter set 
up for culturing MAK 33 cells.
Key : A - Water bathB - Fermenter vessel C - Magnetic stirrer control D - Gallenkamp modular unit for pH controlE - Valves controlling air followF - Oxygen probeG - Russel pH probeH - Sampling portI - Stirrer shaftJ - Air sparger
6.2.2 Establishment of hybridoma cultures in 1 litre 
fermentors
After autoclaving the vessels, 500ml of culture 
medium (see section 2.1.3) was introduced into them
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with the aid of a vacuum pump. The inoculum, previously 
prepared from a single 10ml culture of MAK 33 cells, 
was introduced in a similar fashion. A final working 
volume of 800ml was used. Each vessel was seeded with a 
cell density of 2 x1 0  ^ cells/ml.
6.2.3 Metabolite Determination
The following parameters were determined as 
described in chapter 2; intracellular ATP, energy 
charge, glucose, glutamine, lactate and ammonia 
concentrations.
6.3 Results
6.3.1 Energy levels in MAK 33 cells under growth 
inhibited condition
This experiment was designed to determine whether 
inhibition of DNA synthesis caused changes in the 
internal energy content of hybridoma cells.
Two identical 500ml cultures were established in 1 
litre duran bottles as described in chapter 5 section 
5.2.2. One was incubated with Ara-C at a concentration 
of 1.6xlO"^M which was previously found to maintain the 
cell culture in a minimal-proliferating state with 
elevated CSAPR (see section 5.2.2). Replicate samples 
were recoverd from both cultures and processed as 
described else where for the determination of;
a. viable cell count,
179
b. antibody concentration,
c. intracellular ATP concentrations,
d . energy charge.
Results presented in Table 6.1 show that 1.6xlO“*^ M 
concentration of Ara-C reduced the mean growth rate of 
the culture by 41%. Consequently maximum cell density 
attained was also reduced to 47% of the control. The 
mean CSAPR under these culture conditions was elevated 
by 57% which is reflected in the final antibody titre 
for this culture. These results were typical of a 
culture exhibiting limited growth induced by the 
inhibition of DNA synthesis.
The changes in the cell growth rate and CSAPR 
during the culture period for both cultures are shown 
on Figures 6.1(a) and (b) respectively. The inverse 
relationship between CSAPR and cell growth rate for the 
growth limited culture is indicative of antibody 
production that is growth-independent. A greater value 
for CSAPR was observed for this culture than the 
control at most points of measurement during batch 
growth (see Figure 6.1(b)). The elevation in CSAPR is 
brought about by restricting cell division which is 
demonstrated by a drop in cell growth rate in Figure
6 .1 (a).
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Table 6.1 : Results of cell growth and antibody
production kinetics for a batch culture of MAK 33 
cells.
Cultures 
Control Growth inhibited
Mean growth rate (hr“^) 0.0287 0.0172(59%)
Max. cell density (10^/ml) 14.1 6.7(47%)
Mean CSAPR (ug/lO^cells/hr) 0.0948 0.148(between 0-52 hrs) (157%)
Antibody titre (ug/ml) 47.7 48.2(at 120 hrs) (1 0 1%)
Figures in parenthesis depicts the percentage each value represents of the control.
The intracellular ATP concentrations in both 
cultures increased rapidly during lag and early 
exponential phase (0-28 hrs ) . This was followed by a 
progressive decline as cells traversed mid 
exponential phase and a leveling off shortly after the 
onset of cell death (see Figure 6.2(a)). However, the 
intracellular concentration of ATP for cells of growth 
inhibited culture was significantly higher at each 
point of measurement. But the energy status of cells of 
both cultures, reflected by the values of the energy 
charge was comparable throughout the culture period. 
Therefore it appears that the inhibition of DNA 
synthesis in MAK 33 cells causes a rise in the
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intracellular ATP concentration without causing a 
significant change in the energy status. This may have 
been achieved by releasing then salvaging the energy 
normally expended in biosynthetic activities pertaining 
to DNA synthesis and cell division.
A correlation between the high levels of 
intracellular ATP and high values of CSAPR was observed 
for these hybridoma cells. It is probable that CSAPR is 
elevated in these cells because more ATP is made 
available for antibody synthesis as result of the 
inhibition of DNA synthesis.
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Figure 6.1 : Cell growth and antibody production 
kinetics of the control culture and the growth 
inhibited culture; (a) Growth rate, (b) CSAPR.
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Figure 5.2 : The energy status of hybridoma cells of 
the control culture and the growth inhibited culture; 
(a) Intracellular ATP concentration (each point 
represents the mean of 2 determinations, and the error 
bars -/+ SD), (b) Energy charge
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6.3.2 Batch cultivation of MAK 33 cells exposed to 
Ara-C in a Gallenkamp 1 Litre fermentor
In a batch culture both the cell nutrients and 
products of cell metabolism are in a constant state of 
flux. The effect of this on the phy Biochemical 
properties of the medium is known to affect cell 
growth and antibody production (Glacken et ai., 1986; 
Luan et ai., 1987c; Dodge et ai., 1987; Miller et ai., 
1988a, 1988b) Therefore in this investigation changes
in the medium pH and dissolved oxygen concentration 
(DOC) were controlled. This permitted a more thorough 
evaluation to be carried out on the effects of 
inhibiting DNA synthesis on CSAPR and cell metabolism.
Two identical cultures were established as 
described in section 6.2.1 and 6.2.2. Both cultures 
were seeded with a cell density of 2x10^ cells/ml. They 
were run simultaneously until cell division had ceased. 
However one had been cultured with Ara-C (1.6xlO“'^ M) 
introduced into the culture medium prior to the 
initiation of the fermentor run. Eight millilitre 
samples for determining the following parameters were 
recovered periodically;
a. Viable cell count,
b. Antibody concentration (CK ELISA was used for 
determining whole functionally active antibody 
molecules),
c. Intracellular ATP concentration.
185
d. Energy charge,
e. Glutamine and Glucose concentrations,
f. Lactate and Ammonia concentrations.
The necessary preparations of the samples for the 
evaluation of parameters (c)-(f) are fully described in 
chapter 2 .
Figure 6.3 illustrates the changes in pH and DOC. 
The pH was maintained within a narrow range between 
7.2-7.3 in both cultures after the first 15 hours of 
batch cultivation and did not drop below pH 7.2, The 
DOC initially fell dramatically from 100% air 
saturation for both cultures but then stabilised at 
different values. In neither case did the DOC fall 
below 40% air saturation (set value). The decline in 
culture DOC was indicative of active respiration. The 
sharper decline in the untreated control culture was a 
reflection of the unrestricted cell division.
Table 6.2 : Results of cell growth and antibody
production kinetics of MAK 33 cells cultured in the 
Gallenkamp fermentor. Figures in the parenthesis 
represents each value as a percentage of the control.
Cultures 
Untreated Ara-C treated
Mean growth rate (hr""^) (during 0-55 hrs) 0.019 0.0075 (39%)
Max cell density (lO^/ml) 6.7 3.2 (47%)
Mean CSAPR (ug/lO^cells/hr) (during 0-55 hrs) 0.078 0.193 (247%)
Antibody titre (ug/ml) 23.2 27.3 (118%) -
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Table 6.3 : A comparison of the metabolism of drug
treated and untreated cultures. Each value represents 
the mean over the whole culture period (0-71hrs). 
Figures in the parenthesis show each value as a 
percentage of the control (untreated culture).
Mean values over culture period (0-71 hrs) Cultures Untreated Ara-C treated
A 0.0056 0.0078 (139%)
B 0.0041 0.005 (1 2 2%)
A/B 1.36 1.56
C 0.0068 0.0075 (1 1 0%)
D 0.0068 0.009 (132%)
C/D 1 0.83
Key: A - Mean glucose uptake rate (mg/lO^cells/hr)B - Mean lactate production rate (mg/10 cells/hr) A/B - Quotient (Qq ) generated by dividing A by B. Indicates the relationship between glucose consumption and lactate production in each culture over the growth period.C - Mean glutamine uptake rate (mM/lO^cells/hr)D - Mean ammonia production rate (mM/lO^cells/hr) C/D - Quotient (Qy) generated by dividing C by D. Indicates the relationship between glutamine consumption and ammonia production in each culture over the culture period.
Table 6.2 above, in brief, summarises the results 
of the cell growth and antibody production kinetics 
observed for both cultures. The DNA synthesis inhibitor
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reduced the mean growth rate dramatically in the 
treated culture. Consequently the maximum cell density 
attained in the growth inhibited culture was reduced to 
47% of the untreated control. Growth inhibition of this 
order elevated the mean CSAPR by 147%. This was 
reflected in the increase in the titre of functionally 
active antibody (see Figure 6.4(b)). The changes in 
viable cell count, antibody concentration, growth rate, 
and CSAPR for both cultures during batch cultivation 
are illustrated in Figures 6.4(a) and (b), and 6.5(a) 
and (b) respectively. These results are similar to 
those observed in the previous experiment.
Changes in cell metabolism, reflected in the 
alterations in nutrient uptake rates and waste material 
production rates are summarised in Table 6.3 and 
illustrated in Figures 6.6 and 6.7. Glucose uptake rate 
and lactate production rate were both enhanced in the 
growth inhibited culture. Despite the fact that the 
curves for these two parameters for the drug treated 
and untreated cultures overlap at certain points, when 
the data for the whole culture period is viewed 
together it becomes apparent that the glucose uptake 
rate and lactate production rate were elevated by a 
mean value of 39% and 22% respectively. A comparison of 
the metabolic quotient, Q^, for the two cultures 
suggests that the ratio of glucose consummed to lactate 
produced was also raised in the drug treated culture.
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These results suggest that the cells of the growth 
inhibited culture have experienced an increase in 
anaerobic glycolysis. They also demonstrate that cells 
in the growth inhibited state are more efficient at 
utilising glucose since less lactate was produced in 
proportion to glucose consummed in comparison to the 
control.
Glutamine uptake rate and ammonia production rate 
were also elevated in the growth inhibited culture. The 
increase in the mean production rate of ammonia over 
the culture period (32%) was greater than the mean 
glutamine uptake rate (10%). This becomes more apparent 
when the metabolic quotient, Q|^ , for both cultures are 
compared. It can be inferred from the metabolic 
quotient, Q^, for the control culture that the 
deamination of 1 mole of glutamine generated 1 mole 
ammonia. However, from the results of the Ara-C treated 
culture it is clear that more than 1 mole of ammonia 
was produced from 1 mole glutamine consummed. The 
additional amount of ammonia may have been generated 
from the catabolism of another nitrogen source.
Figure 6 .8 (a) shows that intracellular ATP 
concentrations of both cultures flucuated as cells 
traversed various stages of batch growth. As 
observed in the previous experiment, intracellular ATP 
concentrations were significantly greater at each point 
of measurement for the cells of the growth inhibited 
culture. However, the energy status of these cells,
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reflected by the value of the energy charge was 
comparable to the untreated control indicating that 
cells of both cultures were metabolically equally 
viable. Nevertheless the intracellular environment of 
the cells of the growth inhibited culture represent a 
more favourable metabolic state for antibody synthesis 
due to the availability of more ATP.
The rise in the intracellular ATP concentration 
observed for the cells of the growth inhibited culture 
correlates with the increase in the uptake rates of the 
two energy sources, glucose and glutamine and also with 
the increase in CSAPR. These results therefore 
suggest that the catabolism of additional amounts of 
glucose and glutamine have contributed to the increase 
in intracellular ATP levels. Subsequently the CSAPR 
was elevated because more ATP was made available for 
antibody synthesis.
The results of this experiment indicate that the 
inhibition of DNA synthesis generates a more favourable 
metabolic environment for antibody production i.e. 
increases intracellular ATP levels. The availability of 
more ATP for antibody synthesis in these cells may be 
an important factor governing the rise in the CSAPR 
observed.
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Figure 6,3 : The changes in medium pH and DOC for the 
the Ara-C treated and untreated culture during batch 
cultivation in a Gallenkamp fermentor.
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Figure 6.4 : Cell growth and antibody production in 
Ara-C treated and untreated culture; (a) Viable cell 
count, (b) Antibody concentration.
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Figure 6.5 : Cell growth and antibody production 
kinetics of the Ara-C treated and untreated culture; 
(a) Growth rate, (b) CSAPR.
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Figure 6 . 6  : Glucose uptake rate (a) and lactate
production rate (b) in the Ara-C treated and untreated 
culture. Each point and error bars represent the mean 
“/+ SD of 2 determinations respectively.
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Figure 6.7 : Glutamine uptake rate (a) and ammonia
production rate (b), in the Ara-C treated and untreated 
culture. Each point and error bars represent the mean 
+/- SD of 2 determinations respectively.
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Figure 6.8 : Energy status of MAK 33 cells of the Ara-C 
treated and untreated culture; (a) Intracellular ATP 
level (each point and error bars represent the mean 
+/- SD of 2 determinations respectively), (b) Energy 
charge.
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6.4 Discussion
A. Introduction
The results of this chapter demonstrate that 
hybridoma cells are sustained in a metabolic state 
more favourable for antibody synthesis when DNA 
synthesis is inhibited using Ara-C. The induction of 
this favourable state is associated with changes in 
metabolism of nutrients responsible for ATP production.
Similar results concerning the changes in CSAPR, 
intracellular ATP (ATP^^) concentrations, and energy 
charge (EC) were observed for the growth inhibited 
cultures of experiment 6.3.1 and 6.3.2 irrespective of 
whether or not the physiochemical parameters (pH and 
DOC) were controlled. Therefore all results presented 
in this chapter will be discussed together.
B. Changes in cell metabolism
The pattern of change in A T P c o n c e n t r a t i o n  
observed in MAK 33 cells (illustrated in Figure 6.2) 
cultured in either growth inhibited or uninhibited 
conditions were similar. An initial rise during lag 
phase followed by a progressive decline as cells 
traversed the exponential phase to enter the decline 
phase was observed. Similar changes in ATP^ levels have 
also been reported by numerous authors for other 
mammalian cells; hybridomas (Ryll et al., 1990), mouse 
fibroblasts (Yamaguchi et al., 1988) and Ehrlich’s
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tumour cells (Skog et al., 1982). The rise in ATP^ 
levels observed in MAK 33 cells during lag phase can be 
explained in the light of the experimemtal results 
reported by others. High levels of ATP^ have been 
detected in animal cells found in the S-phase (Chapman 
et al., 1971; Skog et al., 1983), the phase in which a 
large proportion of the cells in lag phase are found to 
reside in (Sen et al., 1988).
Although the pattern of change in ATP^ levels was 
similar for both cultures, cells of the growth 
inhibited culture exhibited higher values at each point 
of measurement. A mean rise of 45% was experienced at 
each point for the results illustrated in Figure 6 .8 . 
This observation coincided with a mean rise of 39% and 
2 2 % in the glucose uptake rate and lactate production 
rate respectively, over the culture period (see Figure
6 .6 ), indicating that ATP^ levels were elevated as a 
consequence of an increase in anaerobic glycolysis. 
This is corroborated by the decline in oxygen 
consumption observed for this culture in comparison to 
the control culture (see Figure 6.1) and further 
supported by the observation that the flux of glucose 
through the metabolic pathways of anaerobic glycolysis 
is increased in cultures demonstrating elevated glucose 
consumption rates (Reitzer et al., 1979, Lazo, 1981; 
Miller et al., 1989a). Furthermore an increase in 
glucose consumption rate has been reported to be the
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direct cause of the rise in the ATPj^ concentration 
observed in other mammalian cell lines including 
hybridomas (Nakashima et al., 1984; Tollefsbol and 
Cohen, 1985; Miller et al., 1989a).
Studies on continuous cultures have shown that a 
reduction in cell growth rate is not normally 
accompanied by an elevation in glucose uptake rate (Low 
et al., 1987, Miller et al., 1988a; Hayter, 1989), 
However the results presented in this chapter 
demonstrate this to be the case. It is probable that 
reduction in the cell number due to inhibition in cell 
replication demonstrated in this investigation presents 
a situation in which a large glucose/ce11 ratio is 
maintained throughout the culture period. This in 
effect would mimic a culture in which glucose 
concentration of the culture medium is always 
maintained at a higher value. In this situation an 
increase in uptake rate would not only be anticipated 
but sustained for a longer period. However, in a 
culture in which the cell density is allowed to expand 
the glucose/cell ratio would be ever decreasing and 
therefore the uptake rate would be anticipated to 
decrease more rapidly. The results illustrated in 
Figure 6 .6 (a) are in agreement with this.
A slight increase in glutamine uptake rate was 
observed in the cells of the growth inhibited culture. 
A mean rise of 10% was experienced at each point (see 
Figure 6.7) of measurement. An elevated glutamine
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consumption rate has been shown to be associated with 
the increase in ATP production in hybridoma cells 
(Miller et al., 1989b). Therefore it is feasible that 
some of the additional amount of glutamine entering 
the cells of the growth inhibited culture could have 
been catabolised to generate more ATP. It is unlikely 
that increased catabolism of glutamine alone could 
account for the increase in ATP^ levels observed in 
this case, because several groups have shown that 
glutamine oxidation is severely reduced in mammalian 
cells, particularly hybridomas, in the presence of a 
high glucose consumption rate (Zielke et al., 1978; 
Kuchka et al., 1981; Miller, 1987; Miller et al., 
1989b). Also since glutamine is essential for antibody 
synthesis (Crawford and Cohen, 1985; Dalili and Ollis, 
1990) it would be more beneficial for hybridoma 
cells to conserve this nutrient for this process rather 
than to utilise it for generating ATP, particularly in 
the presence of excess glucose.
The maintenance energy requirement in mammalian 
cell cultures of growth rate 0.025 hr“  ^ was estimated 
to account for 65% of the total energy expenditure 
(Kilburn et al 1969) which was in agreement with that 
calculated by Miller et al. (1989a) for their hybridoma 
culture. The maintenance energy requirement is reported 
to increase with decrease in growth rate (Low et al.,
1987). It is therefore reasonable to suggest that the
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maintenance energy requirement for cells of the growth 
inhibited culture (demonstrating a very low growth 
rate) would be elevated. Cells in this situation would 
have to increase the production of energy to meet this 
need. One way would be to increase the consumption of 
nutrients normally catabolised to generated ATP.
C. Correlation between CSAPR and ATP levels in cells
Figures 6.2 and 6 . 8 showed that although higher 
levels of ATP^ were detected in cells of the growth 
inhibited culture, the energy status of these cells, 
reflected by the energy charge was comparable to the 
cells of the control culture. The calculated mean value 
of EC for both cultures during cell growth (0-55 hrs. 
Figure 6 .8 (b)) was above 0.8. This would suggest that 
cells of both cultures were metabolically equally 
viable. However, because the metabolic potential 
(ability to synthesize macromolecules) of mammalian 
cells is governed by the availability of ATP^ (Glacken,
1988), the internal environment of the cells of the 
growth arrested culture represents a metabolic state 
more favourable for antibody synthesis. Yamaguchi et 
al, (1988) demonstrated a direct correlation between 
ATP^ concentration and intracellular protein content 
during batch cultivation. In the light of the 
observations reported by Yamaguchi et al, (1988) and 
Glacken (1988) it would be reasonable to anticipate a 
rise in CSAPR in cells demonstrating increased levels 
of ATPj^, particularly if antibody synthesis in
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hybridoma cells is speculated to occupy up to 50% of 
total protein synthesis (Schreiner and Unanue, 1976; 
Coding, 1980) and operate at a rate of 1000 antibody 
molecules/cell/second (Merten, 1987). The results 
illustrated in Figures 6.1(b) and 6.2(a) and also 
Figures 6.5(b) and 6 .8 (a) demonstrate this to be the 
case. An increase in ATP^ concentration was 
accompanied by a rise in CSAPR at almost every point of 
measurement.
D. Salvaging energy
The salvage of energy normally expended in DNA 
synthesis would also contribute to the rise in ATP^ 
levels observed in the cells of the growth arrested 
culture. A significant amount of energy would be 
released from inhibiting DNA synthesis because it is 
estimated that a nucleic acid monomer is constructed at 
the expense of 6 ATP molecules (Paul , 1965). Because
36 ATP molecules are produced from the complete 
oxidation of glucose, the catabolism of 1/6 of a mole 
of glucose is required for each nucleic acid monomer. 
Therefore the energy requirement for DNA synthesis in 
rapidly dividing cells would be substantial. This is 
confirmed by the observation reported by White et al. 
(1989). They demonstrated that a 35% drop in ATP^ 
concentration observed at 60 minutes after PHA- 
stimulation of human lymphocytes was correlated to DNA 
synthesis detected later at 72 hours.
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Glacken (1988) stated that biosynthetic reactions 
in mammalian cells compete for the same ATP pool. In 
this case it can be envisaged that energy salvaged by 
inhibiting DNA synthesis would naturally be channeled 
into antibody synthesis causing a rise in CSAPR.
Glutamine is an essential constituent for both DNA 
replication (Zetterberg and E n g s t r o m , 1981) and
antibody synthesis (Crawford and Cohen, 1985; Dalili 
and 01 l i s , 1990). It is hypothesised that more
glutamine would be made available for the latter in 
cells of the growth arrested culture. Undoubtedly this 
would bring about an increase in antibody synthesis and 
therefore elevate CSAPR. Evidence for this has been 
shown by Hayter (1989). He demonstrated that the ratio, 
of antibody yield/mg glutamine utilized increased with 
decrease in growth rate.
E. Conclusion
It was observed that the inhibition of DNA 
synthesis in hybridoma cells cultured in optimum growth 
conditions was accompanied by a concurrent rise in 
intracellular ATP and CSAPR. A high concentration of 
intracellular ATP was thought to be the key factor 
governing the rise in CSAPR observed. The rise in 
intracellular ATP concentration was suggested to be 
brought about by;
a. An increase in anaerobic glycolysis initiated by an 
enhanced rate of glucose consumption.
b. The salvage of energy normally expended in DNA
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synthesis and processes pertaining to cell division.
It is also hypothesized that more glutamine is 
made available for antibody synthesis when DNA 
synthesis is inhibited under these culture conditions. 
This too was thought to contribute to the rise in CSAPR 
observed.
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Chapter 7
Concluding Remarks and Recommendations
7.1 Concluding remarks
A. Introduction
In this investigation the feasibility of 
inhibiting DNA synthesis without impairing DNA- 
dependent RNA and protein synthesis in hybridoma cells 
was acertained. On the premiss that DNA synthesis is 
confined to a particular phase of the cell cycle while 
RNA and protein synthesis are continuous throughout the 
cell cycle (for reviews see Mitchison, 1971; Lloyd et 
al., 1982), the possibility of accomplishing this 
seemed probable. Furthermore, this has been 
demonstrated in numerous mammalian cell lines (Baserga, 
1985) and recently in hybridomas (Sherr et al., 1988; 
Teillaud et al., 1989 ) with the aid of growth 
inhibitors. These reports suggested that it would be 
possible of achieving this in MAK 33 cells using the 
same approach. The purpose of achieving this was 
associated with the observations that antibody 
production in many hybridoma cell lines is not 
dependent on cell growth (replication) (Reuveny et al., 
1986; Birch et al., 1987; Low et al., 1987) and is 
enhanced in conditions which are inhibitory for cell 
division (Miller et al., 1988a; Dalili and Ollis, 1988; 
Teillaud et al., 1989), Therefore the application of 
DNA synthesis inhibitors to hybridoma cultures was 
dthought to provide a novel way of enhancing antibody
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productivity.
B. Assay development/screening programme
As part of this investigation two assays were 
developed and a new quotient called the Growth Quotient 
(GQ) was formulated to interpret the results generated 
by these assays. The application of the GQ enabled the 
indentification of compounds which demonstrated the 
potential of enhancing CSAPR by selectively inhibiting 
DNA synthesis without impairing cell metabolism.
An inverse correlation was found to exist between 
GQ and CSAPR (see Figure 4.10). Therefore it was used 
to estimate the effect of various compounds on the 
CSAPR of MAK 33 cells. In general a value of GQ<1 was 
accompanied by an elevation in CSAPR for the cells 
treated with a compound in comparison to the 
untreated controls. A value below 1 was indicative of 
selective inhibition of DNA synthesis. Conversely a 
value of GQ>1 was accompanied by a fall in CSAPR 
because such a value was indicative of a situation in 
which the compound either favoured DNA synthesis or 
impaired cell metabolism to a greater extent.
Not all GQ values less than 1 demonstrated the 
anticipated results for CSAPR (Figure 4.10(c)). It was 
discovered that compounds which directly inhibited 
protein synthesis, as in the case of cycloheximide, 
could also indirectly inhibit DNA synthesis and thus 
generate low values for GQ without producing the
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expected results for CSAPR.
A 95% confidence limit was established for GQ 
values falling outside the range of 1.102-0.852. These 
values were taken as being statistically significant 
and originating from the action of the compound on DNA 
synthesis and cell metabolism and not as a result of 
statistical variance inherent in the assays developed.
The efficacy of GQ as an index for identify 
compounds demonstrating the desired effect on CSAPR in 
MAK 33 cells was illustrated during the screening 
programme. The only two compounds which were 
able to elevate the CSAPR by at least 100%, upon 
repeated trials, were identified soley on their GQ 
values which fell within a significant range of 6 8-9 5% 
or >95%. Furthermore both compounds (5-FUDR, and Trif) 
were later shown to elevate the CSAPR of MAK 33 cells 
in large stirrer cultures (chapter 5, expt 5.2.2).
The suitability of neutral red dye and MTT 
(3-{4,5-dimethyl thiazol-2-yl}-2,5-diphenyl tétrazolium 
bromide) in the developement of assays designed to 
provide information on hybridoma cell DNA content and 
metabolism in microtitre plates was described in 
chapter 4. The combined application of these assays to 
hybridoma cultures in conjunction with ELISA for 
determining antibody concentration was useful in 
evaluating the action of numerous compounds on DNA 
synthesis, cell metabolism, and CSAPR of MAK 33 cells 
simultaneously (see Appendix 5).
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c. The effects of DNA synthesis inhibitors on cell 
growth, antibody production and cell morphology
MAK 33 cells demonstrated a growth-independent 
antibody production kinetics (Figure 3.1(b) and 3.5). 
Irrespective of the method used, growth inhibition was 
accompanied by a rise in CSAPR (see expts. 3.2.2- 
3.3.4). However, it was apparent from the results that 
the maintenance of cells in a physiological state where 
they showed their highest CSAPR was achieved by using 
DNA synthesis inhibitors rather than nutrient 
limitation. Arresting cell division under optimum 
culture conditions represented the most favourable 
condition for antibody synthesis (Hayter, 1989).
Evidence for continued RNA and protein synthesis 
in cells inhibited in their DNA synthetic activity was 
provided indirectly by the detection of enlarged cells 
(Plate 5.1). Cell enlargement was demonstrated to be a 
manifestation of continued RNA and protein synthesis in 
the absence of DNA replication by Cohen and Studzinski 
(1957). MAK 33 cells treated with Ara-C demonstrated 
cell diameters that were 40-45% (28.8 +/- 2.4um) larger 
than the controls (18.7 +/- 0.9um). Cohen and
Studzinski (1967) also showed that the protein content 
(which was correlated to the rate of protein synthesis) 
of these cells could be used as an accurate index for 
measuring cell size. Although more than a 100% rise in 
the mean CSAPR was observed in DNA synthesis inhibited
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cells (see Table 5.3), the enlargement of MAK 33 cells 
was probably a consequence of both increased levels of 
intracellular antibody (Sherr et al al., 1988) and 
other non-secretory proteins (Teillaud et al., 1989).
SEM studies performed on enlarged cells showed 
that Ara-C did not cause any physical changes to the 
cell surface. The protrusions detected on the cell 
surface were suspected to be features of normal cell 
growth as similar projections were also found upon the 
cell surfaces of the control culture and have also been 
reported to be present on the surfaces of other cells 
in normal physiological growth conditions (Hodge and 
Muir, 1972; Lloyd et al., 1982; Handa, 1986).
D. The effects of DNA synthesis inhibitors on MAK 33 
cell metabolism
Due to the growth-independent production 
kinetics demonstrated by numerous hybridoma cell lines 
a number of workers have begun to refer to monoclonal 
antibody production in these cells as secondary 
metabolite production. This has provided many with the 
opportunity to speculate that parallels may exist 
between the control of monoclonal antibody production 
in hybridoma cells and antibiotic production in 
microorganisms. The general consensus of opinion is 
that antibiotic production in microorganisms is 
observed at stationary phase and coincides with the 
depletion of an important growth factor (usually 
phosphate or nitrogen), a low energy charge, and low
209
concentrations of intracellular ATP (ATP^) (see review 
by Martin, 1977). Furthermore the energy charge (EC) is 
considered to be more important in regulating 
antibiotic production in microorganisms than absolute 
concentrations of ATP^ (Martin, 1977). However, as yet 
evidence has not been reported to substantiate these 
speculations. Also contrary to the evidence that EC is 
more significant in antibiotic production than absolute 
concentrations of ATP , the results of this 
investigation suggests that it may be the ATP^ 
concentration in hybridoma cells which plays a 
significant role in controlling antibody synthesis and 
not the EC. Furthermore it may also determine the rate 
at which antibody synthesis operates.
The results of the experiments described in 
chapter 6 demonstrated that while the values of EC at 
each point of measurement were comparable for cells 
recovered from growth inhibited and control cultures 
(Figures 6.2(b) and 6 .8 (b)) the ATP^ concentrations 
were not (Figures 6.2(a) and 6 .8 (a)). Furthermore 
the elevation in CSAPR in growth inhibited cells was 
correlated to elevated values of ATP^ suggesting that 
the rise in CSAPR was associated with ATP^ levels 
rather than the EC.
It is proposed that the rise in CSAPR 
observed in growth inhibited cells was brought about by 
more energy being made available for antibody
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synthesis. Biosynthetic reactions in mammalian cells 
are thought to compete for the same ATP pool (Glacken, 
1988), Priority in apportioning ATP in growth inhibited 
hybridoma cells would be shown to antibody synthesis 
since antibody synthesis in these and related cells 
has been shown to be preserved in unfavourable culture 
conditions (Sonenshein and Brawerman, 1976; Morenkov et 
al., 1989) to the loss of other proteins. Furthermore 
antibody synthesis is speculated to operate at a rate 
of 1000 molecules/ce11/second (Merten, 1987) which 
places a considerable demand on the energy resources. 
The results reported by Yamaguchi et al. (1988) is in 
support of this proposal. They demonstrated a direct 
correlation between ATP concentration and 
intracellular protein concentration (and therefore 
indirectly, the rate of protein synthesis) at each 
point of measurement throughout batch cultivation of 
mouse fibroblasts.
The rise in ATP^ concentration of growth 
inhibited cells correlated with the concurrent rise in 
glucose uptake rate (39%) and lactate production rate 
(22%). Taken together with the results of the metabolic 
quotient presented in Table 6.3 which illustrated an 
elevation in the ratio of the amount of glucose 
consummed to lactate produced in these cells, it is 
clear that the rise in ATP^ concentration was brought 
about by an increase in anaerobic glycoysis. Such a 
change in glucose metabolism may have been related to
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the suspected increase in the demand for maintenance 
energy.
It is also feasible that the inhibition of DNA 
synthesis may have directly contributed to the rise in 
the ATP^ concentration observed in growth inhibited 
cells. The energy consummed by DNA synthesis in rapidly 
dividing cells would be substantial as demonstrated by 
White et al. (1989). They showed that a drop of 35% in 
the total ATP^ concentration during the earlier part of 
their experiment was correlated to DNA synthesis in 
PHA-stimulated lymphocytes. Therefore an inhibition of 
DNA synthesis by possibly 60-70% as shown by the 
dramatic fall in the mean growth rate (Table 5.2; drug 
treated cultures) would bring about the release of a 
considerable amount of energy causing a rise in the 
ATP^ concentration.
Both DNA (Zetterberg and Engstrom, 1981) and 
antibody synthesis (Crawford and Cohen, 1985; Dalili 
and Ollis, 1990) have been shown to be inhibited in the 
absence of glutamine indicating that this metabolite 
plays a key role in the proper functioning of both 
biosynthetic reactions. Therefore limiting glutamine 
supplies to either process would reduced their rate of 
synthesis. It then follows that a reduction in growth 
rate (by inhibiting DNA synthesis) would be accompanied 
by an increase in glutamine availability for antibody 
synthesis. Consequently the incorporation of glutamine
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into antibody molecules would be elevated. This may be 
probable since Hayter (1989) demonstrated that the 
ratio of antibody yield/mg glutamine utilized was 
larger for cultures of low growth rate. In this 
investigation a rise in glutamine uptake rate (1 0%) was 
observed in cells which had been inhibited in their DNA 
synthetic activity (Table 6.3). An increase in the 
intracellular glutamine concentration in the absence 
of DNA synthesis would most probably cause a rise in 
CSAPR since it would represent a more favourable 
environment for antibody synthesis.
The observed and suspected changes in cell 
metabolism of the growth inhibited cells thought to 
contribute to the rise in ATP^ levels and CSAPR are 
shown in Figure 7.1 below.
Figure 7.1 : The diagram depicts the metabolic changes 
observed or suspected to have occurred in growth 
inhibited cells which may have contributed to the rise 
in intracellular ATP concentration and CSAPR.
Key:1 - Increase in glucose uptake rate2 - Increase in glutamine uptake rate3 - Increase in ATP production via anaerobic glycolysis-------->  - Indicates reduced need of metabolite
^  - Indicates increased supply of metabolite 
- Inhibition of DNA synthesis
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E. The effect of DNA synthesis inhibitors on antibody 
yield
Dalili and Ollis (1988) reported that 
growth arrested hybridoma cultures demonst r a t e d  
elevated cell specific antibody production rates. 
However, the antibody yield (final titre) of these 
cultures was either comparable to or below that 
observed for the control culture but not greater. 
Similar observations were illustrated in this 
investigation in experiment 5.2.2, chapter 5. A rise in 
the mean CSAPR of 84-135% (Table 5.2) induced by the 
inhibition of DNA synthesis with various inhibitors was 
not sufficient alone to elevate the antibody yield. The 
key factor producing this phenomenon was identified as 
being low viable cell concentration. Therefore it was
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concluded that although growth inhibited cultures on a 
per unit cell per hour basis demonstrated a greater 
capacity to produce antibody, the concentration of 
viable cells available for antibody production were not 
adequate to enhance antibody production rate (APR; 
ug/ml/hr) sufficiently to increase the yield. The 
antibody yield of hybridoma cultures is therefore 
governed, to some extent, by the viable cell 
concentration (Fazekas de St. Groth, 1983; Tolbert et 
al., 1985; Reuveny et al., 1986; Velez et al., 1987; 
Long et al., 1988). This was confirmed in a subsequent 
experiment (5.2.3) in which the elevation of maximium 
cell concentration in a growth inhibited culture from 
36.6% to 51% (of that the control culture) was 
accompanied by an increase of 40% in the mean APR and 
26% in the antibody yield above that observed for the 
control. Therefore it appears that the antibody yield 
of a culture is a function of both viable cell 
concentration and CSAPR. According to these results the 
most appropriate application for DNA synthesis 
inhibitors would be their use as agents to arrest cell 
division in dense culture systems (see section 1 .4 .2 ). 
Maintaining cultures of high-cell density in a viable 
non-proliferating state with enhanced CSAPR would 
markedly improve the yield. Much advantage could also 
be gained by their application to batch cultures, but 
modification to the existing strategy of monoclonal
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antibody production would be necessary. The 
implementation of the following two stages is suggested 
if yields are to be improved using DNA synthesis 
inhibitors;
Stage 1 ; A period allocated to generating a high
viable cell concentration. This period would cover the 
time up until mid-exponential growth phase.
Stage 2 : The application of a DNA synthesis inhibitor 
at mid-exponential growth phase to arrest cell division 
and raise CSAPR.
F . Summary
It has been demonstrated in this investigation 
that it is feasible to selectively inhibit DNA 
synthesis with the aid of specific DNA synthesis 
inhibitors without impairing antibody synthesis in 
hybridoma cells. Arresting cell division under optimum 
culture conditions proved to be most favourable for 
elevating the CSAPR. It appears that the inhibition of 
DNA synthesis under these conditions induces a 
metabolic state in MAK 33 hybridoma cells more 
favourable for antibody synthesis. The induction of 
this favourable state is associated with changes in 
cell metabolism bringing about a rise in the 
intracellular ATP concentration. The availability of 
more ATP, and possibly glutamine also, for antibody 
synthesis in these cells are proposed to be the key 
factors causing the rise in CSAPR observed.
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7.2 Recommendations
7.2.1 Studies on other cell lines
Much of the evidence presented in this 
investigation strongly suggests that the concentration 
of ATPjy and its availability for antibody synthesis 
influences the CSAPR in MAK 33 cells. Whether such 
observations are specific for this cell line alone need 
to be ascertained. This can be achieved by measuring 
the ATP^ concentration and the CSAPR simultaneously in 
other cell lines exposed to the DNA synthesis 
inhibitors used in this investigation.
7.2.2 Studies on amino acid metabolism in cells 
inhibited in DNA synthesis.
It was hypothesized from the results of this 
investigation that more glutamine may have been made 
available for antibody synthesis in growth inhibited 
cells thus contributing to the increase in CSAPR 
observed. This may also have been true for other amino 
acids essential for both DNA and antibody synthesis. 
This is probable since the supplementation of essential 
amino acids to hybridoma cultures at the onset of 
decline phase (Luan et al., 1987b) particularly, 
glutamine, valine, leucine, isoleucine and tryptophan 
(Duval et al., 1989) has been shown to enhance both 
cell viability and antibody productivity. Therefore to 
test the hypothesis it is suggested that the fate of
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glutamine and other essential amino acids in both 
growth inhibited and uninhibited culture conditions be 
analysed. This could be achieved by radiolabelling 
individual amino acids and determining their 
concentrations in DNA and antibody molecules.
7.2.3 The application of DNA synthesis inhibitors to a 
dense culture system
From the evidence presented in this investigation 
it can be inferred that a dense culture (culture with 
high cell concentration) maintained in a viable non­
proliferating state with enhanced CSAPR would represent 
the ideal conditions for producing large quantities of 
monoclonal antibody. It is proposed that this can be 
achieved by the application of a DNA synthesis 
inhibitor at a cytostatic concentration to a perfusion 
culture system during the steady-state.
This would be achieved by first establishing a 
steady-state in a hollow fibre bioreactor, then 
introducing the DNA synthesis inhibitor into the 
reactor through the medium feed bottle. Further cell 
division would be inhibited and the cells would be 
maintained in a viable, non-proliferating state with 
enhanced CSAPR until the inhibitor is removed.
The steady-state in a perfusion system does not 
represent a true 'steady-state' in which cells remain 
in a viable non-proliferating state. They are in a 
dynamic state with regard to cell proliferation but an
218
equilibrium between cell generation and cell death has 
been attained (personal communication, A. Handa, 1989). 
Therefore DNA synthesis in cells of the steady-state 
culture would still be competing for energy with 
antibody synthesis unless it was inhibited.
7.2.4 Broadening the screening programme
An overwhelming amount of evidence has been 
provided by this investigation and recently by a few 
others (Dalili and Ollis, 1988; Sherr et al., 1988; 
Teillaud et al., 1989) that inhibitors of cell growth 
(replication) enhance CSAPR. Therefore it would be 
beneficial to broaden the screening programme to 
include any compound suspected to inhibited cell 
growth, for example, culture medium constituents, some 
of which are known to inhibit cell growth at extreme 
concentrations (Oyass et al., 1989; Sato et al., 1989). 
Compounds such as the culture medium constituents 
demonstrating the ability of selectively inhibiting DNA 
synthesis may be preferred over extraneous inhibitors 
(usually anticancer drugs) for their implementation in 
a production strategy.
Information generated from these studies is 
hoped to be of value in the design of new production 
strategies directed at improving the use of energy and 
metabolite resources by hybridoma cultures for antibody 
s y n t h e s i s .
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Appendix I . Standard curves
Figures in this section are those referred to in 
chapter 2.
F igure  A: Glucose s tan d ard  curve  
(n =2, l in e a r  f i t )
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F ig u re  C: G lu tam in e  s ta n d ard  curve  
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Figure  E: C reatin e  Kinase specific  ELISA 
S ta n d ard  curve (n=4. L inear f i t )
0.20
o
o
0.05-
0.00
A ntibody conc. (nm oles)
F igure  F: ATP s ta n d ard  curve  
(n =2, lin e a r  f it )
16000 -
12000 -
5
8000-
4000 -
2520
ATP conc, (nM)
252
appendix II. Optimization of the Neutral red assay 
Shown below are the results of the optimisation of 
neutral red assay discussed in section 4.3.
Figure  A : N e u tra l re d  u p ta k e  by 4x10  cells over
a p e rio d  of 55 m in u tes . Each p o in t rep resen ts  
th e  m ean  —/ +  SD of 4 d e te rm in a tio n s .
0.25
0 .1 0 -
0.00 50 6020 30 40
Tim e (M ins)
F igure  B : N e u tra l re d  u p ta k e  by 1x10 cells in  
solutions c o n ta in in g  d iffe re n t n e u tra l  
re d  c o n cen tra tio n s .
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F igure  C : The e x tra c tio n  of n e u tra l re d  .fro m  4x10  cells by 
d iffe re n t solvents a fte r  dye u p take .
A. 60:50 (v /v )  m ix tu re  of O .IM  ace tic  acid  and e th an o l
B. 50:50 (v /v )  m ix tu re  of O .IM  NagHgPO^ and e th an o l
C. O .IM  HCL
D. 0.05M acetic  acid  and 0.5 SDS
Each p o in t rep resen ts  th e  m e an  —/4 -  SD 
of 3 d e te rm in a tio n s
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Appendix III. Optimization of the MTT assay
Shown below are the results for the optimisation 
of the MTT assay discussed in section 4.3.
Figure  A
0.70
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The p ro d u c tio n  of fo rm a z a n  by 2x 10® 
cells in c u b a ted  in  RPMI 1640 co n ta in in g  5 m g /m l  
MTT and (A) w ith o u t b ic a rb o n a te  of (B) w ith  
b ic arb o n a te . Each p o in t re p res e n ts  th e  m ean  
- / +  SD of 6 d e te rm in a tio n s .
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Figure B : The p ro d u c tio n  of fo rm a za n  by 2x10
cells in c u b a te d  in  RPMI 1640 m e d iu m  co n ta in in g  
5 m g /m l MTT, (A) w ith o u t seru m  and (B) w ith  serum . 
Each p o in t re p res e n ts  th e  m e an  - / +  SD of 6 d e te rm in a tio n s .
0.40
oCO
CO 0.30 -
oGi
0,00
D iffe re n t m e d ia
255
Figure C : The p ro d u c tio n  of fo rm a za n  by 1x10
ceils c u ltu re d  in  RPMI 1640 con ta in ing  
A) 0 .6 2 4 m g /m l MTT, (B) 1 .2 5 m g /m l MTT, 
Ç) 2 .5 m g /m l MTT , (D) 5 m g /m l MTT.
Each p o in t rep resen ts  th e  m ean  —/ +  SD 
of 6 d e te rm in a tio n s .
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Figure D : The p ro d u c tio n  of fo rm a za n  by 2x10  
cells c u ltu re d  in  RPMI 1640 m e d iu m  
co n ta in in g  5m g /m l MTT and in c u b a te d  fo r  
vario u s  t im e  in te rva ls . Each p o in t  
re p res e n ts  th e  m e an  —/4 - SD of 6 sam ples.
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Appendix IV. Compounds screened 
Listed below are the compounds screened in this 
investigation,
1. Antitumour agents
5-Fluorodeoxyuridine 5-Azacytidine 5-Azauridine
Cytoarabinoside-C 5-Aminouracil
Dacarbazine 
8-Aminoguanosine 
Prednisolone
Cytoarabinoside-A 
6-Mercaptopurine 
lododeoxyuridine 
Bromodeoxyuridine 
Aphidicoline
2. Other DNA synthesis inhibitors
Guanosine monophosphate Azathyraine 
Trifluorothymidine Colchicine
Retinoic acid
3. Other inhibitors
Cycloheximide Quinolinic acid
Cycloserine Nalidixic acid
Retinol
4. Growth constituents
Butyric acid 
Methotrexate 
Prednisone 
Hydroxyurea
2,6-Diaminopurine Melanotropin
Sodium chloride 
Potassium phosphate 
Magnesium sulphate 
Calcium chloride
Uridine 
Folic acid 
Inositol 
Adenosine
Ascorbic acid 
Thymidine
B-carotene
Azaserine
Nicotinic acid 
Riboflavin 
Cytidine 
Guanosine
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Appendix V. Results of the screening programme
Listed below are the results of some of the compounds screened to demonstrate the variation in the results observed.
Compound Concentration
Thymidine(raM)GQCSAPR (% of control)
350.910101
16.50.846118
8.250.915107
4.10.947112
21.032117
Nalidixic acid (lxlO“^M) 10 1 0.1 0.01 0.001GQ 1.118 0.970 1.271 1.021 1.176 1CSAPR (% of control) 109 103 121 157 91
5-Aminouracil (lxlO“^M) 10 1 0.1 0.01 0.0011GQ 1.019 1.0 0.956 0.933 1.01 !CSAPR (% of control) 96 90 101 103 97 1
Retinol (IxlC’^ M) 10 1 0.1 0.01 0.001GQ 1.023 1.031 1.03 1.05 0.934CSAPR (% of control) 92 94 103 105 129
Ascorbate (lxlO“^M) 10 1 0.1 0.01 0.001GQ 0.649 0.727 0.755 0.854 1,0CSAPR (% of control) 197 122 141 72 100
Trifluprothymidine (lxlO"°M) 10 1 0.1 0.01 0.001GQ 0.857 0.891 0.920 0.950 1.04CSAPR (% of control) 322 246 185 130 125
Nicotinate (IxlO'^M) 100 10 1 0.1 0.01GQ 1.097 0.921 1.0 0.954 0.886CSAPR (% of control) 108 111 112 107 137
Guanosine (lxlO”^M) 10 1 0.1 0.01 0.001GQ 1.104 1.104 1.149 1.177 1.072CSAPR (% of control) 111 100 111 88 84
Adenosine (lxlO”^M) 10 1 0.1 0.01 0.001GQ 3.28 2.62 1.35 1.23 1.30CSAPR (% of control) 55 63 74 87 95
Cycloserine (lxlO"^M) 10 1 0.1 0.01 0.001GQ 1.04 1.01 1.06 1.02 1.04CSAPR (% of control) 100 92 91 103 104
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